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Abstract 
N-Methylwelwitindolinone C isothiocyanate (7), isolated from the blue green algae 
Hapalosiphon welwitschii and Westiella intricate, is a structurally novel alkaloid related to 
the welwitindolinone family. This thesis describes studies towards the total synthesis of this 
natural product. 
 
Chapter One introduces the biological activities and the proposed biosyntheses of the 
welwitindolinone alkaloids. The synthetic studies towards the synthesis of this class of natural 
products will be also discussed. 
 
Chapter Two describes the different strategies towards the synthesis of a bicyclo[4.3.1]decane 
scaffold possessing a gem-dimethyl group present in the natural product 7. The geminal group 
was envisioned via a methyl addition to a carbonyl, a deprotonation of a sulfone or an 
intramolecular Michael addition. Generation of the desired skeleton 182 was achieved by 
using an intramolecular palladium-catalysed α-arylation of a trimethylsilyl enol ether. 
 
Chapter Three describes various attempts to the direct installation of a nitrogen functionality 
at the bridgehead position. In an indirect mode, a regioselective deprotonation allowed 
functionalisation of the desired bridgehead position and the access to isocyanate 297 and 
diketoazide 276, respectively obtained from a [3,3]-sigmatropic rearrangement and an aza-
Michael reaction. A three step sequence involving a regioselective deprotonation of 
diketoazide 276, followed by aldol condensation and dehydration led to the advance 
intermediate 306. 
 
Chapter Four describes the recent breakthrough in the synthesis of the welwitindolinone 
alkaloids. The total synthesis of N-methylwelwitindolinone D isonitrile (19) and                   
N-methylwelwitindolinone C isothiocyanate (7), along with related studies reported this year. 
 
Chapter Five includes the experimental procedures and analytical data for the preparation of 
novel compounds described during the course of this study. 
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1.1 The welwitindolinones: isolation and structural elucidation 
 
In 1994, Moore and co-workers reported the isolation of structurally unusual oxindole 
alkaloids from the lipophilic extracts of the blue green algae Hapalosiphon welwitschii W. & 
G.S. West (UH strain IC-52-3) and Westiella intricate Borzi (UH strain HT-29-1).
1
 The 
former strain was found to exhibit antifungal and multidrug resistance (MDR)-reversing 
activities, while the latter displayed insecticidal activity against blowfly larvae. Several 
alkaloids were isolated from H. welwitschii: a unique spirocyclobutane oxindole, 
welwitindolinone A isonitrile (1) and six unprecedented tetracyclic bridged 3,4-oxindoles 2-7 
(Figure 1.1). 
 
 
Figure 1.1 
The major indole alkaloid isolated from the algal extract, N-methylwelwitindolinone C 
isothiocyanate (7), was found to be responsible for the MDR-reversing activity, while 
welwitindolinone A isonitrile (1) showed fungicidal activity. 
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The absolute configuration of N-methylwelwistatin 7 was determined by X-ray 
crystallography and interestingly the relative stereochemistry of C-12, C-13 and C-15 of 
welwitindolinone A isonitrile (1) led to the hypothesis that 1 could be a biogenetic precursor 
to 2-7. In its first report,
 Moore’s group also co-isolated eight biogenetically-related alkaloids: 
these were four novel fischerindoles 8-11, the known tricyclic 12-epi-hapalindole E isonitrile 
(14) and three novel hapalindoles 12, 13 and 15 (Figure 1.2). 
 
Figure 1.2 
Moore and co-workers subsequently reported the isolation of four more highly oxidized 
welwitindolinones 16-19 from strains of cyanobacteria Fischerella musciola and Fischerella 
major, along with previously isolated compounds 1, 2 and 4 (Figure 1.3).
2
 Welwitindolinones 
16 and 17 are clearly the result of C-3 oxidation of 6 and 7, respectively, while                       
N-methylwelwitindolinone D isonitrile (19) possesses an interesting spiro-ether link as a 
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result of a more complex oxidation process. Lastly, formamide derivative 18 seemed to be an 
artefact formed from 16 during the isolation process. 
 
Figure 1.3 
To date, no biological activity has been reported in relation to these oxidised 
welwitindolinones. 
 
1.2 The welwitindolinones: biological properties 
 
1.2.1 The welwitindolinones as MDR-reversing agents  
Chemotherapy is widely utilised as a treatment of many cancers but unfortunately during the 
last few decades a major drawback of this therapy has been the ability of tumours to develop 
resistance against anticancer agents.
3
 This protective response is usually developed by tumour 
cells against chemotherapeutic agents. To understand the MDR process, extensive studies 
were conducted and revealed a correlation with the over-expression of plasma membrane 
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glycoprotein (P-gp).
4,5
 This protein was found to be located in many tissues, e.g. kidney, 
pancreas, intestine and adrenal gland and is assumed to play a role in drug regulation in the 
organism. Significant efforts were made to understand the mechanism of action of P-gp.
6
  
There are currently a variety of proposed mechanisms of action, however all models suggest 
that P-gp acts as an ATP-dependent efflux pump.
7,8
 In this process, ATP (adenosine 
triphosphate ) hydrolysis provides the required energy to P-gp to transport and expel the drug 
from the cell, thereby reducing its intracellular concentration. Therefore to limit the effects of 
MDR resistance in cancer cells, research is directed at the screening and creation of agents, 
which can interact with, and inhibit, this efflux mechanism. 
 
After isolation of the welwitindolinones, Moore and co-workers investigated their MDR-
reversing activities by using drug-resistant SK-VLB-1 and MCF-7/ADR cells (derived, 
respectively, from ovarian and breast tumours).
9
 They found that welwitindolinone 7 
demonstrated MDR-reversing efficacy towards the two different MDR cell lines. In the case 
of MCF-7/ADR, they observed the ability of 7 to chemosensitise the cells at doses as low as 
0.1 μM, which means it is 20-100 times more potent than verapamil (a standard              
MDR-reversing agent). Interestingly, at this dose, the concentration of 7 is 30-fold lower than 
its IC50, which gives it a reasonably large therapeutic index. N-Methylwelwitindolinone C 
isonitrile (6) was found to be inactive, which demonstrated the importance of the 
isothiocyanate group in the interaction with P-gp. Welwitindolinone C isothiocyanate (5, 
welwistatin) showed moderate MDR-reversing activity, but it was 25 times more cytotoxic 
than N-methylwelwistatin 7, suggesting that the presence of the methyl group might attenuate 
cytotoxicity. 
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1.2.2 The welwitindolinones as antimicrotubule agents 
Microtubules are present in cellular cytoplasm and are responsible for a variety of functions 
including organelle organisation and mitotic spindle formation.
10
 Microtubules are made up of 
straight hollow tubes that undergo constant elongation and contraction. These processes are 
dependent on the addition and loss of tubulin dimers to microtubules. Several compounds e.g. 
vinblastine, colchicines and paclitaxel disturb the dynamic equilibrium of microtubule 
assembly and disassembly, and consequently block the cell division in the mitotic phase. 
 
Antimicrotubule agents have been used as anticancer drugs but tumour cells have acquired 
resistance to many natural product antimicrotubule agents via action of the drug-efflux pump 
P-gp. To overcome this problem of drug resistance, antimicrotubule agents and P-gp 
antagonists have to be combined. 
 
Smith and Zhang discovered that welwistatin 5 disrupted microtubule formation in SK-OV-3 
human ovarian carcinoma cells and A-10 vascular smooth muscle cells.
11
 Interestingly, 
treatment of A-10 cells with welwistatin disturbs microtubule dynamics but does not cause 
irreversible loss of tubulin. Moreover, pre-treatment of A-10 cells with paclitaxel prevented 
microtubule depolymerisation in response to 5. Finally, overexpression of P-gp did not confer 
resistance to welwistatin. All of these factors contribute to indicate that welwistatin 5 has 
potential as a possible chemotherapeutic agent. This study also showed that                           
N-methylwelwistatin 7 has lower antimicrotubule activity, while N-methylwelwitindolinone C 
isonitrile (6) has similar activity to 5. 
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1.3 Biosynthesis of the welwitindolinones 
 
In addition to isolation and characterisation studies, Moore suggested a biogenesis of the 
welwitindolinones and chlorinated fischerindoles via a common intermediate,                      
12-epi-hapalindole E isonitrile (14) (Scheme 1.1).
1
  
 
Scheme 1.1 
This precursor was isolated by Schwartz and co-workers in 1987 and was found to be the 
second-most abundant alkaloid in Hapalosiphon welwitschii.
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chloronium-ion promoted polyolefin cyclisation. From this tricyclic precursor, Moore and co-
workers suggested that cyclisation of the isopropenyl group to the C-2 or C-4 positions of the 
indole ring system would lead, respectively, to fischerindole 8 or hapalindole 23. They further 
proposed that hapalindole 14 could undergo an oxidation/acid-catalysed cyclisation sequence 
to provide welwitindolinone A isonitrile (1). They also suggested that the bridged               
3,4-oxindole present in welwitindolinone B isonitrile (25) would arise from a rearrangement 
of the epoxide 24. 
 
Welwitindolinone 26 could be the common precursor to the remaining members of this 
alkaloid family. Therefore, N-methylation and appropriate oxidation could lead to the 
formation of welwitindolinones 3, 6 and 7.  Finally, the highly oxidised welwitindolinones 16 
and 19 could arise from the hydroperoxy intermediate 27, which could be obtained from a 
photocatalytic oxidation at C-3 of the oxindole 6 (Scheme 1.2). 
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Reduction of peroxide 27 would give 16 and alternatively, intramolecular epoxidation of vinyl 
chloride followed by epoxide opening and elimination of chloride would provide                  
N-methylwelwitindolinone D isonitrile (19). Surprisingly Moore and co-workers did not 
address the stereochemical conflict arising from this epoxide opening by the 3-OH oxygen. 
However, they showed that photo-oxidation of welwitindolinone 6 led to 16 and 19, albeit in 
low isolated yields, 4.9% and 3.2% respectively.
2
 
 
Baran pointed out that intermediate 22 has not been isolated, its mechanism of conversion 
into 1 seems unlikely and therefore suggested an alternative biosynthesis to welwitindolinone 
A isonitrile (1) (Scheme 1.3).
13
 
 
Scheme 1.3 
Baran suggested that the formation of welwitindolinone 1 could occur via a benzylic 
oxidation of 12-epi-fischerindole G 8 followed by an oxidative ring-contraction of               
12-epi-fischerindole I 11. Both fischerindoles 8 and 11 were initially co-isolated with the 
welwitindolinones. 
 
 
 
 
N
H
CN
H
Cl
Me
H
Me
Me
12-epi-fischerindole
G isonitrile (8)
N
H
CN
Cl
Me
H
Me
Me N
H
O
CN
Cl
H
Me
Me
Me
welwitindolinone
A isonitrile (1)
12-epi-fischerindole 
I isonitrile (11)
[o]
[o] ring
contraction
Chapter 1 
10 
 
1.4 Studies towards the synthesis of welwitindolinones 
 
The unique and fascinating structures of the welwitindolinones have attracted the attention of 
many synthetic groups. Welwitindolinone A isonitrile (1) and especially                                
N-methylwelwitindolinone C isothiocyanate (7), which possesses promising MDR-reversing 
and anticancer properties have received particular attention (Figure 1.4). The compact 
tetracyclic structure of 7 with four stereogenic centres, three quaternary carbons and two 
unusual and sensitive functionalities e.g. the isothiocyanate and vinyl chloride groups, 
represents a real synthetic challenge. 
 
Figure 1.4 
This section will review the synthetic work towards the welwitindolinones prior to the 
commencement of this project and during our studies from 2007 to 2010. The total syntheses 
of welwitindolinone A isonitrile (1) and the synthetic studies towards N-methylwelwistatin 7 
will be described. 
 
1.4.1 Previous synthetic work towards the welwitindolinones 
The first approach towards N-methylwelwistatin 7 was published by Wood and co-workers in 
1999.
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ring-opening. Thus, α-diazoketone 29 was prepared in six steps from isatin and aryl C-H 
insertion was accomplished upon treatment with Rh2(TFA)4 in the presence of the mildly 
Lewis-acidic clay Montmorillonite K-10 to yield derivative 30 in 57% yield. Subsequent 
benzylic oxidation and regioselective diazotisation furnished α-diazoketone 31 in a three-step 
sequence. Compound 31 was coupled with allyl alcohol using Rh2(OAc)4 as a catalyst to 
provide intermediate 32, which underwent cyclopropane opening to afford the seven-
membered C ring. Further manipulations, including Grignard addition, Claisen rearrangement 
and ring-closing metathesis to generate the cyclohexanone ring D, led to the first synthesis of 
the bicyclo[4.3.1]decane core structure 34 (Scheme 1.4). 
 
Scheme 1.4 
A decade later, Wood and co-workers published a second-generation synthesis.
15
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fruitless attempts to install nitrogen at the bridgehead position from alcohol 34, they turned 
their attention to a nitrone-mediated transannular [3+2] dipolar cycloaddition. The key 
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previous work on the synthesis of welwitindolinone A isonitrile (1) using chloronium ion-
induced semi-pinacol rearrangement to obtain the desired quaternary centre and neopentyl 
chlorine.
16
 After further manipulation, the target alcohol 37 was obtained in nine steps. 
Exposure to CeCl3·7H2O and NaOCl afforded the rearranged compound 38, but over- 
chlorination could not be controlled and oxindole 38 was obtained in 71% yield (Scheme 1.5). 
 
Scheme 1.5 
A second synthesis, reported by Menéndez, described the formation of the central C ring by 
ring expansion from Kornfeld’s ketone 3917 (obtained in two steps from                                 
3-(indol-3-yl)propionic acid).
18
 Thus, ketone 39 underwent ring expansion by treatment with 
ethyl diazoacetate and triethyloxonium tetrafluoroborate to give 40. Then a one-pot sequence 
involving Michael addition, intramolecular aldol condensation and N-pivaloyl hydrolysis 
provided the bicyclo[4.3.1]decane skeleton 41 in 93% yield. N-Methylation followed by 
oxidation of the secondary alcohol led to diketoester 43 (Scheme 1.6).  
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Scheme 1.6 
Two groups reported their attempts to generate the cycloheptane ring C directly via an aryl  
C-H insertion at the 4-position of an indole or oxindole ring system. 
 
First, Jung and Slowinski reported their synthetic efforts to construct the seven-membered C 
ring using rhodium(II) to catalyse the cyclisation reaction.
19 
The synthesis of diazo derivative 
44 was achieved in three steps from N-methyl indole. Unfortunately, upon treatment with 
Rh2(OAc)4, insertion of the carbenoid into the 4-position of the indole was not observed; 
instead reaction occurred at the 2- and 3-position to afford compounds 45 and 46 (Scheme 
1.7).  
 
Scheme 1.7 
Moreover, the same unwanted reactivity at the 2-position was also observed with the oxindole 
47, which afforded derivatives 48 and 49 (Scheme 1.8). 
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Scheme 1.8 
Second, Avedaño and co-workers reported the synthesis of oxindoles 52 and 53 by Michael 
addition of enamine 51 onto oxindole 50 (Scheme 1.9).
20
 They demonstrated that the 
stereoselectivity of this addition could be controlled by the temperature of the reaction. 
Unfortunately, all attempts to generate the corresponding α-diazoketone cyclisation precursor 
failed and ultimately led to the abandonment of this route. 
 
Scheme 1.9 
In 2005, Rawal reported the feasibility of generating the bicyclo[4.3.1]decane core from 
cyclohexanone derivative 54 by formation of the C-4–C-11 bond of the cycloheptane C ring 
via a palladium-catalysed intramolecular enolate arylation reaction.
21 
Thus β-ketoester 54, 
obtained in seven steps from 4-bromoindole, was treated with palladium acetate, tri-tert-
butylphosphine and potassium tert-butoxide to provide tetracycle 55. Subsequent nucleophilic 
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dealkylation using LiI and pyridine afforded carboxylic acid 56. Curtius rearrangement was 
achieved by treatment of 56 with diphenylphosphoryl azide (DPPA) to provide isocyanate 57 
(Scheme 1.10). 
 
Scheme 1.10 
In 2009, Garg and co-workers published a similar strategy in the elaboration of the 
bicyclo[4.3.1]decane skeleton. Instead of a palladium-catalysed reaction to generate the C 
ring, they relied on an indolyne cyclisation.
22
 Treatment of bromoindole precursor 58, with 
NaNH2/
t
BuOH, led to the formation of 4,5-indolyne intermediate 59 and subsequently to a 
1.2:1 mixture of 60 and O-arylated product 61 respectively (Scheme 1.11).  
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They also showed that oxidation of indole 60 to give oxindole 62 could be achieved in a   
two-step sequence. Thus, C-2 bromination with NBS followed by hydrolysis furnished 
oxindole 62 with the correct stereochemistry at C-3 (Scheme 1.12). 
 
Scheme 1.12 
In 2010, Martin reported a strategy involving formation of the cycloheptane C ring first and 
the cyclohexanone D ring second via two palladium-catalysed enolate cyclisation reactions 
(Scheme 1.13).
23
 
 
Scheme 1.13 
Coupling between vinylogous silyl ketene acetal 64 (obtained in three steps from tert-butyl 
acetoacetate) and tertiary alcohol 63 in the presence of TMSOTf provided bromoindole 
derivative 65 in 35% yield. The masked ketoester 65 was revealed by heating with methanol 
and underwent a palladium-catalysed cyclisation to afford 66 in 71% yield over two steps. 
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Desilylation, followed by a selective acetylation of the resultant primary alcohol gave 
precursor 67. The second enolate cyclisation was achieved using Pd2(dba)3 and NaH to 
generate the bicyclo[4.3.1]decane core 68 in 71% yield. Subsequent oxidative cleavage of the 
exocyclic olefin under Johnson-Lemieux conditions afforded dione 69 (Scheme 1.14). 
 
Scheme 1.14 
Konopelski and co-workers developed a strategy to form the C-4–C-11 bond using lead(IV) 
indole derivatives.
24,25
 Thus, an aryllead coupling of cyclohexanone derivative 71 with indolyl 
lead reagent 70 provided the 4-substituted indole compound 72 in excellent yield with a 
diastereoselectivity of 2:1 (Scheme 1.15). The workers planned to perform an aldol-type 
reaction in order to generate the welwistatin framework. Unfortunately, all attempts to 
generate the bicyclo[4.3.1]decane core in this way failed. 
 
Scheme 1.15 
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coupling product 74 was not observed presumably due to the increased steric hindrance 
created by the methyl and vinyl groups (Scheme 1.16).  
 
Scheme 1.16 
In 2005, our group published a rapid access to the bicyclo[4.3.1]decane framework in only 
four steps from commercially available starting materials.
26
 The strategy involved palladium 
coupling between cyclohexanone and N-methylbromoindole 75 under Buchwald conditions to 
afford the indole derivative 77. Subsequent Vilsmeier-Haack formylation gave indole 78 and 
following treatment with p-TsOH furnished an equimolar mixture of two bridged structures 
79 and 80 (Scheme 1.17).  
 
Scheme 1.17 
The formation of these two products can be explained by invoking an initial aldol 
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order to obtain only one product, the iminium could be intercepted by an appropriate 
nucleophile. Satisfyingly, conducting the cyclisation reaction of 78 in the presence of an 
external source of hydride (Et3SiH), resulted in the formation of 79 as the sole product in 92% 
yield. Conversely, in the presence of an oxidant (DDQ), only ketone 80 was obtained in a 
moderate 45% yield (Scheme 1.18).  
 
Scheme 1.18 
It has been demonstrated in the first instance that formation of the oxindole 81 could be 
achieved using NBS and 
t
BuOH, in moderate yield.
26
 The structure, confirmed by NMR 
spectroscopic studies and X-ray analysis, revealed that the C-3 stereochemistry was opposite 
to that in the natural product (Scheme 1.19). However, epimerisation of oxindole 81 can be 
achieved upon treatment with p-TsOH in THF at 50 °C. 
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Our group reported another method to obtain oxindole derivatives 81 and 82.
27
 Exposure of 
indole 79 to singlet oxygen and tetraphenylporphyrin (TPP) as sensitiser afforded unsaturated 
oxindole 83 in good yield. Subsequent hydrogenation afforded a mixture of epimeric 
oxindoles 81 and 82 (Scheme 1.20). 
 
Scheme 1.20 
Our group published the first synthesis of the welwistatin core possessing the isothiocyanate 
functional group present in the natural product.
28
 Having the key intermediate 79 in hand, two 
bridgehead deprotonations were realised sequentially to afford indole 84. Removal of the silyl 
group was followed by conversion of the ester to the corresponding carboxylic acid 85. 
Surprisingly, β-ketoacid 85 in the presence of an excess of DPPA led to azido oxazolidinone 
86 in good yield. Under basic conditions, oxazolidinone 86 undergoes ring-opening and 
subsequent removal of the resultant carbamate furnished bridgehead amine 87 (Scheme 1.21). 
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Finally, isothiocyanate 89 was obtained in good yield by exposure of the bridgehead amine 87 
to the thiocarbonyl transfer reagent 88 (Scheme 1.22). 
 
Scheme 1.22 
Lauchli and Shea described a synthesis of the welwistatin framework using an intramolecular 
Diels-Alder cyclisation as a key step.
29
 This strategy allowed the creation of the central and 
cyclohexanone rings in a single step. Indole derivative 90 was obtained in four steps from     
4-bromoindole. Oxidation of the allylic alcohol with manganese dioxide provided the indole 
derivative 91. Upon heating at 120 °C an intramolecular Diels-Alder reaction took place to 
generate the central C ring and cyclohexanone D ring in a single step giving the desired 
bicyclo[4.3.1]decane 92 in 69% yield over two steps (Scheme 1.23). 
 
Scheme 1.23 
More recently, Shea and co-workers described the synthesis of a more densely functionalised 
cycloadduct.
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 They utilised the same key step, but with inversion of the position of the diene 
and dienophile on the indole. In a one-pot sequence, 2-silyloxy indole 93 was alkylated with 
furan alcohol 94 using ZnI2 as the Lewis acid and 2,6-di-tert-butylpyridine (DTBP) as an acid 
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scavenger. The intermediate 95 underwent spontaneous intramolecular cyclisation to provide 
cycloadduct 96. Removal of the TIPS group led to a mixture of the desired enone 97 
alongside lactone 98 in a ratio of 25:1 (Scheme 1.24). 
 
Scheme 1.24 
Greshock and Funk were the first to report a strategy towards the welwistatin core not based 
on indole or oxindole derivatives.
31
 They decided to build the indole ring system using an 
annelation sequence developed in their laboratory.
32
 The synthesis started with cyclohexanone 
derivative 99, readily available form 3-methyl-3-cyclohexenone, which provided compound 
100 through a two-step sequence involving an alkylation and a cyanation. Thermal 
degradation of 100 followed by intramolecular Michael addition generated the 
cycloheptanone C ring with no epimerisation at the bridgehead position. Further 
manipulations furnished α-bromoenone 102, which underwent Stille coupling with α-stannyl 
enecarbamate 103 to afford derivative 104. Subsequent heating of compound 104 in the 
presence of DDQ led to the expected aryl system 105 (Scheme 1.25). 
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Scheme 1.25 
Boc cleavage followed by a reductive amination of the resulting aniline with glyoxylic acid 
gave intermediate 106. Indole ring formation using Ac2O and Et3N furnished tetracycle 107 
and subsequent isonitrile hydrolysis, followed by a Hoffman rearrangement afforded the 
advance intermediate 110 (Scheme 1.26). 
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Recently, Trost and McDougall reported another approach to the welwistatin core structure 
without using an indole or oxindole precursor.
33
 The sequence features the use of two 
cycloaddition reactions to obtain the desired core structure. The first key step is a palladium-
catalysed [6+3] cycloaddition between the tropone 111, obtained in four steps from anisole, 
and cyano trimethylenemethane precursor 112. This furnished 114 as a single regio- and 
diastereoisomer in good yield and high enantioselectivity (94% ee). A three-step sequence 
from the cycloadduct 114 provided furan-containing intermediate 115. Thermal [4+2] 
cycloaddition provided the Diels-Alder adduct 116 in excellent yield as a single stereoisomer. 
Upon treatment with a catalytic amount of Yb(OTf)3, ring-opening and dehydration of 
oxabicycle 116  afforded oxindole 117 in moderate yield (Scheme 1.27). 
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1.4.2 Syntheses of welwitindolinone A isonitrile 
In 2005, Baran and Richter reported the enantioselective synthesis of (+)-welwitindolinone A 
isonitrile as well as fischerindoles I and G.
13
 Creation of the key spiro-oxindole was achieved 
through an efficient oxidative ring contraction. Their synthesis started with the preparation of 
ketone 118 using (S)-carvone oxide. Subsequent enolisation of 118 followed by addition of 
indole and a source of copper(II) led to 119 as a single diastereoisomer. Upon acidic treament 
with Montmorillonite K-10, Friedel-Crafts cyclisation provided the fischerindole skeleton 
120. Transformation of the ketone to the vinyl isonitrile function led to                                 
12-epi-(–)-fischerindole I isonitrile (11) in a further three steps. Treatment with tBuOCl at      
-30 °C, followed by warming with aqueous TFA, furnished welwitindolinone A isonitrile (1) 
in 28% yield (Scheme 1.28).  
 
Scheme 1.28 
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efficient synthesis of members of the hapalindole, fischerindole, welwitindolinone and 
ambiguine families without using protecting groups.
34,35
 
 
A second synthesis of welwitindolinone A isonitrile was reported shortly after by Wood.
16,36
 
The synthesis featured a key semi-pinacol rearrangement and highlighted their previous work 
on the synthesis of spiro-oxindoles (Scheme 1.29).  
 
Scheme 1.29 
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provided isonitrile 126 and exposure to LHMDS furnished 1 as a single diastereoisomer. The 
synthesis was completed in 23 steps and 2.5% overall yield. 
 
In summary, the welwitindolinones have generated interest from many research groups and 
numerous and remarkable progress in the synthesis of the bicyclo[4.3.1]decane scaffold has 
been reported. In 2005, welwitindolinone A isonitrile (1) was independently synthesised by 
Baran and Wood as the first synthesis of a member of this family.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 1 
28 
 
1.5 References 
 
(1) Stratmann, K.; Moore, R. E.; Bonjouklian, R.; Deeter, J. B.; Patterson, G. M. L.; 
Shaffer, S.; Smith, C. D.; Smitka, T. A. J. Am. Chem. Soc. 1994, 116, 9935. 
(2) Jimenez, J. I.; Huber, U.; Moore, R. E.; Patterson, G. M. L. J. Nat. Prod. 1999, 62, 
569. 
(3) Avendaño, C.; Menéndez, J. C. Curr. Med. Chem. 2002, 9, 159. 
(4) Bellamy, W. T. Annu. Rev. Pharmacol. Toxicol. 1996, 36, 161. 
(5) Germann, U. A.; Pastan, I.; Gottesman, M. M. Semin. Cell Biol. 1993, 4, 63. 
(6) Endicott, J. A.; Ling, V. Annu. Rev. Biochem. 1989, 58, 137. 
(7) Eckford, P. D. W.; Sharom, F. J. Chem. Rev. 2009, 109, 2989. 
(8) Gottesman, M. M.; Pastan, I. Annu. Rev. Biochem. 1993, 62, 385. 
(9) Smith, C. D.; Zilfou, J. T.; Stratmann, K.; Patterson, G. M.; Moore, R. E. Mol. 
Pharmacol. 1995, 47, 241. 
(10) Keller, C. E.; Lauring, B. P. Trends Cell Biol. 2005, 15, 570. 
(11) Zhang, X.; Smith, C. D. Mol. Pharmacol. 1996, 49, 288. 
(12) Schwartz, R. E.; Hirsch, C. F.; Springer, J. P.; Pettibone, D. J.; Zink, D. L. J. Org. 
Chem. 1987, 52, 3704. 
(13) Baran, P. S.; Richter, J. M. J. Am. Chem. Soc. 2005, 127, 15394. 
(14) Wood, J. L.; Holubec, A. A.; Stoltz, B. M.; Weiss, M. M.; Dixon, J. A.; Doan, B. D.; 
Shamji, M. F.; Chen, J. M.; Heffron, T. P. J. Am. Chem. Soc. 1999, 121, 6326. 
(15) Freeman, D. B.; Holubec, A. A.; Weiss, M. W.; Dixon, J. A.; Kakefuda, A.; Ohtsuka, 
M.; Inoue, M.; Vaswani, R. G.; Ohki, H.; Doan, B. D.; Reisman, S. E.; Stoltz, B. M.; 
Day, J. J.; Tao, R. N.; Dieterich, N. A.; Wood, J. L. Tetrahedron 2010, 66, 6647. 
Chapter 1 
29 
 
(16) Reisman, S. E.; Ready, J. M.; Hasuoka, A.; Smith, C. J.; Wood, J. L. J. Am. Chem. 
Soc. 2006, 128, 1448. 
(17) Teranishi, K.; Hayashi, S.; Nakatsuka, S.; Goto, T. Synthesis 1995, 506. 
(18) Ruiz, M.; López-Alvarado, P.; Menéndez, J. C. Org. Biomol. Chem. 2010, 8, 4521. 
(19) Jung, M. E.; Slowinski, F. Tetrahedron Lett. 2001, 42, 6835. 
(20) López-Alvarado, P.; García-Granda, S.; Álvarez-Rúa, C.; Avendaño, C. Eur. J. Org. 
Chem. 2002, 1702. 
(21) MacKay, J. A.; Bishop, R. L.; Rawal, V. H. Org. Lett. 2005, 7, 3421. 
(22) Tian, X.; Huters, A. D.; Douglas, C. J.; Garg, N. K. Org. Lett. 2009, 11, 2349. 
(23) Heidebrecht, R. W., Jr; Gulledge, B.; Martin, S. F. Org. Lett. 2010, 12, 2492. 
(24) Deng, H.; Konopelski, J. P. Org. Lett. 2001, 3, 3001. 
(25) Xia, J.; Brown, L. E.; Konopelski, J. P. J. Org. Chem. 2007, 72, 6885. 
(26) Baudoux, J.; Blake, A. J.; Simpkins, N. S. Org. Lett. 2005, 7, 4087. 
(27) Boissel, V.; Simpkins, N. S.; Bhalay, G. Tetrahedron Lett. 2009, 50, 3283. 
(28) Boissel, V.; Simpkins, N. S.; Bhalay, G.; Blake, A. J.; Lewis, W. Chem. Commun. 
2009, 1398. 
(29) Lauchli, R.; Shea, K. J. Org. Lett. 2006, 8, 5287. 
(30) Brailsford, J. A.; Lauchli, R.; Shea, K. J. Org. Lett. 2009, 11, 5330. 
(31) Greshock, T. J.; Funk, R. L. Org. Lett. 2006, 8, 2643. 
(32) Greshock, T. J.; Funk, R. L. J. Am. Chem. Soc. 2006, 128, 4946. 
(33) Trost, B. M.; McDougall, P. J. Org. Lett. 2009, 11, 3782. 
(34) Baran, P. S.; Maimone, T. J.; Richter, J. M. Nature 2007, 446, 404. 
(35) Richter, J. M.; Ishihara, Y.; Masuda, T.; Whitefield, B. W.; Llamas, T.; Pohjakallio, 
A.; Baran, P. S. J. Am. Chem. Soc. 2008, 130, 17938. 
Chapter 1 
30 
 
(36) Reisman, S. E.; Ready, J. M.; Weiss, M. M.; Hasuoka, A.; Hirata, M.; Tamaki, K.; 
Ovaska, T. V.; Smith, C. J.; Wood, J. L. J. Am. Chem. Soc. 2008, 130, 2087. 
  
 
 
 
 
 
 
 
CHAPTER 2 
 
Studies towards the bicyclo[4.3.1]decane scaffold possessing 
the gem-dimethyl group 
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2.1 Aims and objectives 
 
A rapid access to the bicyclo[4.3.1]decane framework 79 and the first synthesis of 
isothiocyanate analogue 89
 
have been described by our group.
1,2
 However, in order to 
complete the total synthesis of N-methylwelwitindolinone C isothiocyanate (7), the synthesis 
of more densely functionalised core structures is required. Access to important functional 
groups still remains a challenge, such as preparing the vinyl chloride moiety, installing the   
C-12 quaternary centre possessing methyl and vinyl groups and also the gem-dimethyl at C-
16 (Figure 2.1). 
 
Figure 2.1 
The first aim of our project was to investigate the formation of the bicyclo[4.3.1]decane 
framework possessing the gem-dimethyl group. 
 
2.2 Previous studies towards the installation of the gem-dimethyl group 
 
Preliminary studies towards the synthesis of the welwistatin skeleton possessing a             
gem-dimethyl group were carried out by V. Boissel, a former PhD student in our group.
3
 
Treatment of 80 with MeLi showed that the bridging ketone is more reactive than the 
carbonyl group at C-16 towards nucleophilic attack (Scheme 2.1).  
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Scheme 2.1 
Therefore protection of this ketone was necessary to investigate introduction of a methyl 
group at C-16 and so ketone 80 was selectively protected as an acetal with ethylene glycol. 
Treatment of ketone 128 with MeMgBr or MeLi did not lead to addition of a methyl group to 
the desired position; instead it appeared that the organometallic reagent added at the less 
hindered C-2 position of the indole via a Michael addition reaction (Scheme 2.2).  
 
Scheme 2.2 
In an attempt to avoid this problem, the 2-position of the indole was blocked with a TMS 
group but ketone 130 was unreactive upon treatment with MeMgBr, and treatment with MeLi 
furnished desilylated indole (Scheme 2.3).  
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Steric hindrance within the cyclic system appeared to prevent addition of the methyl group. In 
light of these results, an alternative approach to the bicyclo[4.3.1]decane skeleton was 
considered wherein the indole ring system would possess an electron-withdrawing group 
(EWG) on the nitrogen to direct addition of Grignard reagents into the carbonyl group and to 
prevent addition at the C-2 position. For example, tosylated indole 131 was used by Rawal 
and co-workers in their synthesis of the welwistatin skeleton (Scheme 2.4).
4  
 
 
Scheme 2.4 
Therefore, the synthesis of a bicyclo[4.3.1]decane scaffold with an EWG on nitrogen, such as 
a tosyl protecting group, was envisaged and subsequent Grignard addition was anticipated. 
 
2.3 Synthesis of a bicyclo[4.3.1]decane framework possessing an electron- 
withdrawing group on the indole 
 
In order to study methylation at C-16, the synthesis of tosylated diketoindole 133 was 
proposed following the route established for the methylated indolic system (Scheme 2.5).
1 
Tosylated diketoindole 133 would be obtained from an acid-mediated cyclisation of formyl 
indole 134, which would arise from indole 135. A palladium-catalysed enolate arylation 
between tosylated bromoindole 136 and cyclohexanone would provide 135. 
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Scheme 2.5 
The synthesis began with N-tosylation of commercially available 4-bromoindole. Subjection 
of N-tosylated indole 136 to the Buchwald-Hartwig conditions previously optimised for the 
N-methyl series did not afford the coupled product 135; but instead the removal of the N-tosyl 
protecting group was observed (Scheme 2.6).
3,5 
It appeared that the use of NaO
t
Bu to generate 
the enolate from the cyclohexanone was not compatible with the tosyl protecting group. 
 
Scheme 2.6 
The palladium-mediated α-arylation of ketones has been widely investigated by Buchwald 
and Hartwig.
6,7
 Indeed, Buchwald reported that substrates bearing base-sensitive groups 
undergo the reaction using a mild base. For example, K3PO4 was used in the coupling reaction 
between aryl bromide 137 and cyclohexanone to provide 139 in good yield (Scheme 2.7).
6 
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To prevent the removal of the N-tosyl protecting group, the milder base K3PO4 was used and 
the desired coupling product 135 was isolated in 20% yield (Scheme 2.8). Even with 
extensive screening of reaction conditions (bases, palladium sources, ligands, solvents, 
temperatures) the conversion to indole 135 could not be improved. 
 
Scheme 2.8  
In 2006, inspired by the work of Kuwajima and Urabe,
8
 Hartwig
9
 and Rawal
10 
independently 
described a palladium-catalysed α-arylation of trimethylsilyl enol ethers with aryl halides. For 
example, Hartwig (Equation 1) and Rawal (Equation 2) reported coupling reactions with aryl 
halides 140 and 143 to afford 142 and 145 respectively in good yield (Scheme 2.9). 
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Interestingly, these palladium-catalysed cross-coupling reactions avoid the use of a free base 
by using a silyl enol ether as coupling partner. It was hoped that these mild reaction 
conditions might prevent N-detosylation of 136 and improve conversion to 135.
 
Thus,          
N-tosylbromoindole 136 and silyl enol ether 144 were subjected to these two cross-coupling 
conditions and the desired coupling product 135 was isolated in 16% and 28% yield, 
respectively (Scheme 2.10).  
 
Scheme 2.10 
Initial attempts to obtain 135 gave similar yields to the previous coupling reaction (Scheme 
2.8). However after screening different reaction parameters the conversion was improved. 
Under reflux (130 °C) and by using an increased amount of catalyst and ligand, the desired 
compound 135 was obtained in 63% yield (Scheme 2.11). 
 
Scheme 2.11 
Rawal suggested a plausible mechanism for this coupling reaction wherein the silyl enol ether 
144 would react with Bu3SnF to generate the tin enolate 146, which would undergo 
N
Ts
Br
N
Ts
O
Pd2(dba)3·CHCl3 (0.025 eq),
PtBu3 (0.06 eq), Bu3SnF (2 eq),
toluene, reflux
OTMS
136 144 135
28%
Pd(OAc)2 (0.03 eq), P
tBu3 (0.054 eq),
Bu3SnF (1.4 eq), CsF (1.4 eq),
toluene, 85 °C
16%
N
Ts
Br
N
Ts
O
Pd2(dba)3·CHCl3 (0.05)
 PtBu3 (0.12), Bu3SnF (2 eq)
toluene, reflux
63%
OTMS
136 144 (2 eq) 135
Chapter 2 
38 
 
transmetallation to generate the Pd-enolate species I. Reductive elimination would provide the 
coupling product III and regenerate Pd
0 
(Scheme 2.12). 
 
Scheme 2.12 
With intermediate 135 in hand, cyclisation precursor 134 was to be obtained via a formylation 
reaction. However, the Vilsmeier conditions used previously in the N-methyl series cannot be 
applied to an electron-deficient ring as the formylating agent is a weak electrophile.
11
 
Therefore, Friedel-Crafts acylation
 
of indole 135 in the presence of methyl 
dichloromethylether and AlCl3
12
 provided aldehyde 134 in 62% yield. Surprisingly, 
subsequent treatment with dry p-TsOH furnished alcohol 148 as a single diastereoisomer 
(Scheme 2.13). A mixture of ketone and diketone was expected as observed in the methylated 
series (See Section 1.4.4, Scheme 1.17)
 
but the electron-withdrawing group prevented 
disproportionation and allowed isolation of alcohol 148.  
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Scheme 2.13 
Evidence for the formation of alcohol 148 was provided by IR spectroscopy showing a broad 
stretching band for the hydroxyl  and carbonyl groups at, respectively, 3425 and 1699 cm
-1 
and mass spectrometry showed one peak at [M+Na]
+
= 418.1074 (C22H21NO4SNa requires 
418.1089). 
1
H NMR and 
13
C NMR spectroscopy confirmed the formation of tetracycle 148 
with the presence of three non aromatic CH groups. The stereochemistry at C-16 was 
determined by nOe which showed a correlation between H-16 and both H-15 and H-14. 
 
Subsequent oxidation of alcohol 148 with MnO2 gave diketone 133 in 70% yield. Protection 
of the bridging ketone furnished ketal 149 (Scheme 2.14). 
 
Scheme 2.14 
With the desired intermediate 149 in hand, the influence of the tosyl group upon the 
installation of the gem-dimethyl group from the carbonyl functionality at C-16 could be 
investigated. 
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2.4 Attempts to install the gem-dimethyl group by methyl addition 
 
Reetz and co-workers reported that geminal dimethylation of a carbonyl could be achieved in 
one step using two equivalents of (CH3)2TiCl2, generated in situ from an equimolar amount of 
TiCl4 and Zn(CH3)2. For example bis-methylated compounds 151 were obtained in good yield 
from the corresponding ketones 150 (Scheme 2.15).
13,14
 
 
Scheme 2.15 
This methodology was applied to ketone 149 but it failed to give the desired methylated 
derivative 152; only starting ketone was recovered (Scheme 2.16). The reaction was also 
attempted at room temperature, but only degradation of starting material was observed. 
 
Scheme 2.16 
In a similar fashion, Kim and co-workers reported the transformation of ketone 153 into the 
corresponding gem-dimethyl derivative 154 by using a combination of AlMe3 and TMSOTf 
(Scheme 2.17).
15 
Unfortunately, applying the reaction conditions to ketone 149 only resulted 
in the recovery of starting material even when ten equivalents of Me3Al-TMSOTf were used. 
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Scheme 2.17 
Unfortunately, installation of the gem-dimethyl could not be achieved in a single step. The 
failure could be due to steric hindrance or a low electrophilicity of the carbonyl group, which 
is better viewed as a vinylogous amide rather than a ketone. A poorly electrophilic carbonyl 
group makes the first methyl addition difficult but the second methyl addition should be 
facilitated as described by Hughes and Trauner in their synthesis (–)-frondonsin B.16 In this 
case vinylogous aryl ketone 155 did not undergo direct gem-dimethylation using Reetz’s 
procedure and so a two-step process was used. Thus, treatment of ketone 155 with MeMgBr 
provided tertiary alcohol 156, which was converted into gem-dimethyl derivative 157 in the 
presence of (CH3)2TiCl2 (Scheme 2.18). 
 
Scheme 2.18 
Intermediate 149 was treated with MeMgBr at 0 °C, which led to the formation of a new 
compound. Work-up, followed by concentration under reduced pressure, gave indoline 
intermediate 158 as a single diastereoisomer, which rapidly converted to the methylated 
indole 159 on standing. Prompt mass spectrometry of the residue showed a major peak at 
[M+Na]
+
= 476.2, which corresponded to the indoline intermediate 158 and no traces of indole 
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159. After purification only 2-methylated indole was isolated, demonstrating that the tosyl 
protecting group did not change the regioselectivity seen previously in the N-Me series 
(Scheme 2.19).  
 
Scheme 2.19 
An identical study was carried out with alcohol 160, under the assumption that the O-MgBr 
functionality would be less sterically demanding than the acetal group but unfortunately, upon 
treatment with MeMgBr, the same reactivity at C-2 of the indole ring was observed (Scheme 
2.20).  
 
Scheme 2.20 
Indoline intermediate 161 was detected by mass spectrometry with a single peak at    
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+
= 434.1 and the 
1
H NMR spectrum showed a doublet at 1.50 ppm corresponding to 
the methyl group. After three days indoline 161 was oxidised to the corresponding indole 162, 
the 
1
H NMR spectrum showed a characteristic singlet at 3.05 ppm due to the methyl group at 
C-2. 
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Considering the cage-like shape of the bicyclo[4.3.1]decane system, it appeared that steric 
hindrance was preventing Grignard addition to the carbonyl even with the presence of an 
electron-withdrawing group on the indole. 
 
2.5 Attempts to install the gem-dimethyl group using sulfone chemistry 
 
In an alternative approach to the installation of the gem-dimethyl group, the presence of an 
EWG, which also had to be capable of acting as a leaving group, was envisaged in order to 
change the reactivity at C-16. Thus, gem-dimethyl derivative 163 would arise from precursor 
166 by deprotonation at C-16 and treatment with MeI to give monomethylated intermediate 
164. Transformation of the electron-withdrawing group would lead to gem-dimethyl ketone 
163 (Scheme 2.21). 
 
Scheme 2.21 
Petrini and co-workers have reported examples of α-deprotonation of sulfone 167, followed 
by trapping with a wide range of electrophiles.
17 
For example, deprotonation of sulfone 167 
was achieved with sodium hydride and trapping with butyl iodide gave 168 in good yield 
(Scheme 2.22). 
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Scheme 2.22 
In a different report, they showed that it was possible to remove the sulfone group and replace 
it with a methyl group by treating indole 169 with three equivalents of MeMgBr. The first 
equivalent of MeMgBr is used to deprotonate the indole and cleave the sulfone group to 
generate the corresponding iminium, which can react with a second equivalent of MeMgBr to 
provide 170 (Scheme 2.23).
18 
 
 
Scheme 2.23 
Petrini also described the formation of sulfone 173, which was obtained from indole 171. 
Condensation with acetone followed by dehydration led to iminium intermediate 172, which 
could react with p-toluenesulfinic acid (p-TolSO2H) to provide sulfone 173 in good yield 
(Scheme 2.24).
19 
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Inspired by Petrini’s work, we suggested that a tosyl group at C-16 could be synthetically 
useful. The sulfone derivative 174 would be generated from dehydration of 148 and treatment 
of the iminium intermediate with p-TolSO2H (Scheme 2.25). 
 
Scheme 2.25 
Gratifyingly, a one-pot reaction involving ring-closure/dehydration/tosylation proved possible 
by heating a solution of aldehyde 134 at reflux in the presence of p-TolSO2H and p-TsOH in 
CH2Cl2, to give sulfone 174 in 61% yield as a single diastereoisomer (Scheme 2.26). 
Evidence for the formation of the bicyclo[4.3.1]decane derivative 174 was provided by 
1
H 
NMR and 
13
C NMR spectroscopy showing the presence of three non-aromatic CH groups as 
observed in the previous cyclised product 148. The incorporation of the tosyl group was 
supported by mass spectrometry  ([M+Na]
+
= 556.1220) and 
1
H NMR spectroscopy, which 
showed two singlets at 2.31 and 2.32 ppm, which each integrated for three protons and were 
attributed to the methyls of the tosyl groups. Identically to 148, nOe analyses showed a 
correlation for H-16 with H-15 and H-14. 
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Protection of the bridging ketone as a ketal was attempted without success and this is 
probably due to the steric hindrance generated by the presence of the tosyl group at C-16 
(Scheme 2.27). 
 
Scheme 2.27 
Preliminary investigations to probe the α-deprotonation of the sulfone 174 were encouraging. 
Treatment of sulfone 174 with sodium hydride followed by trapping with deuterium oxide 
afforded the deuterated derivative 177 (Scheme 2.28). 
 
Scheme 2.28 
Unfortunately, repeating the reaction with methyl iodide as the electrophile failed to provide 
the desired product 178 and only starting sulfone 174 was detected by 
1
H NMR spectroscopy 
(Scheme 2.29).  
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The failed installation of the methyl group to the core structure was probably due to steric 
hindrance. As we were unable to install the first methyl at C-16, this route was abandoned. 
 
2.6 Synthesis of cyclisation precursors bearing the gem-dimethyl group 
on the cyclohexanone ring 
 
An alternative strategy was considered wherein the cyclisation precursor would bear the   
gem-dimethyl group. This approach was based on an intramolecular Michael addition of 
enone 179 or 180 possessing the gem-dimethyl on the cyclohexanone ring to provide 
tetracycle 181 or 182, respectively (Scheme 2.30).  
 
Scheme 2.30 
During the course of this study, Garg and co-workers reported, an iodine-promoted Michael 
addition between 5-bromoindole 183 and tetrasubstituted enone 184 to furnish 58 in good 
yield (Scheme 2.31).
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The preparation of cyclisation precursors 179 and 180 was envisaged using a           
palladium-catalysed cross-coupling reaction. Previous work in our group had showed that in 
one case, the more complex cyclohexanone 185 underwent a coupling reaction with              
N-methylated bromoindole 75 (Scheme 2.32).
21
 
 
Scheme 2.32 
During the attemped installation of the gem-dimethyl group with an indole possessing an 
EWG on nitrogen (see Section 2.3), the cross-coupling reaction with functionalised 
cyclohexanones was studied to enable access to various functional groups present in the 
natural products. Thus, the coupling reaction between silyl enol ether 188, obtained from the 
corresponding enone 187, and bromoindole 136 afforded the derivative 189 (Scheme 2.33). 
 
Scheme 2.33 
Several other coupling products were synthesised to examine the scope of this cross-coupling 
reaction. Thus, silyl enol ethers 190, 192 and 194, obtained from the corresponding ketones, 
provided the enone 191, ketal 193 and enol 195 respectively. Silyl enol ether 196, obtained 
from an acyloin reaction, furnished the alcohol 197 (Table 2.1). These results demonstrated 
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that this cross-coupling reaction permitted the introduction of different functionalities on the 
cyclohexanone ring. 
Entry Silyl enol 
ether 
Product Yield 
(%) 
Entry Silyl enol 
ether 
Product Yield 
(%) 
 
 
1 
   
 
52 
 
 
3 
   
 
49 
 
 
2 
   
 
57 
 
 
4 
   
 
18 
 
Table 2.1  
In order to activate the indole ring, removal of the tosyl group was realised by treatment of 
tosylindole 189 with cesium carbonate in a mixture THF/MeOH to provide 179 (Scheme 
2.34). 
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The second cyclisation precursor 180 was obtained from α-arylation of silyl enol ether 188 
with indole 75 (Scheme 2.35). 
 
Scheme 2.35 
The two cyclisation precursors 179 and 180 were treated with I2 in methanol
22
 but no traces of 
Michael product 181 or 182 were observed and only the starting enones were detected 
(Scheme 2.36). Alternative modes of activation were also examined (e.g. Bi(OTf)3,
23,24
 
ZrCl4,
25
 InCl3
26
 or phosphoric acid
27
) but unfortunately without success. 
 
Scheme 2.36 
The failure of the Michael reaction to generate the bicyclo[4.3.1]decane ring system may be 
explained by considering the position of the bulky N-methylindole in an equatorial orientation 
on the cyclohexanone (A). Therefore C-3 of the indole and the β-position of the enone are 
kept distant from each other. The conformer B, in which the indole ring is placed axially, is 
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of enol C might be favoured and this would compromise formation of the seven-membered 
ring system (Figure 2.2). 
 
 
 
 
Figure 2.2 
Although palladium-catalysed cross-coupling with pre-functionalised cyclohexanones was 
developed, and allowed access to enones 179 and 180 possessing the gem-dimethyl group on 
the cyclohexanone ring, the formation of the bicyclo[4.3.1]decane skeleton via an 
intramolecular Michael addition was unsuccessful.  
 
2.7 Synthesis of cyclisation precursors bearing the gem-dimethyl group 
on the indole 
 
Another route towards the core structure would involve the synthesis of a cyclisation 
precursor possessing the gem-dimethyl group as part of an oxindole. The desired 
bicyclo[4.3.1]decane core would be obtained by ring closure of isopropylidene 199 via 
intramolecular Michael addition, for example (Scheme 2.37). 
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The previously described palladium-catalysed α-arylation reaction between N-methylindole 
75 and cyclohexanone was realised in 76% yield.
3 
Oxidation of indole 77 to give an oxindole 
was achieved using NBS in a mixture of 
t
BuOH/H2O. The product, oxindole 200, was 
obtained in 57% yield (Scheme 2.38). 
 
 
Scheme 2.38 
Alternative methods to improve the efficiency of the oxidation step were tested. First, Savige 
and Fontana reported oxidation of tryptophan-containing peptides and proteins using 
concentrated HCl and DMSO.
28 
This procedure was applied to indole 201 by Jung and co-
workers during their study towards the welwistatin core structure (Scheme 2.39).
29 
Unfortunately, under these conditions rapid degradation of indole 77 was observed, although 
traces of oxindole 200 were detected by 
1
H NMR spectroscopy. 
 
Scheme 2.39 
Yadav and co-workers reported the use of IBX in the presence of CeCl3·7H2O to afford the 
corresponding isatin derivative.
30
 This methodology could be interesting with regard to the 
installation of the desired gem-dimethyl group.
 
Indole 77 was subjected to these oxidation 
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conditions and afforded the desired isatin derivative 203 in only 26% yield, along with 
oxindole 200 in 11% yield (Scheme 2.40). 
 
Scheme 2.40 
Efforts to improve the conversion of indole 77 into oxindole 200, or alternatively into isatin 
derivative 203, were unsuccessful. The use of NBS in a mixture of 
t
BuOH/H2O proved to be 
the most efficient access to oxindole 200 (Scheme 2.38).  
 
With the desired oxindole 200 in hand, installation of the gem-dimethyl group might be 
realised in one step by condensation with acetone. In the synthesis of marcfortine B, Trost 
described condensation of acetone with oxindole 204 under acidic conditions (Scheme 
2.41).
31 
He also reported an alternative procedure using acetone and ethanol in piperidine.
32 
 
Scheme 2.41 
Unfortunately, oxindole 200 was unreactive under both sets of reaction conditions and 
therefore formation of the desired isopropylidene 199 was not observed (Scheme 2.42). 
Formation of the isopropylidene might be hampered by the presence of the bulky 
cyclohexanone at C-4 of the indole ring. 
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Scheme 2.42 
Bordwell and Fried measured equilibrium acidities of several heterocyclic compounds in 
DMSO and this study revealed a pKa value of 18.5 for the 3-position of N-methyloxindole.
33
 
Therefore, selective deprotonation of oxindole was anticipated to install the gem-dimethyl 
group onto the oxindole ring via an aldol reaction. Treatment of oxindole 200 with LHMDS 
followed by addition of acetone showed formation of a new compound by TLC and 
1
H NMR 
spectroscopic analysis of the crude material. After purification, only the starting oxindole was 
recovered in 82% yield, probably due to the desired alcohol 206 undergoing a retro-aldol 
process (Scheme 2.43). 
 
Scheme 2.43 
A Mukaiyama condensation with an acetal was envisaged
 
to overcome this retro-aldol 
problem.
34
 Mukaiyama described a method where the use of a silyl enol ether avoids the 
problem of self-condensation in the aldol reaction.
35
 For example, silyl enol ether 144 
underwent condensation with trimethyl orthoformate in the presence of TiCl4 to give ketal 
207 (Scheme 2.44). The gem-dimethyl group could potentially be installed on the oxindole 
ring using this approach with an appropriate ketal reagent such as 2,2-dimethoxypropane. 
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Scheme 2.44 
When oxindole 200 was treated with one equivalent of TBDMSOTf and triethylamine, the 
formation of indole silyl enol ether 208 was achieved. The use of two equivalents of 
TBDMSOTf and triethylamine generated bis-enol silane 209 (Scheme 2.45). 
 
Scheme 2.45 
Interestingly, the bis-enol silane 209 might be useful to access the bicyclo[4.3.1]decane core 
structure via a cascade Mukaiyama reaction. For example, Kuwajima and co-workers reported 
direct formation of bicycle 211 via a Mukaiyama reaction using SnCl4 and an aromatic acetal. 
Thus, a five-membered ring was generated from bis-silyl enol ether 210 (Scheme 2.46).
36
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The use of 2,2-dimethoxypropane and SnCl4 with our bis-silyl enol ether 209 resulted in 
cleavage of both silyl enol ethers. However, upon treatment with TiCl4 the condensation 
product 212 was isolated as a mixture of diastereoisomers in 66% yield, alongside desilylated 
oxindole 200 in 16% yield (Scheme 2.47). Unfortunately, the desired cyclised product was 
not detected. 
 
Scheme 2.47 
The use of milder Lewis acids such as BF3·Et2O and ZnCl2 was also investigated. Treatment 
of 209 with BF3·Et2O led to the formation of condensation product 212 in 26% yield 
alongside desilylated oxindole 200 in 25% yield. The use of ZnCl2 afforded condensation 
product 213 in 27% yield alongside monosilylated oxindole 214 in 50% yield (Scheme 2.48).  
 
Scheme 2.48 
Unfortunately, in both reactions the desired bicyclo[4.3.1]decane product was not observed 
and formation of the isopropylidene was then investigated. 
 
Elimination of the methoxy group was attempted under acidic conditions. Oxindole 212 was 
treated with p-TsOH or TFA but showed no traces of elimination product 199 or cyclised 
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derivative 198, and oxindole 200 was formed instead (Scheme 2.49). Unfortunately, basic 
treatment with DBU only provided epimerisation at the 3-position of the oxindole. 
 
Scheme 2.49 
All attempts to synthesise the intermediate 199 from oxindole 200 or 212 were fruitless. 
These results could be rationalised by the steric hinderance between the methyl group and the 
cyclohexanone at the 4-position, which prevents the formation of the double bond.  
 
Unfortunately, the installation of the gem-dimethyl group at C-16 in a novel way failed to 
work and a reordering of the steps in the synthesis was envisioned to generate the 
bicyclo[4.3.1]decane skeleton. 
 
2.8 Synthesis of the bicyclo[4.3.1]decane framework possessing the gem-
dimethyl group 
 
In order to progress towards the synthesis of N-methylwelwistatin 7, the synthesis of the 
known intermediate 215, described by Rawal, was envisaged (Scheme 2.50).
4
 The core 
structure 182 would then be obtained by an intramolecular palladium-catalysed enolate 
arylation. 
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Scheme 2.50 
Direct access to the desired intermediate 215 employing a Michael addition reaction was 
investigated; thus 4-bromoindole 75 and enone 187
37 
were subjected to various Lewis acids 
e.g. ZrCl4,
25
 RuCl3,
38
 Yb(OTf)3.
39
 Unfortunately, formation of the desired compound 215 was 
not observed; TLC and 
1
H NMR spectroscopic analysis showed only the presence of starting 
materials (Scheme 2.51). The steric hinderance generated by the bromine atom at the            
4-position might be responsible for the failure of the Michael addition to the enone 187. 
Moreover during these studies, the same observation was reported by Garg.
20
 
 
Scheme 2.51 
The synthesis of oxindole derivative 219 was also attempted. N-Methylation of 4-bromoisatin 
followed by reduction with hydrazine provided oxindole 217. Enol silane 218 was obtained 
by treatment with TBDMSOTf and triethylamine. Subsequent treatment with different Lewis 
acids e.g. TiCl4, SnCl4, BF3·Et2O, ZnCl2, TBDMSOTf and Cu(OTf)2 in the presence of enone 
187 resulted only in desilylation of 218 (Scheme 2.52). 
Me
Me
N
Me
O
Me
Me
N
Me
Br
215
N
H
Br
182
O
N
Me Me
Me
O
N
Me
Me
Me
21518775
Lewis acid
Br
Br
O
Chapter 2 
59 
 
 
Scheme 2.52 
Finally, the synthesis of derivative 215 was obtained following Rawal’s synthesis (Scheme 
2.53).
4
 
 
Scheme 2.53 
Thus, Friedel-Crafts acylation of 4-bromoindole and N-tosylation provided indole derivative 
131. Subsequent treatment with MeMgBr followed by alkylative coupling with silyl enol 
ether derivative 144 promoted by TiCl4 gave the intermediate 221. After removal of the tosyl 
protecting group, N-methylation was realised to yield derivative 215. 
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With precursor 215 in hand, our standard conditions for the palladium-catalysed enolate 
arylation (previously described) and also Rawal’s conditions were tested in order to generate 
the desired bicyclo[4.3.1]decane. Unfortunately, under these conditions the desired cyclised 
product was not observed (Scheme 2.54). This could conceivably be due, under 
thermodynamic conditions, to formation of the thermodynamic enolate, which compromised 
the formation of cyclised product 182. 
 
Scheme 2.54 
To favour formation of the desired enolate intermediate, kinetic silyl enol ether 222 was 
generated with KHMDS and trapped with TMSCl. Thus, cyclisation via the correct silyl enol 
ether could be anticipated. Rawal
10
 and Hartwig
9
 cross-coupling conditions were tried. This 
time, Hartwig’s procedure provided a cleaner reaction and after purification, tetracycle 182 
was isolated in 83% yield (Scheme 2.55). 
 
Scheme 2.55 
The synthesis of the desired bicyclo[4.3.1]decane scaffold possessing the gem-dimethyl group 
was achieved in eight steps from 4-bromoindole by using the first steps of Rawal’s approach.4 
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Thus, the formation of the tetracycle 182 was accomplished via an intramolecular palladium-
catalysed α-arylation of the trimethylsilyl enol ether 222.  
 
2.9 Summary 
 
We demonstrated that the important gem-dimethyl group at C-16 could not be introduced by 
using our initial disconnection approach with a tosyl group on nitrogen. Moreover any 
attempts to obtain the bicyclo[4.3.1]decane skeleton via an intramolecular Michael addition 
reaction were fruitless. However, a successful synthesis of the tetracycle 182 possessing the 
desired gem-dimethyl group at C-16 was obtained in eight steps from commercially available                  
4-bromoindole. 
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CHAPTER 3 
 
Progress towards the total synthesis of 
N-methylwelwitindolinone C isothiocyanate 
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3.1 Aims and objectives 
 
With bicyclo[4.3.1]decane core 182 possessing the gem-dimethyl moiety in hand, a new route 
to the isothiocyanate functionality was investigated to enable installation of the required 
group in a shorter sequence. This chapter will focus on the installation of nitrogen 
functionality at the bridgehead position and progress towards installation of the methyl and 
vinyl groups at C-12. 
 
3.2 New synthetic approach towards the isothiocyanate group 
 
Previous studies in our group demonstrated the synthesis of the bridgehead isothiocyanate 
derivative 89 in five steps from ester 223 via a Curtius rearrangement (Scheme 3.1).
1 
 
Scheme 3.1 
A shorter route to the required isothiocyanate group was proposed via direct introduction of a 
nitrogen at the bridgehead position. Two routes were investigated for installation of the 
nitrogen, employing either regioselective bridgehead deprotonation of tetracycle 182 or 
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cyclisation of α-ketoazide derivative 228. Azide derivative 227 could then be converted into 
isothiocyanate 226 (Scheme 3.2). 
 
Scheme 3.2 
The choice of an azide functionality was influenced by the work of Isoda and co-workers, 
who reported the transformation of azides into isothiocyanates in one step by a tandem 
Staudinger/aza-Wittig reaction.
2 
For example, isothiocyanate derivative 230 was obtained in a 
single step from the corresponding azide 229 (Scheme 3.3). 
 
Scheme 3.3 
With an azide group at the desired bridgehead position, access to the isothiocyanate 
functionality should therefore be possible in one step instead of five. 
 
3.2.1 Cyclisation attempts to introduce nitrogen at the bridgehead position 
The synthesis of bridgehead azide 227 was first envisaged via cyclisation of α-ketoazide 228, 
which would be generated through the nucleophilic substitution of α-bromoketone 231 with 
sodium azide. Ketone 231 could in turn be derived from enol silane 222 described previously 
(Scheme 3.4). 
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Scheme 3.4 
α-Bromoketone 231 could be synthesised following the literature example of Harrowven and 
co-workers who showed that kinetic silyl enol ether 233 in the presence of NBS provided     
α-bromoketone 234 in good yield (Scheme 3.5).3 
 
Scheme 3.5 
Silyl enol ether 222 was treated with NBS to provide α-bromoketone 231 in a quantitative 
yield as a mixture of diastereoisomers. Azide 228 was obtained in 57% yield as a mixture of 
diastereoisomers by treatment of 231 with sodium azide (Scheme 3.6). 
 
Scheme 3.6 
Surprisingly, the corresponding enamine 235 was also observed and isolated in 12% yield. 
The formation of an enamine derivative was also observed by Hazra and co-workers, in this 
case during the transformation of α-bromo ketone 236 into the corresponding azide 237 in 
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64% yield.
4
 Although, α-ketoazides are known to be unstable under basic conditions,5 a large 
excess of sodium azide is required to form enamine 238 from 237 (Scheme 3.7).  
 
Scheme 3.7 
The formation of enamine 235 is proposed to occur by loss of molecular nitrogen to afford   
α-iminoketone 240, which undergoes a subsequent tautomerisation (Scheme 3.8).4 
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Treatment of α-bromoketone 231 with a large excess of sodium azide in DMF at 100 °C 
furnished 235 in 44% yield alongside unidentified degradation products (Scheme 3.9).  
 
Scheme 3.9 
The tendency of the α-ketoazide 228 to generate the corresponding enamine rather than to 
undergo enolisation and coupling might be an issue for the cyclisation reaction. Indeed, when 
azide 228 was submitted to Rawal’s conditions using the mild base Cs2CO3, cyclised product 
227 was not observed and instead rapid formation of enamine 235 occurred (Scheme 3.10). 
 
Scheme 3.10 
α-Arylation of the corresponding silyl enol ether from azide 228 could be envisaged but there 
are no reported examples of formation of a silyl enol ether from an α-ketoazide possessing a 
hydrogen at the β-position. This is probably due to instability of the azide as described above. 
Although the synthesis of bridgehead azide 227 using α-ketoazide 228 was unsuccessful, the 
use of enamine 235 could be envisaged. The bicyclo[4.3.1]decane system possessing a 
nitrogen at the bridgehead position might be accessed via an intramolecular cyclisation under 
Heck or radical conditions to provide respectively derivatives 242 or 243 (Scheme 3.11). 
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Scheme 3.11 
The challenge of these approaches would be the generation of a quaternary centre via a         
7-exo-trig cyclisation. Formation of a seven-membered ring fused to an aromatic ring by a 
radical reaction is relatively rare and of those reported, most proceed in moderate yield.
6 
For 
example, Jones and co-workers reported a 7-exo-trig cyclisation of bromobenzene derivative 
244 providing 245 in 25% yield along with a 60% yield of the reduced compound arising 
from the 1,5-H transfer (Scheme 3.12).
7
 
 
 
 
Scheme 3.12  
Another point to consider was the regioselectivity of the cyclisation induced by a protected   
α-ketoenamine function. Interestingly, Parsons and Williams demonstrated the formation of 
tetracycle 247 as the major compound through a 5-exo/5-exo tandem reaction of aryl bromide 
derivative 246 (Scheme 3.13).
8
  
 
 
 
 
Scheme 3.13  
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These results encouraged us to examine the feasibility of a radical cyclisation reaction to 
generate the bicyclo[4.3.1]decane framework and therefore prior to any cyclisation 
investigations, enamine 235 was protected as the formylated derivative 249 (Scheme 3.14). 
 
Scheme 3.14 
Radical initiation was attempted on protected enamine 249 using tri-n-butyltin hydride and 
AIBN in refluxing toluene. Unfortunately, cyclisation product 250 was not detected from      
7-exo-trig mode and only reduced compound 251 was isolated in 25% yield (Scheme 3.15). 
 
Scheme 3.15 
This result provides evidence that the aryl radical species D is formed but that it does not add 
to the enamine double bond. Considering the possibilities of 1,5-H-abstractions, either at the 
α-position to the ketone or at the geminal methyls, the desired cyclisation reaction might be 
hampered (Figure 3.1). 
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Figure 3.1 
Alternatively, the desired seven-membered ring could be envisioned to be formed by Heck 
cyclisation of the enamine 249. Like radical cyclisation, Heck intramolecular cyclisation is 
well documented for the preparation of five- and six-membered rings by 5-exo-trig and         
6-exo-trig cyclisation processes.
9
 Encouragingly, several reports described a palladium-
mediated 7-exo-trig cyclisation; for example, bromoindole 252 was shown to undergo an 
intramolecular Heck reaction to give cyclised product 253 in excellent yield (Scheme 3.16).
10
 
 
Scheme 3.16 
The nature of our olefin could be an issue because it possesses both enamine and enone 
character. Gibson and Middleton reported the synthesis of 7-, 8- and 9-membered rings via 
endo Heck cyclisations.
11
 Cyclisation of iodobenzene derivatives 254 using vigorous Heck 
reaction conditions generated 255 arising from the 7-endo cyclisation, whereas products 256 
and 257 are derived from the 6-exo cyclisation (Scheme 3.17).  
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Scheme 3.17 
With our substrate, two sources of palladium were tested, namely Pd(PPh3)2Cl2 and 
Pd(OAc)2.  Transformation occurred only with Pd(PPh3)2Cl2 and the isolated product was the 
bicyclo[4.2.2]decane 259 arising from 8-endo cyclisation (Scheme 3.18). 
 
Scheme 3.18 
Evidence for the formation of 259 was provided by mass spectrometry, which showed one 
peak at [M+Na]
+
= 333.1573 ([C19H22NO2Na]
+ 
requires 333.1579). Moreover, the 
13
C NMR 
spectrum showed the presence of two CH2 groups at 21.0 and 25.0 ppm and three CH groups 
at 41.4, 55.9 and 56.9 ppm. 
1
H NMR spectroscopy showed the absence of alkene 
functionality, instead a broad singlet at 5.84 ppm (NHCHO), a triplet at 5.14 ppm (J = 6.5 Hz, 
H-11) and the characteristic multiplet of the benzylic proton at 3.91-3.98 ppm were observed. 
The stereochemistry of the formamide substituent was determined by nOe showing for H-11 a 
correlation with H-12 and H-14, which interestingly proved that the cyclohexanone adopts a 
boat conformation.  
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In summary, attempts to generate the bicyclo[4.3.1]decane system from either α-ketoazide 
228 or enamine 249 failed. Firstly, α-ketoazide 228 was found to be unstable to basic 
conditions. Secondly, enamine 249 gave the reduced derivative 251 under radical conditions 
and the undesired 8-endo cyclisation product 259 under Heck reaction conditions. 
 
3.2.2 Attempts to install an azide group at the bridgehead position 
An alternative approach to bridgehead azide 227 was envisioned via bridgehead deprotonation 
and quench with an electrophilic source of azide such as tosyl azide (Scheme 3.19). 
 
Scheme 3.19 
Previous work in our lab demonstrated bridgehead metallation of the model system 79 was 
possible.
12
 The kinetic bridgehead enolate was generated with LTMP and trapped with 
TMSCl.
13
 Subsequent deprotonation of the second bridgehead position followed by reaction 
with methyl chloroformate provided ester 84 (Scheme 3.20). 
 
Scheme 3.20 
The presence of a gem-dimethyl group at C-16 in the tetracycle 182 could reverse the 
preference for bridgehead metallation and allow direct functionalisation at the benzylic 
position. In order to study the regioselective deprotonation of 182, previous studies on the 
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simpler system were reproduced. Indeed, treatment of tetracyle 79 with ten equivalents of 
LTMP in the presence of ten equivalents of TMSCl (in situ quench) provided silylation at 
both bridgehead positions in 71% yield (Scheme 3.21).
1
  
 
Scheme 3.21 
In the same fashion, tetracycle 182 was treated with ten equivalents of the bulky lithium 
amide, LTMP, in presence of ten equivalents of TMSCl. The formation of doubly silylated 
product was not observed under these conditions and mono-silylated indole 262 was isolated 
in 60% yield alongside a 28% yield of unreacted tetracycle 79 (Scheme 3.22).  
 
Scheme 3.22 
In light of this result, direct installation of nitrogen at the bridgehead position was envisaged 
in the form of an azide group. Kühlein and Jensen reported the first electrophilic azide 
transfer onto an enolate using a sulfonyl azide.
14 In this study, β-lactam 263 was sequentially 
treated with LDA and tosyl azide to form intermediate adduct 264. Subsequent treatment with 
TMSCl gave α-azide 265 in moderate yield (Scheme 3.23). 
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Scheme 3.23 
Inspired by Kühlein and Jensen’s work, Evans developed an asymmetric version and 
described optimal conditions to achieve the azide transfer.
15
 The screening of several reaction 
parameters first showed that a potassium enolate minimises side reactions between the enolate 
and the sulfonyl azide. Second, the use of the sterically bulky trisyl azide prevents the 
formation of the corresponding diazo-transfer product. Lastly, quenching the reaction with a 
simple proton source i.e. glacial acetic acid gave the best conversion to azidation products. 
Applying these optimal conditions to the carboximide 266 furnished the corresponding azido 
product 267 in excellent yield and diastereoselectivity (Scheme 3.24).  
 
Scheme 3.24 
In order to avoid steric congestion of the bulky trisyl azide, tosyl azide was used as the 
electrophile. Treatment of 182 with LTMP followed by quenching with tosyl azide did not 
afford the desired azide 227, and only starting material detected by 
1
H NMR spectroscopy 
(Scheme 3.25). 
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Scheme 3.25 
Kita and co-workers have described direct azidation of the benzylic position of several          
p-alkylanisole derivatives under radical conditions
16 
by
 
using PhI(OCOCF3)2 and TMSN3. 
Benzylic azide 269 was prepared in this fashion in 73% yield (Scheme 3.26). Unfortunately, 
tetracycle 182 was unreactive to these conditions. 
 
Scheme 3.26 
Although the bicyclo[4.3.1]decane derivative 182 was regioselectively metallated and 
functionalised at the bridgehead position with a TMS group, installation of an azide group 
using electrophilic azide reagents proved to be fruitless. 
 
3.3 Indirect installation of an azide group at the bridgehead position 
 
3.3.1 New strategies and retrosynthesis 
New strategies were explored to install nitrogen at the desired C-11 position of the 
bicyclo[4.3.1]decane framework. The synthesis of a bridgehead alkene was previously 
described by our group.
12
 Thus, oxidative elimination of selenide 270 using m-CPBA afforded 
bridgehead alkene 271 in 66% yield (Scheme 3.27).
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Scheme 3.27 
The synthesis of bridgehead alkene 275 possessing the gem-dimethyl group was envisaged 
and synthesis of azide 272a and 276 could subsequently be investigated. Inspired by Renaud’s 
radical methodology to form carbon-nitrogen bonds,
17
 azide 272a might be obtained from 
radical cyclisation of iodoester 273 followed by trapping with a sulfonyl azide. Alternatively, 
it was anticipated that the alkene group of enedione 277 would not be conjugated with the 
bridging ketone due to strain in the structure. Therefore, bridgehead azide 276 could be 
generated via a regioselective aza-Michael addition of an azide to 277 (Scheme 3.28). 
 
Scheme 3.28 
In both cases, a common intermediate, the allylic alcohol 274, could conceivably be accessed 
from bridgehead alkene 275. 
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3.3.2 Synthesis of oxidised bridgehead alkenes 
Studies on enantioselective bridgehead deprotonations, carried out by our group showed the 
possibility of fluoride-mediated silyl exchange to introduce various substituents.
18 
Treatment 
of 278 with tetrabutylammonium triphenyldifluorosilicate (TBAT),
19
 a non-hygroscopic 
source of fluoride, in the presence of various electrophiles, resulted in the formation of 
ketones 279-281 (Scheme 3.29). 
 
Scheme 3.29 
Therefore the use of silyl ketone 262, described previously (see Section 3.2.2), might enable 
the synthesis of selenide 282. Indeed, treatment of silyl ketone 262 with TBAT in the 
presence of diphenyl diselenide afforded bridgehead selenide 282 in a moderate 54% yield. 
Oxidative elimination using m-CPBA provided bridgehead alkene 275 in 75% yield (Scheme 
3.30). 
 
Scheme 3.30 
Attempts to install an azide using TsN3 as the electrophile were unsuccessful and only 
desilylated compound 182 was observed by 
1
H NMR spectroscopy. 
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To our surprise, initial studies of regioselective bridgehead deprotonation of 182 followed by 
an external quench with diphenyl diselenide to obtain 282 proved to be difficult with only 
traces of the desired compound observed by 
1
H NMR spectroscopy. Bridgehead 
deprotonation followed by an external quench with methyl chloroformate proved a little more 
effective, affording the known ester 55
20
 in 26% yield (Scheme 3.31).  
 
Scheme 3.31 
After extensive efforts, it was found that bridgehead selenide 282 was obtained when the 
reaction was conducted at higher temperatures, to enhance the reactivity between the enolate 
and the electrophile. Therefore, carrying out the reaction at -10 °C was found to be optimal to 
obtain 282 in good yield (Scheme 3.32). However these optimised reaction conditions failed 
to work using tosyl azide in the place of diphenyl diselenide as the electrophile to form azide 
227. At this temperature only degradation was observed. 
 
Scheme 3.32 
Allylic oxidation of bridgehead alkene 275 using selenium dioxide afforded allylic alcohol 
274 as a single diastereoisomer and subsequent treatment with Dess-Martin periodinane 
(DMP) afforded enedione 277 (Scheme 3.33). 
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Scheme 3.33 
The mechanism of allylic oxidation using selenium dioxide is well established and could 
explain the stereoselectivity of this reaction.
21,22
 The formation of allylic alcohol 274 initiates 
with an ene reaction between bridgehead alkene 275 and selenium dioxide to give the selenic 
intermediate 283. The particular cage-like structure of the tetracycle forces the                 
[2,3]-sigmatropic rearrangement to occur on the exo face of the cyclohexanone to form 
selenate 284, which after hydrolysis, provides 274 (Scheme 3.34).   
 
 
 
Scheme 3.34 
Evidence for the formation of allylic alcohol 274 was provided by mass spectrometry, 
showing a peak at [M+Na]
+
 = 304.1317 (C18H19NO2Na requires 304.1313). Futhermore, the      
1
H NMR spectrum showed the presence of a new multiplet integrating for one proton at 4.63-
4.66 ppm, and the 
13
C NMR spectrum showed a CH resonance at 64.8 ppm. Lastly, the 
stereochemistry at C-13 was determined by its NOESY spectrum, which showed a correlation 
between the endo proton,   H-14, and H-13 (Figure 3.2). 
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Figure 3.2 
Various methods to convert 275 directly to enedione 277 were also considered. For example, 
in the synthesis of (–)-samaderine Y, Shing and Yeung described the transformation of enone 
285 into enedione 286 upon treatment with CrO3 and 3,5-dimethylpyrazole (Scheme 3.35).
23
 
 
Scheme 3.35 
Unfortunately, under these conditions alkene 275 was degraded rapidly. Alternative radical 
methods using systems such as Mn3O(OAc)9/
t
BuOOH,
24
 PhI(OAc)2/
t
BuOOH,
25 
or     
Pd(OH)2-C/
t
BuOOH,
26 
were also attempted. In all cases, degradation was observed without 
formation of the desired enedione 277 or allylic alcohol 274. 
 
3.3.3 Allylic alcohol (274) as precursor to a bicyclo[4.3.1]decane core possessing a 
nitrogen at the bridgehead position 
Radical azidation using organic azides has been investigated by Renaud.
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1,3-triazenyl radicals. The latter could fragment to liberate radical X• and Y-N3, which 
corresponds to an azidation of Y• (Scheme 3.36). 
 
Scheme 3.36 
In his work, Renaud used azides as radical traps. Several methods involving the use of 
sulfonyl azides permitted the formation of new carbon-nitrogen bonds. For example, iodoester 
287 underwent radical cyclisation initiated by dilauroyl peroxide (DLP) and iodine transfer 
provided intermediate 288. Subsequent treatment with DLP and ethanesulfonyl azide 
furnished azide 289 in good yield (Scheme 3.37).
27
 The reactivity of these sulfonyl azides 
however suffers from a major drawback in that they do not react with electrophilic radicals. In 
the case of our study, the first aim was to investigate radical cyclisation followed by the 
iodine transfer. Curran described iodine transfer cyclisation reaction of 287 using a tin radical 
initiator and Renaud reported the same transformation using dilauroyl peroxide to obtain 
lactone 288.
28,29 
 
Scheme 3.37 
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Thus, esterification of allylic alcohol 274 was accomplished by treatment with iodoacetic acid 
in the presence of DCC and DMAP to afford the radical precursor 273 (Scheme 3.38). With 
radical precursor 273 in hand, the feasibility of the radical reaction with iodine exchange was 
first investigated. Radical initiation was attempted using DLP or di-tert-butyl-hyponitrite 
(DTBHN) in the presence hexabutylditin. Unfortunately, the desired lactone 272b 
functionalised at the bridgehead position was not observed, instead addition of lauroyl was 
detected by mass spectrometry, when DLP was used as initiator. 
 
Scheme 3.38 
An alternative route to install nitrogen at the bridgehead position was inspired by studies 
published by Ichikawa (Scheme 3.39).
30
 
 
Scheme 3.39  
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His work described the transformation of allyl cyanate to isocyanate via a concerted [3,3]-
sigmatropic rearrangement. Upon treatment with trichloroacetyl isocyanate followed by 
hydrolysis with potassium carbonate, allylic alcohol 290 afforded carbamate 291 in 97% 
yield. Subsequent dehydration
 
followed by [3,3]-sigmatropic rearrangement of allyl cyanate 
292 furnished allyl isocyanate 293. Due to the instability of the isocyanate group, 293 was 
converted into urea 294 or acetamide 295.
31
  
 
Applying Ichikawa’s reaction conditions to allylic alcohol 274 followed by dehydration with 
triphenyl phosphine and carbon tetrabromide was unsuccessful in our hands. Instead, an 
alternative dehydration method, also described by Ichikawa, was employed and trifluoroacetic 
anhydride (TFAA) was used providing allyl isocyanate 297 in 15% yield (Scheme 3.40). 
 
Scheme 3.40 
Synthesis of isocyanate 297 was confirmed by IR spectroscopy with an intense stretching 
band for N=C=O (2223 cm
-1
), while the 
1
H NMR spectrum showed the presence of an alkene 
group with a multiplet at 5.51-5.57 ppm and a signal at 5.79 ppm (dd, J = 9.4 and 3.0 Hz). 
Mass spectrometry showed a peak at [M+Na]
+
= 329.1271 (C19H18N2O2Na requires 
329.1266). 
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Although the synthesis of isocyanate 297 was not achieved in good yield, nitrogen 
functionality was introduced at the desired bridgehead position. Transformation of this 
isocyanate 297 into the corresponding isothiocyanate 299 should be possible in the same 
fashion as described (See Scheme 3.1) for the model system (Scheme 3.41). 
 
Scheme 3.41 
Although a new route has been established to functionalise the bridgehead position, the low 
yield of this procedure led back to the primary objective, installation of a bridgehead azide 
group. 
 
3.3.4 Enedione 277 as precursor to the bicyclo[4.3.1]decane core possessing a nitrogen 
functionality at the bridgehead position 
Molecular models showed that in the bicyclo[4.3.1]decane model system 271 the bridgehead 
alkene group is not conjugated with the bridging ketone due to strain in the structure (Figure 
3.3).
12 
 
 
Figure 3.3 
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In the case of enedione 277, substantial planarity with the carbonyl at C-13 was expected and 
so Michael addition of an azide group at C-11 was envisaged.  
 
In 1951, Boyer reported the addition of hydrazoic acid to several conjugated systems.
32 
The 
drawback of this method is the use of this highly toxic and explosive reagent. Therefore, 
several methods have been developed to avoid to the use of hydrazoic acid, either using safer 
azide donors
33 
or by generating hydrazoic acid in situ from trimethylsilyl azide and a 
carboxylic acid.
34 
For example, Miller and co-workers described the addition of azides to α,β-
unsaturated compounds, using five equivalents of TMSN3 and acetic acid in the presence of 
an amine to initiate the formation of hydrazoic acid in situ (Scheme 3.42).  
 
Scheme 3.42 
Under these conditions cyclohexenone 300a was converted into β-keto azide 301b in good 
yield. However, they showed that the efficiency of the azide addition decreased dramatically 
with enone 301b disubstituted at the β-position. 
 
When enedione 277 was subjected to Miller’s reaction conditions, we were delighted to 
observe that the desired azide 276 was isolated in 95% yield (Scheme 3.43). Evidence for the 
azide group was provided by IR spectroscopy showing an intense stretching band at         
2115 cm
-1
. The regioselectivity of the addition was confirmed by 
13
C NMR spectroscopy, 
which showed a quaternary carbon at 74.9 ppm and the presence two CH2 groups at 42.7 and 
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55.5 ppm. Mass spectrometry showed one peak at [M+Na]
+
= 345.1337, which confirmed 
installation of an azide group (C18H18N4O2Na requires 345.1327). 
 
Scheme 3.43 
Aziridination of enedione 277 was also envisaged as an alternative route to install nitrogen at 
the bridgehead position. For example, in studies towards the synthesis of calicheamicinone, 
Magnus described aziridination of intermediate 302 in 95% (Scheme 3.44).
35 
 
Scheme 3.44  
Unfortunately, upon treatment with diphenylsulfilimine, enedione 277 not even traces of the 
corresponding aziridine were observed by 
1
H NMR spectroscopy and mass spectrometry 
(Scheme 3.45).  
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In summary, we have demonstrated the synthesis of isocyanate 297 and azide 276 possessing 
nitrogen at the bridgehead position, which could lead to the isothiocyanate function present in 
N-methylwelwistatin (7). 
 
3.4 Studies towards the installation of the geminal methyl and vinyl 
groups 
 
It was proposed that the synthesis of the advanced intermediate 305 could arise from azide 
276. Introduction of the methyl group at C-12 might be possible by deprotonation at the γ-
position of enone 306 followed by an external quench with methyl iodide. A regioselective 
aldol reaction at C-12 of 276 with acetaldehyde and subsequent dehydration would give enone 
306 (Scheme 3.46). 
 
Scheme 3.46 
To functionalise the C-12 position, a regioselective deprotonation of 276 was desired, and so 
the protons at C-12 and C-14 needed to be differentiated. A computational study of 276 based 
on MM2 energy minimisation was used to identify its stable conformation. Therefore, the exo 
proton at C-12 seems to be axial while the exo proton at C-14 looks equatorial, so a 
regioselective deprotonation of diketoketone 276 might be possible (Figure 3.4).
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Figure 3.4 
To study the regioselectivity of the deprotonation at the α-position, C-12 versus C-14, of 
ketone 276, formation of the corresponding enol silane was carried out under both 
thermodynamic and kinetic conditions. Encouraging results were observed, with experimental 
work confirming the computational study. Under thermodynamic conditions, deprotonation 
occurred mainly at C-14 and 307a and 308a were observed in a 1:2 ratio determined by 
1
H 
NMR spectroscopy. Under kinetic conditions, the desired deprotonation at C-12 was favoured 
in a 4:1 ratio as determined by 
1
H NMR spectroscopy (Scheme 3.47). Ratios were determined 
by integration of the signal of the proton of the silyl enol ether at 4.88 ppm (doublet J = 2.3 
Hz) and 4.94 ppm (apparent triplet J = 2.9 Hz), respectively attributed to enol silane 307 and 
308. Attempts to purify the product by column chromatography using basified silica resulted 
in desilylation, so aldolisation was envisaged without any purification. 
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Scheme 3.47 
Satisfyingly, after screening different kinetic conditions in an attempt to favour the formation 
of the desired enol silane 307b, an internal quench with TMSCl and the use of LHMDS as the 
base were found to form exclusively the silyl enol ether 307b. Subsequent treatment of 307b 
with BF3·Et2O and acetaldehyde at -60 °C provided aldol product 309 as a single 
diastereoisomer (Scheme 3.48). 
 
Scheme 3.48 
Attempts to purify the alcohol 309 afforded very small quantities of the desired product (27% 
yield), suggesting a retro-aldol reaction was occurring during the purification process, and 
demonstrating the instability of this aldol product. However, it was found that column 
chromatography using a more polar system than normal (toluene/Et2O, 80/20) minimised 
retroaldolisation, providing alcohol 309 in 43% yield. 
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Many methods to perform the dehydration of aldol products to give the corresponding enones 
have been described. MsCl/DBU,
37
 Ac2O/DMAP/pyridine,
38
 TFA,
39
 CeCl3·7H2O/NaI
40
 were 
tested on very small scale (5-10 mg) but formation of the desired enone was not observed. 
 
However, when using MsCl and DBU, a new product was isolated (2 mg) and to our surprise, 
1
H NMR spectroscopy showed the formation of vinyl group with three protons at 5.54 ppm 
(dd, J 11.6 and 1.8 Hz), 6.29 ppm (dd, J 17.6 and 1.8 Hz) and 6.67 ppm (dd, J 17.6 and 11.6 
Hz). Mass spectrometry showed a single peak at [M+Na]
+
= 328.2, corresponding to loss of  
HN3, which was confirmed by IR spectroscopy with disappearance of the intense stretching 
band of the azide group. Alkene 310 was proposed and was suggested to arise from sequential 
dehydration and azide elimination (Figure 3.5) 
 
Figure 3.5 
Fortunately, the desired enone could be obtained by treatment of 309 with 
trifluoromethanesulfonic anhydride and pyridine (Scheme 3.49).
41
 Evidence for the formation 
of the desired enone 306 was provided by 
1
H NMR spectroscopy showing a doublet at 2.14 
ppm (J = 7.5 Hz), which integrates for three protons and a quadruplet at 6.91 ppm (J = 7.5 
Hz). IR spectroscopy showed the presence of the azide group (2109 cm
-1
) and mass 
spectrometry gave one peak at [M+Na]
+
= 371.1491 (C20H20N4O2Na requires 371.1484). 
N
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O
Me
Me
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Scheme 3.49 
The formation of the vinyl substituent and introduction of the methyl group at C-12 was 
envisioned in a single step via generation of the extended enolate of enone 306 followed by 
quenching with methyl iodide. Smith and co-workers reported the generation of enolate 312 
in their synthesis of a lactone precursor for the synthesis of penitrem D. They used potassium 
tert-butoxide in the presence of diphenyl sulfoxide, followed by addition of methyl iodide, to 
afford methylated derivative 313 in moderate yield (Scheme 3.50).
42
 
 
Scheme 3.50 
Treatment of enone 306 under these reaction conditions did not provide the methylated 
derivative at C-12 (Scheme 3.51). 
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The problem encountered seemed to be the azide group at the bridgehead of the enone 306. 
The 
1
H NMR spectrum of the crude material showed the presence of a vinyl group but the 
vinyl peaks are very similar to those in the byproduct 310. This could probably be due to the 
elimination of the azide group as observed previously. 
 
3.5 Summary 
 
We have demonstrated that a nitrogen functionality could be introduced at the bridgehead    
C-11 position via a [3,3]-sigmatropic rearrangement or an aza-Michael addition, which could 
provide a rapid transformation to the required isothiocyanate functionality present in the 
natural product 7. Moreover, a regioselective deprotonation, aldol functionalisation and 
dehydration afforded enone 306. This advanced intermediate is potentially very useful for the 
total synthesis of N-methylwelwitindolinone C isothiocyanate (7). 
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4.1 Epilogue 
 
During the course of this work towards the total synthesis of N-methylwelwitindolinone C 
isothiocyanate (7), two research groups recently published the first total syntheses of two 
members of the welwitindolinone family possessing the bicyclo[4.3.1]decane scaffold. 
Firstly, Rawal and co-workers reported the synthesis of N-methylwelwitindolinone D 
isonitrile (19),
1
 and secondly Garg and co-workers described the synthesis of                          
(–)-N-methylwelwitindolinone C isothiocyanate (7) (Figure 4.1).2 
 
Figure 4.1 
The synthesis of 19 began with acetyl indole 314, which upon addition of methylmagnesium 
bromide provided the unstable tertiary alcohol 63. Subsequent alkylative coupling of 63 with 
cyclohexanone intermediate 315 was achieved using TMSOTf and aqueous acidic work up 
furnished the vinylogous acid 316 as a single diastereoisomer in 78% yield. The formation of 
the bicyclo[4.3.1]decane framework was accomplished in 73% yield via a                
palladium-catalysed intramolecular enolate arylation. Removal of the TBDMS protecting 
group, followed by oxidation of the resultant alcohol and subsequent α-bromination afforded 
derivative 318 (Scheme 4.1).  
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Scheme 4.1 
Diastereoselective oxidation of indole 318 with DMDO followed by spontaneous cyclisation 
provided oxindole 319 in moderate yield (Scheme 4.2).  
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Conversion of the aldehyde 319 to the corresponding oxime 320 and subsequent treatment 
with N-chlorosuccinimide followed by thiourea 321 and triethylamine furnished 
isothiocyanate 322. Desulfurisation of the isothiocyanate functional group using 
oxazaphospholidine 323 completed the synthesis of    N-methylwelwitindolinone D isonitrile 
(19) in 14 steps and a 4.8% overall yield. 
 
After reporting the synthesis of N-methylwelwitindolinone D isonitrile (19), Rawal also 
described another method to generate the desired tetracycle via an oxidative cyclisation using 
manganese(III) acetate.
3
 This type of cyclisation usually occurrs on the pyrrolo part of the 
indole and therefore protection of C-2 position of the indole was necessary. Chlorine was 
employed, not only to block the position but to allow a subsequent transformation into the 
corresponding oxindole. For example, treatment of chloroindole 324 with manganese(III) 
acetate led to the desired bicyclo[4.3.1]decane framework 325 in 66% yield (Scheme 4.3). 
 
Scheme 4.3 
Rawal has also described the synthesis of the 20,21-dihydro N-methylwelwitindolinone B 
isothiocyanate 330.
4
 Aldehyde 326 was available through a seven-step sequence previously 
employed in the total synthesis of N-methylwelwitindolinone D isonitrile (19). The vinyl 
group of 326 was hydrogenated to prevent its participation during the deoxygenative 
chlorination of the alcohol moiety. Alcohol 327 was treated with the electron-deficient 
phosphine, tri(2-furyl)phosphine, and hexachloroacetone to afford chloride 328. Upon 
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treatment with RuO4, indole 328 was oxidised to the corresponding oxindole 329 in moderate 
yield but with the desired stereochemistry at the C-3 position. In the same fashion as in the 
synthesis of 19, the isothiocyanate functional group was achieved in two steps to furnish 330 
(Scheme 4.4). 
 
Scheme 4.4 
The synthesis of (–)-N-methylwelwitindolinone C isothiocyanate (7) by Garg and co-workers 
started with the removal of the pivalate protecting group of enone 331, obtained in five steps 
from (S)-carvone. Iodine-mediated conjugate addition of indole 183, followed by protection 
of the alcohol 332 with TBDMS under relatively forcing conditions, afforded the cyclisation 
precursor 333. The bicyclo[4.3.1]decane skeleton was obtained via an indolyne cyclisation 
providing the desired tetracycle 334 alongside 335 in a 2.5:1 ratio, respectively (Scheme 4.5). 
 
Cl
N
Me
O
OH
Me
MeOHC
Me
326
N
Me
O
OH
Me
MeOHC
Me
Me
327
N
Me
O
Me
MeOHC
Me
Me
328
H2, Pd(OH)2
EtOAc, rt
O
CCl3Cl3C
P(2-furyl)3
CH2Cl2, reflux
70% over 2 steps
NaIO4, RuCl3
CH3CN/H2O, rt
48%, brsm
(81% conv)
N
Me
O
Me
MeOHC
Me
Me
Cl
O
H
N
Me
O
Me
MeSCN
Me
Me
Cl
O
H
1. NH2OH·HCl, pyridine
2. NCS, DMF, then
    THF, 321, Et3N
52% over 2 steps
329 330
Chapter 4 
104 
 
 
Scheme 4.5 
Removal of the TBDMS protecting group with TBAF and oxidation of the resultant alcohol 
with DMP provided diketone 336. Vinyl stannane 337 was obtained in a two-step sequence 
involving the formation of an enol triflate using KHMDS and Comin’s reagent, and followed 
by a palladium-catalysed stannylation (Scheme 4.6). 
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Chlorodestannylation of 337 with CuCl2 furnished vinyl chloride derivative 338. Bromination 
of indole 338 with NBS followed by hydrolysis afforded oxindole 339 with the correct 
stereochemistry at C-3.  
 
Installation of the isothiocyanate function at the bridgehead position was realised via a nitrene 
insertion (Scheme 4.7). Thus, reduction of the bridging ketone with 
i
Bu2AlH and subsequent 
carbamoylation led to carbamate 340. A nitrene insertion occurred by exposure of 340 to 
AgOTf, bathophenanthroline and PhI(OAc)2 to yield oxazolidinone 341. A barium  
hydroxide-mediated hydrolysis followed by oxidation with IBX provided aminoketone 342. 
Finally, transformation of the bridgehead amine into the corresponding isothiocyanate was 
realised upon treatment with thiocarbonate 343, which completed the first synthesis of          
(–)-N-methylwelwitindolinone C isothiocyanate (7). The synthesis of 7 was accomplished in 
17 steps in 0.8% overall yield from carvone derivative 331. 
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In summary, a breakthrough was achieved in 2011 by Rawal and Garg with respectively the 
first total syntheses of N-methylwelwitindolinone D isonitrile (19) and                                    
(–)-N-methylwelwitindolinone C isothiocyanate (7). 
 
4.2 Future studies 
 
The results disclosed in this thesis could provide an alternative route to the synthesis of        
N-methylwelwitindolinone C isothiocyanate (7). In order to complete this synthesis, the major 
challenge is installation of a methyl group on to C-12. A possible approach to prevent the 
elimination of the azide group at the bridgehead could be envisaged by reduction of this 
functional group into the corresponding amine, followed by Boc-protection to provide 344. 
As originally planned, deprotonation to generate the extended enolate followed by quenching 
with methyl iodide could furnish diketone 345 (Scheme 4.7). 
 
Scheme 4.7 
Further manipulations, involving the formation of the vinyl chloride, oxidation of the indole 
ring and deprotection of the amine could achieve the formal synthesis of                                
N-methylwelwitindolinone C isothiocyanate (7). 
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General details 
All reactions were performed under an atmosphere of argon in dry glassware unless otherwise 
stated. THF was distilled immediately prior to use from sodium and benzophenone; CH2Cl2 
was distilled from calcium hydride. All other dry solvents and reagents were used as received 
from commercial suppliers unless otherwise stated. Solvents and solutions for radical 
reactions were degassed before use by bubbling a steady stream of dry N2 gas through them 
for 30 minutes.  
Infra-red spectra were recorded neat on a Perkin-Elmer Spectrum 100 FTIR spectrometer. 
Wavelengths (ν) are reported in cm-1. Mass spectra were obtained using a VG Micromass 70E 
or VG Micron Autospec spectrometer, using electrospray ionisation (ESI) with                
meta-nitrobenzyl alcohol as matrix. Melting points were recorded on a Gallenkamp melting 
point apparatus and are uncorrected. 
All 
1
H NMR and 
13
C NMR experiments were recorded using Bruker AV300, AV400, 
AVIII300 and AVIII400, spectrometers at 300 K. 
13
C NMR spectra were recorded using the 
PENDANT pulse sequence from the Bruker standard pulse program library. Chemical shifts 
(δ) are quoted in ppm and coupling constants (J) are quoted in Hz to one decimal place. For 
spectra recorded in chloroform-d the 7.26 ppm resonance of residual CHCl3 for proton spectra 
and 77.00 ppm resonance of CDCl3 for carbon spectra were used as internal references. For 
spectra recorded in methanol-d4 the 3.34 ppm resonance of residual CH3OH for proton spectra 
and 49.86 ppm resonance of CD3OD for carbon spectra were used as internal references. 
Spectral data for 
1
H NMR spectra are reported as follows: chemical shift (multiplicity, 
coupling constant, number of protons, assignment); and for 
13
C NMR spectra: chemical shift 
(multiplicity, assignment). The following abbreviations were used for multiplicity in 
1
H NMR 
spectra: s (singlet), d (doublet), t (triplet), q (quadruplet), dd (doublet of doublets), td (triplet 
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of doublets), dm (doublet with unresolved fine coupling), br (broad), app (signal with well 
defined multiplicity that may not be expected), m (multiplet). In the case of ambiguous 
assignments, 2-dimensional homonuclear (
1
H-
1
H) and heteronuclear (
1
H-
13
C) NMR 
experiments were used. Full assignment has been conducted for several representative 
structures whereas analogous compounds were only partially assigned. 
Reaction progress was monitored by thin layer chromatography (TLC) performed on 
aluminium silica gel plates (Kieselgel 60 F254). Visualisation was achieved by a combination 
of ultraviolet light (254 nm) and acidic potassium permanganate or anisaldehyde. Flash 
column chromatography was performed using silica gel 60 (230-400 mesh, Merck and Co.). 
 
Nomenclature 
The numbering of compounds (core structure) used for NMR assignments is based on the 
isolation paper published by Moore and co-workers (J. Am. Chem. Soc. 1994, 116, 9935) 
(Figure 5.1). 
 
Figure 5.1 
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4-Bromo-1-tosyl-1H-indole (136)
1
 
 
A solution of 4-bromoindole (500 mg, 10.2 mmol) in THF (9 mL) was added slowly, over 5 
min, to a suspension of NaH (122 mg, 60% dispersion in mineral oil, 14.9 mmol) in THF (3 
mL) at 0 °C. After 30 min, a solution of TsCl (535 mg, 11.2 mmol) in THF (5 mL) was added 
dropwise, over a period of 5 min, at 0 °C and the mixture was stirred overnight at rt. The 
excess hydride was destroyed by addition of a solution of MeOH/H2O (1/1, 20 mL). The 
mixture was extracted with EtOAc (3  20 mL) and the combined organic layers were dried 
over MgSO4 and concentrated under reduced pressure. The residue was purified by column 
chromatography on silica gel (petroleum ether/EtOAc, 95/5) to provide sulfonamide 136 (864 
mg, 97%) as a white solid; mp 120-121 °C [lit.,
1
 120-122 °C]; Rf 0.67 (petroleum 
ether/EtOAc, 90/10); IR υmax 1369, 1165, 1127, 1003, 751, 674 cm
-1
; 
1
H NMR (400 MHz, 
CDCl3) δ 2.35 (s, 3H, ArCH3), 6.73 (d, J 3.7, 1H, 3-CH), 7.17 (app t, J 8.1, 1H, 6-CH), 7.24 
(d, J 8.4, 2H, ArH), 7.39 (d, J 7.8, 1H, 5-CH), 7.62 (d, J 3.7, 1H, 2-CH), 7.76 (d, J 8.4, 2H, 
ArH), 7.95 (d, J 8.3, 1H, 7-CH); 
13
C NMR (100 MHz, CDCl3) δ 21.6 (CH3, ArCH3), 108.8 
(CH, 3-CH), 112.6 (CH, 7-CH), 115.0 (C, 4-C), 125.5 (CH, 6-CH), 126.2 (CH, 5-CH), 126.8 
(CH, ArCH), 126.9 (CH, 2-CH), 126.9 (C, 9-C), 131.0 (CH, ArCH), 131.4 (C, 8-C), 135.0 (C, 
ArC), 145.3 (C, ArC); MS (ESI) m/z 372.1 ([M+Na]
+
, 100%), 374.1 (97%); HRMS (ESI) m/z 
371.9664 [M+Na]
+
, C15H12NO2S
79
BrNa requires 371.9670. 
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2-(1’-Tosyl-1H-indol-4’-yl)cyclohexanone (135) 
 
General procedure A: A solution of P
t
Bu3 (1 M solution in toluene, 970 L, 0.97 mmol) was 
added to a solution of Pd2(dba)3·CHCl3 (418 mg, 0.40 mmol) and Bu3SnF (5.00 g, 16.2 mmol) 
in toluene (20 mL). A solution of indole 136 (2.83 g, 8.08 mmol) and silyl enol ether 144
2
 
(2.75 g, 16.2 mmol) in toluene (10 mL) was added and the mixture was heated under reflux 
(130 °C) for 17 h. After cooling to rt, the mixture was diluted with Et2O (30 mL), filtered 
through a plug of silica and concentrated under reduced pressure. The residue was purified by 
column chromatography on silica gel (petroleum ether/EtOAc, 90/10 then 80/20) to provide 
cyclohexanone derivative 135 as a yellow foam (1.87 g, 63%); Rf  0.38 (petroleum 
ether/EtOAc, 70/30); mp 95-97 °C; IR υmax  2937, 1709, 1360, 1164, 1130, 758, 675 cm
-1
; 
1
H 
NMR (400 MHz, CDCl3) δ 1.80-1.90 (m, 2H, 13-CH2 and 14-CH2), 2.00-2.33 (m, 4H, 12-
CH2, 13-CH2 and 14-CH2), 2.35 (s, 3H, CH3), 2.47-2.61 (m, 2H, 15-CH2), 3.87 (dd, J 12.3, 
5.6, 1H, 11-CH), 6.50 (d, J 3.8, 1H, 3-CH), 7.04 (d, J 7.4, 1H, 5-CH), 7.22 (d, J 8.5, 2H, 
ArH), 7.28 (app t, J 7.9, 1H, 6-CH), 7.56 (d, J 3.8, 1H, 2-CH), 7.77 (d, J 8.5, 2H, ArH), 7.88 
(d, J 8.4, 1H, 7-CH); 
13
C NMR (100 MHz, CDCl3) δ 21.5 (CH3, ArCH3), 25.5 (CH2, 13-CH2), 
27.7 (CH2, 14-CH2), 34.5 (CH2, 12-CH2), 42.3 (CH2, 15-CH2), 54.8 (CH, 11-CH), 107.1 (CH, 
3-CH), 112.2 (CH, 7-CH), 122.5 (CH, 5-CH), 124.6 (CH, 6-CH), 125.8 (CH, 2-CH), 125.8 
(C, 9-C), 126.9 (CH, ArCH), 129.9 (CH, ArCH), 132.0 (C, 4-C), 134.8 (C, ArC), 135.4 (C, 8-
C), 144.9 (C, ArC), 209.3 (C, 10-C); MS (ESI) m/z 390.1 ([M+Na]
+
, 100%);  HRMS (ESI) 
m/z 390.1134 [M+Na]
+
, C21H21NO3SNa requires 390.1140. 
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4-(2’-Oxocyclohexyl)-1-tosyl-1H-indole-3-carbaldehyde (134) 
 
A solution of indole 135 (1.08 g, 2.94 mmol) in CH2Cl2 (12 mL) was added to a solution of 
dichloromethyl methyl ether (794 μL, 8.82 mmol) and AlCl3 (1.18 g, 8.82 mmoL) in CH2Cl2 
(12 mL) at -78 °C. The reaction mixture was stirred for 3.5 h at this temperature, and then 
quenched at -78 °C with NaHCO3 solution (25 mL of a saturated aqueous solution) and 
warmed to rt. The separated aqueous phase was extracted with CH2Cl2 (3  25 mL) and the 
combined organic layers were dried over MgSO4 and concentrated under reduced pressure. 
The residue was purified by column chromatography on silica gel (CH2Cl2) to give 
formylated indole 134 as a white solid (720 mg, 62%); Rf  0.46 (petroleum ether/AcOEt, 
60/40); mp 190-192 °C; IR υmax  2935, 1704, 1693, 1368, 749, 660 cm
-1
; 
1
H NMR (400 MHz, 
CDCl3) δ 1.54-1.70 (m, 1H, 14-CH2), 1.92-2.09 (m, 3H, 13-CH2 and 12-CH2), 2.14-2.27 (m, 
1H, 14-CH2), 2.27-2.36 (m, 1H, 12-CH2), 2.38 (s, 3H, ArCH3), 2.47 (d, J 13.0, 1H, 15-CH2), 
2.75-2.95 (br s, 1H, 15-CH2), 5.05-5.23 (br s, 1H, 11-CH), 7.18 (d, J 7.6, 1H, 5-CH) 7.30 (d, J 
8.4, 2H, ArH), 7.39 (app t, J 8.0, 1H, 6-CH), 7.86 (dm, J 8.4, 3H, ArH and 7-CH ), 8.27 (s, 
1H, 2-CH), 9.78 (s, 1H, 16-CHO); 
13
C NMR (100 MHz, CDCl3) 21.6 (CH3, ArCH3), 25.7 
(CH2, 13-CH2), 28.0 (CH2, 14-CH2), 33.9 (CH2, 12-CH2), 42.1 (CH2, 15-CH2), 54.9 (CH, 11-
CH), 111.8 (CH, 7-CH), 123.8 (C, 3-C), 123.8 (CH, 5-CH), 124.0 (C, 9-C), 126.3 (CH, 6-
CH), 127.4 (CH, ArCH), 130.4 (CH, ArCH), 134.2 (C, 4-C), 135.1 (C, ArC), 136.1 (C, 8-C), 
141.0 (CH, 2-CH), 146.3 (C, ArC), 184.3 (CH, 16-CHO), 210.7 (C, 10-C); MS (ESI) m/z 
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418.1 ([M+Na]
+
, 100%); HRMS (ESI) m/z 418.1091 [M+Na]
+
; C22H21NO4SNa requires 
418.1089.  
 
Bicyclo[4.3.1]decane compound (148) 
 
A solution of p-TsOH (500 mg, 0.53 M in dry THF) was prepared and dried over 3 Å 
molecular sieves with stirring for 1 h. The solution of p-TsOH (0.36 mL, 0.19 mmol) was 
added to a solution of aldehyde 134 (74 mg, 0.19 mmol) in THF (3 mL) and the resultant 
mixture was heated at 50 °C. After 24 h, the solution was cooled to rt and a freshly prepared 
solution of p-TsOH (0.36 mL, 0.19 mmol) was added. The reaction mixture was heated at    
50 °C for a further 24 h, then NaHCO3 solution (10 mL of a saturated aqueous solution) was 
added at rt. The mixture was extracted with Et2O (3  20 mL) and the combined organic 
layers were dried over MgSO4 and concentrated under reduced pressure. The residue was 
purified by column chromatography on silica gel (petroleum ether/EtOAc, 80/20) to provide 
cyclised product 148 as a yellow foam (29 mg, 39%); Rf 0.21 (petroleum ether/EtOAc, 
70/30); mp 129-130 °C; IR υmax  3425, 2935, 1699, 1368, 1174, 662 cm
-1
; 
1
H NMR (400 
MHz, CDCl3) δ 1.12-1.33 (m, 2H, 13-CH2), 1.76-1.91 (m, 2H, 12-CH2 and 14-CH2), 2.10-
2.21 (m, 1H, 12-CH2), 2.31-2.42 (m, 1H, 14-CH2), 2.35 (s, 3H, ArCH3), 3.11-3.14 (m, 1H, 
15-CH), 3.93 (br s, 1H, 11-CH), 4.97 (dd, J 5.6, 1.9, 1H, 16-CH), 6.97 (d, J 7.4, 1H, 5-CH), 
7.23 (d, J 8.4, 2H, ArH), 7.28 (app t, J 7.9, 1H, 6-CH), 7.75-7.79 (m, 3H, ArH and 2-CH), 
7.88 (d, J 8.4, 1H, 7-CH), OH not observed; 
13
C NMR (100 MHz, CDCl3) δ 17.3 (CH2, 13-
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CH2), 21.6 (CH3, ArCH3), 24.0 (CH2, 14-CH2), 36.8 (CH2, 12-CH2), 56.1 (2 × CH, 11-CH 
and 15-CH), 67.7 (CH, 16-CH), 112.0 (CH, 7-CH), 116.0 (C, 3-C), 123.0 (CH, 5-CH), 123.5 
(C, 9-C), 125.4 (CH, 2-CH), 125.4 (CH, 6-CH), 126.9 (CH, ArCH), 127.0 (C, 4-C), 129.9 
(CH, ArCH), 133.3 (C, 8-C), 135.1 (C, ArC), 145.2 (C, ArC), 212.3 (C, 10-C); MS (ESI) m/z 
418.2 [M+Na]
+
,
 
HRMS (ESI) m/z 418.1074 ([M+Na]
+
, 100%); C22H21NO4SNa requires 
418.1089. 
 
Ketone compound (133) 
 
Manganese(IV) oxide (1.18 g, 13.6 mmol) was added to a solution of alcohol 148 (210 mg, 
0.53 mmol) in CH2Cl2 (17 mL). The resulting suspension was stirred for 3.5 h at rt. The 
reaction mixture was filtered through Celite
®
 and concentrated under reduced pressure. The 
residue was purified by column chromatography on silica gel (petroleum ether/EtOAc, 70/30) 
to provide diketone 133 (146 mg, 70%) as a white solid; Rf 0.37 (petroleum ether/EtOAc, 
70/30); mp 104-105 °C; IR υmax 2936, 1705, 1655, 1521, 1377, 1163, 664 cm
-1
; 
1
H NMR (400 
MHz, CDCl3) δ 1.53-1.63 (m, 2H, 13-CH2), 2.11-2.31 (m, 3H, 12-CH2 and 14-CH2), 2.36 (s, 
3H, ArCH3), 2.43 (dm, J 13.9, 1H, 14-CH2), 3.75 (dm, J 6.3, 1H, 15-CH), 4.00-4.04 (m, 1H, 
11-CH), 7.11 (d, J 7.5, 1H, 5-CH), 7.28 (d, J 8.4, 2H, ArH), 7.36 (app t, J 8.0, 1H, 6-CH), 
7.83 (d, J 8.4, 2H, ArH), 7.90 (d, J 8.4, 1H, 7-CH), 8.43 (s, 1H, 2-CH); 
13
C NMR (100 MHz, 
CDCl3) δ 18.0 (CH2, 13-CH2), 21.6 (CH3, ArCH3), 33.5 (CH2, 14-CH2), 37.1 (CH2, 12-CH2), 
55.5 (CH, 11-CH), 66.1 (CH, 15-CH), 112.2 (CH, 7-CH), 120.2 (C, 3-C), 124.7 (CH, 5-CH), 
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125.5 (C, 9-C), 126.1 (CH, 6-CH), 127.3 (CH, ArCH), 130.3 (CH, ArCH), 131.9 (C, 4-C), 
132.6 (CH, 2-CH), 134.1 (C, ArC), 134.8 (C, 8-C), 146.3 (C, ArC), 191.1 (C, 16-C), 207.2 
(C, 10-C); MS (ESI) m/z 416.2 ([M+Na]
+
, 100%); HRMS MS (ESI) m/z 416.0930 [M+Na]
+
, 
C22H19NO4S requires 416.0932. 
 
Ketal compound (149) 
 
p-TsOH (8 mg, 0.04 mmol) and ethylene glycol (25 μL, 0.45 mmol) were added to a solution 
of diketone 133 (160 mg, 0.41 mmol) in toluene (8 mL). After 10 h at reflux, the reaction 
mixture was cooled to rt, diluted with H2O (25 mL) and extracted with EtOAc (3  30 mL). 
The combined organic layers were dried over MgSO4 and concentrated under reduced 
pressure. The residue was purified by column chromatography on silica gel (petroleum 
ether/EtOAc; 70/30) to provide ketal 149 (173 mg; 97%) as a white solid; Rf 0.25 (petroleum 
ether/EtOAc, 70/30); mp 114-116 °C; IR υmax  2935, 1654, 1526, 1374, 1164, 664 cm
-1
; 
1
H 
NMR (400 MHz, CDCl3) δ 1.06-1.20 (m, 1H, 13-CH2), 1.30-1.40 (m, 1H, 13-CH2), 1.83 (dm, 
J 13.2, 1H, 12-CH2), 1.99-2.16 (m, 2H, 14-CH2), 2.18-2.29 (m, 1H, 12-CH2), 2.38 (s, 3H, 
ArCH3), 3.08-3.12 (m, 1H, 15-CH), 3.36-3.40 (m,1H, 11-CH), 3.85-3.96 (m, 2H, OCH2), 
3.98-4.03 (m, 2H, OCH2), 7.10 (d, J 7.4, 1H, 5-CH), 7.29 (d, J 8.4, 2H, ArH), 7.32 (app t, J 
7.9, 1H, 6-CH), 7.85 (d, J 8.4, 1H, 7-CH), 7.88 (d, J 8.4, 2H, ArH), 8.41 (s, 1H, 2-CH); 
13
C 
NMR (100 MHz, CDCl3) δ 17.4 (CH2, 13-CH2), 21.5 (CH3, ArCH3), 29.1 (CH2, 14-CH2), 
34.2 (CH2, 12-CH2), 48.7 (CH, 11-CH), 57.7 (CH, 15-CH), 64.2 (CH2, OCH2), 65.2 (CH2, 
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OCH2), 107.3 (C, 10-C), 111.4 (CH, 7-CH), 121.3 (C, 3-C), 125.1 (CH, 5-CH), 125.4 (CH, 6-
CH), 126.0 (C, 9-C), 127.4 (CH, ArCH), 130.1 (CH, ArCH), 131.6 (CH, 2-CH), 134.4 (C), 
134.6 (C), 134.8 (C), 145.8 (C), 196.1 (C, 16-C); MS (ESI) m/z 460.1 ([M+Na]
+
, 100%); 
HRMS (ESI) m/z 460.1189 [M+Na]
+
, C24H23NO5SNa requires 460.1195. 
 
Methylated indole compound (159) 
 
MeMgBr (3 M solution in Et2O, 150 μL, 0.45 mmol) was added dropwise, over a period of 5 
min, to a solution of ketal 149 (66 mg, 0.15 mmol) in THF (1.5 mL) at 0 °C. After 3 h at this 
temperature the reaction was quenched with NH4Cl solution (10 mL of a saturated aqueous 
solution) and extracted with Et2O (3  10 mL). The combined organic layers were dried over 
MgSO4 and concentrated under reduced pressure. The residue was purified by column 
chromatography on silica gel (petroleum ether/EtOAc, 70/30) to give methylated compound 
159 as a white solid (38 mg, 56%); Rf 0.47 (petroleum ether/EtOAc, 60/40); mp 93-94 °C; IR 
υmax 2930, 1647, 1526, 1376, 1168, 1111, 1000, 710, 656 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 
1.06-1.20 (m, 1H, 13-CH2), 1.28-1.37 (m, 1H, 13-CH2), 1.83 (dm, J 13.2, 1H, 12-CH2), 1.97-
2.12 (m, 2H, 14-CH2), 2.16-2.27 (m, 1H, 12-CH2), 2.39 (s, 3H, ArCH3), 3.05 (s, 3H, 17-CH3), 
3.06-3.10 (m, 1H, 15-CH), 3.34-3.38 (m, 1H, 11-CH), 3.87-3.97 (m, 2H, OCH2), 3.98-4.03 
(m, 2H, OCH2), 7.10 (d, J 7.5, 1H, 5-CH), 7.26-7.31(m, 3H, ArH and 6-CH), 7.78 (d, J 8.4, 
2H, ArH), 8.20 (d, J 8.5, 1H, 7-CH); 
13
C NMR (100 MHz, CDCl3) δ 14.7 (CH3, 17-CH3), 
17.4 (CH2, 13-CH2), 21.6 (CH3, ArCH3), 29.3 (CH2, 14-CH2), 34.5 (CH2, 12-CH2), 48.9 (CH, 
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11-CH), 59.1 (CH, 15-CH), 64.3 (CH2, OCH2), 65.3 (CH2, OCH2), 107.1 (C, 10-C), 112.4 (C, 
7-CH), 117.9 (C, 3-C), 124.6 (CH, 6-CH), 125.6 (CH, 5-CH), 125.7 (C, 9-C), 126.9 (CH, 
ArCH), 130.1 (CH, ArCH), 133.5 (C, 4-C), 135.6 (C, ArC), 136.0 (C, 8-C), 145.6 (C, ArC), 
147.1 (C, 2-C), 197.7 (C, 16-C); MS (ESI) m/z 474.2 ([M+Na]
+
, 100%); HRMS (ESI) m/z 
474.1340 [M+Na]
+
, C25H25NO5SNa requires 474.1351. 
 
Alcohol compound (160) 
  
LiBH4 (13 mg, 0.61 mmol) was added portionwise to a solution of diketone 133 ( 217 mg, 
0.55 mmol) in THF (10 mL) at 0 °C. After 2 h at that maintained temperature, the reaction 
mixture was quenched with NaOH solution (10 mL of a 1 M aqueous solution) and extracted 
with Et2O (3  10 mL). The combined organic layers were dried over MgSO4 and 
concentrated under reduced pressure. The residue was purified by column chromatography on 
silica gel (petroleum ether/EtOAc, 60/40) to give alcohol 160 as a white solid (84 mg, 39%); 
Rf  0.30 (petroleum ether/EtOAc, 60/40); mp 115-116 °C; IR υmax 3414, 2929, 1644, 1524, 
1374, 1175, 663 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 0.95-1.09 (m, 1H, 13-CH2), 1.23-
1.32(m, 1H, 13-CH2), 1.76-1.87 (m, 1H, 14-CH2), 1.88-1.95 (m, 3H, 12-CH2 and OH), 2.08 
(dm, J 14.2, 1H, 14-CH2), 2.37 (s, 3H, ArCH3), 3.29 (app t, J 5.5, 1H, 15-CH), 3.62-3.68 (m, 
1H, 11-CH), 4.23 (app t, J 5.9, 1H, 10-CH), 7.17 (d, J 7.4, 1H, 5-CH), 7.28 (d, J 8.4, 2H, 
ArH), 7.34 (app t, J 7.9, 1H, 6-CH), 7.85-7.89 (m, 3H, ArH and 7-CH), 8.42 (s, 1H, 2-CH); 
13
C NMR (100 MHz, CDCl3) δ 17.5 (CH2, 13-CH2), 21.6 (CH3, ArCH3), 29.8 (CH2, 14-CH2), 
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34.9 (CH2, 12-CH2), 45.5 (CH, 11-CH), 54.9 (CH, 15-CH), 70.1 (CH, 10-CH), 111.7 (CH, 7-
CH), 122.6 (C, 3-C), 126.6 (C, 9-C), 125.6 (CH, 6-CH), 126.2 (CH, 5-CH), 127.4 (CH, 
ArCH), 130.2 (CH, ArCH), 131.9 (CH, 2-CH), 134.5 (C, 4-C), 134.7 (C, ArC), 135.6 (C, 8-
C), 145.9 (C, ArC), 199.1 (C, 16-C); MS (ESI) m/z 418.1 ([M+Na]
+
, 100%); HRMS (ESI) m/z 
418.1072 [M+Na]
+
, C22H21NO4SNa requires 418.1089. 
 
Methylated indole compound (162) 
 
MeMgBr (3 M solution in Et2O, 106 L, 0.32 mmol) was added to a solution of 160 (84 mg, 
0.21 mmol) in THF (2 mL) at 0 °C and the solution was stirred for 30 min at that maintained 
temperature. The reaction was quenched with NH4Cl solution (5 mL of a saturated aqueous 
solution) and extracted with Et2O (3  5 mL). The combined organic layers were dried over 
MgSO4 and concentrated under reduced pressure. The residue was purified by column 
chromatography on silica gel (petroleum ether/EtOAc, 60/40) to afford alcohol 162 (51 mg, 
59%) as a white solid; Rf 0.16 (petroleum ether/EtOAc, 60/40); mp 103-104 °C; IR υmax 3401, 
2935, 1646, 1525, 1376, 1178, 706, 659 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 0.96-1.09 (m, 
1H, 13-CH2), 1.22-1.33 (m, 1H, 13-CH2), 1.71-1.85 (m, 2H, 14-CH2 and OH) , 1.86-1.99 (m, 
2H, 12-CH2), 1.06-2.14 (m, 1H, 14-CH2), 2.39 (s, 3H, ArCH3), 3.05 (s, 3H, 17-CH3), 3.27-
3.33 (m, 1H, 15-CH), 3.61-3.66 (m, 1H, 11-CH), 4.17-4.24 (m, 1H, 10-CH), 7.18 (d, J 7.4, 
1H, 5-CH), 7.27 (d, J 8.4, 2H, ArH), 7.32 (app t, J 7.9, 1H, 6-CH), 7.77 (d, J 8.4, 2H, ArH), 
8.23 (d, J 8.4, 1H, 7-CH); 
13
C NMR (100 MHz, CDCl3) δ 14.8 (CH3, 17-CH3), 17.4 (CH2, 13-
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CH2), 21.6 (CH3, ArCH3), 30.1 (CH2, 14-CH2), 35.2 (CH2, 12-CH2), 46.0 (CH, 11-CH), 56.4 
(CH, 15-CH), 70.0 (CH, 10-CH), 112.7 (CH, 7-CH), 119.2 (C, 3-C), 124.9 (CH, 6-CH), 125.9 
(C, 9-C), 126.8 (CH, ArCH), 130.2 (2 × CH, ArCH and 5-CH), 134.1 (C, 4-C), 135.7 (C, 
ArC), 136.0 (C, 8-C), 145.7 (C, ArC), 147.2 (C, 2-C), 200.4 (C, 16-C); MS (ESI) m/z 432.2 
([M+Na]
+
, 100%); HRMS (ESI) m/z 432.1244 [M+Na]
+
, C23H23NO4SNa requires 432.1245. 
 
Sulfone compound (174) 
 
A solution of dry p-TsOH (500 mg, 0.53 M solution in CH2Cl2) was prepared and dried over 
3 Å molecular sieves with stirring for 1 h. A dry solution of p-TsOH (587 L, 0.31 mmol) and 
p-TolSO2H
 
(53 mg, 0.34 mmol) were successively added to a solution of formylindole 134 
(123 mg, 0.31 mmol) in CH2Cl2 (3 mL). After 24 h at reflux, the reaction mixture was cooled 
to rt and NaHCO3 solution (5 mL of a saturated aqueous solution) was added. The mixture 
was extracted with CH2Cl2 (3  5 mL) and the combined organic layers were dried over 
MgSO4 and concentrated under reduced pressure. The residue was purified by column 
chromatography on silica gel (petroleum ether/EtOAc, 70/30) to give cyclised product 174 as 
a pale yellow solid (100 mg, 61%); Rf 0.44 (petroleum ether/EtOAc, 50/50); mp 209-210 °C; 
IR υmax 2955, 1710, 1346, 1170, 665 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 1.18-1.35 (m, 2H, 
13-CH2), 1.79 (br d, J 12.8, 1H, 12-CH2), 1.96 (br d, J 14.0, 1H, 14-CH2), 2.01-2.19 (m, 2H, 
12-CH2 and 14-CH2), 2.31 (s, 3H, ArCH3), 2.32 (s, 3H, ArCH3), 3.52 (d, J 7.1, 1H, 15-CH), 
3.96 (br s, 1H, 11-CH), 4.44 (br s, 1H, 16-CH), 6.90 (d, J 7.4, 1H, 5-CH), 7.06 (d, J 8.3, 2H, 
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ArH), 7.23-7.29 (m, 3H, ArH and 6-CH), 7.41 (d, J 8.3, 2H, ArH), 7.83-7.89 (m, 4H, ArH, 7-
CH and 2-CH); 
13
C NMR (100 MHz, CDCl3) δ 17.4 (CH2, 13-CH2), 21.5 (CH3, ArCH3), 34.3 
(CH2, 14-CH2), 39.6 (CH2, 12-CH2), 47.2 (CH, 15-CH), 59.0 (CH, 11-CH), 67.7 (CH, 16-
CH), 110.4 (C, 3-C), 111.9 (CH, 7-CH), 123.3 (CH, 5-CH), 125.7 (CH, 6-CH), 127.1 (CH, 
ArCH), 128.8 (C, 9-C), 129.2 (CH, ArCH), 129.5 (CH, 2-CH), 130.2 (2 × CH, 2 × ArCH), 
131.6 (C, 4-C), 133.0 (C, 8-C), 134.5 (C, ArC), 134.7 (C, ArC), 144.8 (C, ArC), 145.4 (C, 
ArC), 208.6 (C, 10-C); MS (ESI) m/z 556.1 ([M+Na]
+
, 100%); HRMS (ESI) m/z 556.1220  
[M+Na]
+
, C29H27NO5S2Na requires 556.1228. 
 
Deuterated Sulfone (177) 
 
Sulfone 174 (50 mg, 0.09 mmol) was added to a suspension of NaH (5 mg, 60% dispersion in 
mineral oil, 0.11 mmol) in DMF (0.5 mL) at 0 °C. The reaction mixture was stirred for 20 min 
and quenched by addition of D2O (1 mL). The mixture was extracted with Et2O (3  2 mL) 
and the combined organic layers were dried over MgSO4 and evaporated under reduced 
pressure. The residue was purified by column chromatography on silica gel (petroleum 
ether/EtOAc, 80/20) to afford a mixture of sulfone 174 and deuterated sulfone 177 as a single 
diastereoisomer in a 13:87 ratio (36 mg, 72%) as a grey solid; Rf 0.49 (petroleum 
ether/EtOAc, 50/50); mp 134-135 °C; IR υmax 2928, 1705, 1372, 1176, 661 cm
-1
; 
1
H NMR 
(400 MHz, CDCl3) δ 1.21-1.31 (m, 2H, 13-CH2), 1.81 (dm, J 13.3, 1H, 12-CH2), 1.97 (dm, J 
14.1, 1H, 14-CH2), 2.04-2.19 (m, 2H, 12-CH2 and 14-CH2), 2.34 (s, 6H, ArCH3), 3.52 (d, J 
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7.0, 1H, 15-CH), 3.96 (br s, 1H, 11-CH), 6.91 (d, J 7.6, 1H, 5-CH), 7.06 (d, J 8.4, 2H, ArH), 
7.24-7.30 (m, 3H, ArH and 6-CH), 7.40 (d, J 8.4, 2H,  ArH), 7.85-7.90 (m, 4H, ArH, 2-CH 
and 7-CH); 
13
C NMR (100 MHz, CDCl3) δ 17.7 (CH2, 13-CH2), 21.6 (CH3, ArCH3), 34.4 
(CH2, 14-CH2), 39.7 (CH2, 12-CH2), 47.2 (CH, 15-CH), 59.0 (CH, 11-CH), 67.9 (C, t, J 33.4, 
16-C),  110.4 (C, 3-C), 112.0 (CH, 7-CH), 123.4 (CH, 5-CH), 125.7 (CH, 6-CH), 127.2 (CH, 
ArCH), 128.9 (C, 9-C), 129.2 (CH, ArCH), 129.6 (CH, 2-CH), 130.1 (2 × CH, 2 × ArCH), 
131.6 (C, 4-C), 133.1 (C, 8-C), 134.6 (C, ArC), 134.9 (C, ArC), 144.9 (C, ArC), 145.5 (C, 
ArC), 208.6 (C, 10-C); MS (ESI) m/z 557.2 ([M+Na]
+
, 100%); HRMS (ESI) m/z 557.1276 
[M+Na]
+
, C29H26
2
H1NO5S2Na requires 556.1228. 
 
Trimethyl(6-(propan-2’-ylidene)cyclohex-1-enyloxy)silane (188) 
 
BuLi (1.6 M solution in hexane, 7.1 mL, 10.6 mmol) was added to a solution of 
i
Pr2NH (1.2 
mL, 1.6 mL, 11.5 mmol) in THF (28 mL) at -78 °C. The mixture was stirred for 20 min at this 
temperature and a solution of enone 187
3
 (1.22 g, 8.83 mmol) in THF (2 mL) was added 
dropwise over a period of 10 min. After 30 min at -78 °C, TMSCl (2.2 mL, 18 mmol was 
added and the mixture was stirred for 1 h at -78 °C. The reaction was quenched with brine (6 
mL) at -78 °C and extracted with petroleum ether (2  50 mL). The combined organic layers 
were washed with brine (3  50 mL), dried over MgSO4, and concentrated under reduced 
pressure. The residue was purified by reduced pressure distillation (Kugelrohr) providing silyl 
enol ether 188 (1.36 g, 73%) as a colourless oil; Rf 0.88 (petroleum ether/Et2O, 90/10); IR 
υmax 2927, 1611, 1250, 1177, 840 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 0.18 (s, 9H, CH3), 
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1.59-1.65 (m, 2H, 4-CH2), 1.71 (s, 3H, CH3), 1.98 (s, 3H, CH3), 2.09-2.14 (m, 2H, 5-CH2), 
2.27-2.30 (m, 2H, 3-CH2), 4.91 (app t, J 4.2, 1H, 6-CH); 
13
C NMR (100 MHz, CDCl3) δ 0.1 
(CH3), 22.7 (CH3), 23.1 (CH3), 23.4 (CH2, 5-CH2), 24.8 (CH2, 3-CH2), 28.8 (CH2, 4-CH2), 
108.1 (CH, 6-CH), 126.6 (C, 7-C), 127.8 (C, 2-C), 150.1 (C, 1-C); MS (EI) m/z 138.1 (100%), 
210.1 ([M]
+
, 25%); HRMS (EI) m/z 210.1446 [M]
+
, C12H22OSi requires 210.1440. 
 
2-(Propan-2’-ylidene)-6-(1’’-tosyl-1H-indol-4’’-yl)cyclohexanone (189) 
 
A solution of P
t
Bu3 (1 M solution in toluene, 197 L, 0.20 mmol) was added to a solution of 
Pd2(dba)3·CHCl3 (85 mg, 0.08 mmol) and Bu3SnF (508 mg, 1.64 mmol) in toluene (1.5 mL). 
A solution of indole 136 (144 mg, 0.41 mmol) and silyl enol ether 188 (345 mg, 1.64 mmol) 
in toluene (1 mL) was added and the mixture was heated under reflux for 15 h. After cooling 
to rt, the mixture was diluted with Et2O (5 mL), filtered through a plug of silica and 
concentrated under reduced pressure. The residue was purified by column chromatography on 
silica gel (petroleum ether/EtOAc, 90/10) to provide enone 189 as a yellow foam (56 mg, 
33%); Rf  0.25 (petroleum ether/EtOAc, 80/20); mp 78-80 °C; IR υmax 2933, 1676, 1360, 
1177, 757, 674 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 1.72-1.82 (m, 1H, 13-CH2), 1.84 (s, 3H, 
CH3), 1.92 (s, 3H, CH3), 1.95-2.04 (m, 1H, 13-CH2), 2.05-2.17 (m, 1H,12-CH2), 2.17-2.25 
(m, 1H, 12-CH2), 2.32 (s, 3H, ArCH3), 2.42-2.56 (m, 1H, 14-CH2), 2.82 (dm, J 15.2, 1H, 14-
CH2), 3.87 (dd, J 11.4, 6.2, 1H, 11-CH), 6.56 (d, J 3.7, 1H, 3-CH), 7.01 (d, J 7.4, 1H, 5-CH), 
7.20 (d, J 8.4, 2H, ArH), 7.27 (app t, J 7.9, 1H, 6-CH), 7.57 (d, J 3.7, 1H, 2-CH), 7.78 (d, J 
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8.4, 2H, ArH), 7.89 (d, J 8.4, 1H, 7-CH); 
13
C NMR (100 MHz, CDCl3) δ 21.4 (CH3, ArCH3), 
22.1 (CH3), 22.9 (CH3), 23.8 (CH2, 13-CH2), 30.0 (CH2, 14-CH2), 32.5 (CH2, 12-CH2), 55.4 
(CH, 11-CH), 107.2 (CH, 3-CH), 111.9 (CH, 7-CH), 122.5 (CH, 5-CH), 124.5 (CH, 6-CH), 
125.7 (CH, 2-CH), 126.8 (CH, ArCH), 129.8 (CH, ArCH), 132.6 (C), 133.8 (C), 134.7 (C), 
135.2 (C), 142.5 (C), 144.8 (C, ArC), 203.3 (C, 10-C), one C not observed; MS (ESI) m/z 
430.2 ([M+Na]
+
, 100%); HRMS (ESI) m/z 430.1446 [M+Na]
+
, C24H25NO3SNa requires 
430.1453. 
 
6-(1’-Tosyl-1H-indol-4’-yl)cyclohex-2-enone (191) 
 
Following the general procedure A (p.112), using indole 136 (545 mg, 1.56 mmol) and silyl 
enol ether 190
4
 (524 mg, 3.11 mmol) and heated under reflux for 17 h; column 
chromatography on silica gel (petroleum ether/EtOAc, 70/30) afforded enone 191 (295 mg, 
52%) as a yellow foam; Rf 0.40 (petroleum ether/ EtOAc, 70/30); mp 84-85 °C; IR υmax 2971, 
1672, 1360, 1130, 1088, 1164, 758, 673 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 2.21-2.40 (m, 
2H, 12-CH2), 2.34 (s, 3H, ArCH3), 2.45-2.57 (m, 2H, 13-CH2), 3.89 (dd, J 11.7, 5.1, 1H, 11-
CH), 6.19 (dm, J 10.2, 1H, 15-CH), 6.54 (d, J 3.8, 1H, 3-CH), 6.99 (d, J 7.4, 1H, 5-CH), 7.06-
7.12 (m, 1H, 14-CH), 7.21 (d, J 8.4, 2H, ArH), 7.26 (app t, J 8.0, 1H, 6-CH), 7.56 (d, J 3.8, 
1H, 2-CH), 7.77 (d, J 8.4, 2H, ArH), 7.89 (d, J 8.4, 1H, 7-CH); 
13
C NMR (100 MHz, CDCl3) 
δ 21.5 (CH3, ArCH3), 25.7 (CH2, 13-CH2), 30.3 (CH2, 12-CH2), 51.2 (CH, 11-CH), 107.1 
(CH, 3-CH), 112.3 (CH, 7-CH), 122.2 (CH, 5-CH), 124.6 (CH, 6-CH), 126.0 (CH, 2-CH), 
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126.9 (CH, ArCH), 130.0 (CH, ArCH), 130.4 (CH, 15-CH), 132.8 (C), 134.9 (C), 135.3 (C), 
145.0 (C, ArC), 150.5 (CH, 14-CH), 198.7 (C, 10-C), one C not observed; MS (ESI) m/z 
388.1 ([M+Na]
+
, 100%); HRMS (ESI) m/z 388.0979 [M+Na]
+
, C21H19NO3SNa requires 
388.0983. 
 
Ketal compound (193) 
 
Following the general procedure A (p.112), using indole 136 (239 mg, 0.68 mmol) and silyl 
enol ether 192
5
 (311 mg, 1.36 mmol) and heated under reflux for 17 h; column 
chromatography on silica gel (petroleum ether/EtOAc, 70/30) gave ketal 193 (166 mg, 57%) 
as a pale yellow solid; Rf 0.22 (petroleum ether/EtOAc, 60/40); mp 115-116 °C; IR υmax 2960, 
1710, 1366, 1166, 1116, 1018, 752 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 2.13-2.20 (m, 2H, 14-
CH2), 2.21-2.27 (m, 1H, 12-CH2), 2.34 (s, 3H, ArCH3), 2.43 (t, J 13.5, 1H, 12-CH2), 2.50-
2.57 (m, 1H, 15-CH2), 2.80-2.93 (m, 1H, 15-CH2), 3.96-4.13 (m, 4H, OCH2), 4.26 (dd, J 13.5, 
5.7, 1H, 11-CH), 6.50 (d, J 3.8, 1H, 3-CH), 7.01 (d, J 7.4, 1H, 5-CH), 7.22 (d, J 8.4, 2H, 
ArH), 7.28 (app t, J 8.0, 1H, 6-CH), 7.56 (d, J 3.8, 1H, 2-CH), 7.76 (d, J 8.4, 2H, ArH), 7.90 
(d, J 8.4, 1H, 7-CH); 
13
C NMR (100 MHz, CDCl3) δ 21.5 (CH3, ArCH3), 34.6 (CH2, 14-CH2), 
38.5 (CH2, 15-CH2), 41.1 (CH2, 12-CH2), 50.5 (CH, 11-CH), 64.7 (CH2, OCH2), 64.8 (CH2, 
OCH2), 106.9 (CH, 3-CH), 107.3 (C, 13-C), 112.5 (CH, 7-CH), 122.5 (CH, 5-CH), 124.6 
(CH, 6-CH), 126.0 (CH, 2-CH), 126.9 (CH, ArCH), 129.9 (CH, ArCH), 130.1 (C), 130.8 (C), 
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134.8 (C, Ar-C), 135.4 (C), 145.0 (C, Ar-C), 207.8 (C, 10-C); MS (ESI) m/z 448.2 ([M+Na]
+
, 
100%); HRMS (ESI) m/z 448.1200 [M+Na]
+
, C23H23NO5SNa requires 448.1195. 
 
3-Hydroxy-2-(1’-tosyl-1H-indol-4’-yl)cyclohex-2-enone  (195) 
 
Following the general procedure A (p.112), using indole 136 (300 mg, 0.86 mmol) and silyl 
enol ether 194
6
 (316 mg, 1.71 mmol) and heated under reflux for 17 h; column 
chromatography on silica gel (petroleum ether/EtOAc, 70/30) provided 195 (161 mg, 49%) as 
a yellow solid; Rf 0.12 (petroleum ether/EtOAc, 50/50); mp 94-95 °C; IR υmax  3125, 2925, 
1707, 1595, 1356, 1163, 1130, 756, 678 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 2.05-2.13 (m, 
2H, 14-CH2), 2.35 (s, 3H, ArCH3), 2.50 (dd, J 3.3, 2.1, 2H, 13-CH2), 2.62 (t, J 6.3, 2H, 15-
CH2), 6.10 (br s, 1H, OH), 6.36 (d, J 3.7, 1H, 3-CH), 7.04 (d, J 7.4, 1H, 5-CH), 7.24 (d, J 8.4, 
2H, ArH), 7.34 (app t, J 7.9, 1H, 6-CH), 7.57 (d, J 3.7, 1H, 2-CH), 7.78 (d, J 8.4, 2H, ArH), 
7.96 (d, J 8.4, 1H, 7-CH); 
13
C NMR (100 MHz, CDCl3) δ 20.5 (CH2, 14-CH2), 21.5 (CH3, 
ArCH3), 28.1 (CH2, 15-CH2), 36.9 (CH2, 13-CH2), 107.8 (CH, 3-CH), 113.6 (CH, 7-CH), 
115.5 (C, 11-C), 123.8 (C, 9-C), 125.1 (CH, 6-CH), 125.6 (CH, 5-CH), 126.5 (CH, 2-CH), 
126.9 (CH, ArCH), 130.0 (CH, ArCH), 130.5 (C, 4-C), 135.1 (C, ArC), 135.2 (C, 8-C), 145.2 
(C, ArC), 171.6 (C, 12-C), 196.6 (C, 10-C); MS (ESI) m/z 404.2 ([M+Na]
+
, 100%); HRMS 
(ESI) m/z 404.0938 [M+Na]
+
, C21H19NO4SNa requires 404.0932. 
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2-Hydroxy-2-(1’-tosyl-1H-indol-4’-yl)cyclohexanone (197) 
 
Following the general procedure A (p.112), using indole 136 (691 mg, 1.97 mmol) and silyl 
enol ether 196
7
 (1.02 g, 3.95 mmol) and heated under reflux for 48 h; column chromatography 
on silica gel (petroleum ether/EtOAc, 80/20) gave ketal 197 (140 mg, 18%) as a pale yellow 
solid; Rf 0.34 (petroleum ether/EtOAc, 60/40); mp 68-69 °C; IR υmax 3462, 2941, 1710, 1361, 
1166, 1133, 761, 678 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 1.64-1.78 (m, 1H, 14-CH), 1.79-
1.93 (m, 3H, 13-CH2 and 15-CH2 ), 1.99-2.09 (m, 1H, 14-CH2), 2.20-2.30 (m, 1H, 12-CH2), 
2.32 (s, 3H, ArCH3), 2.46 (dm, J 12.5, 1H, 12-CH2), 3.09 (dm, J 13.8 1H, 15-CH2), 4.61 (s, 
1H, OH), 6.59 (d, J 3.8, 1H, 3-CH), 7.20 (d, J 8.4, 2H, ArH), 7.34 (app t, J 8.0, 1H, 6-CH), 
7.42 (d, J 7.6, 1H, 5-CH), 7.54 (d, J 3.8, 1H, 2-CH), 7.74 (d, J 8.4, 2H, ArH), 7.99 (d, J 8.3, 
1H, 7-CH); 
13
C NMR (100 MHz, CDCl3) δ 21.5 (CH3, ArCH3), 23.3 (CH2, 13-CH2), 29.0 
(CH2, 14-CH2), 39.0 (CH2, 12-CH2), 41.0 (CH2, 15-CH2), 80.5 (C, 11-C), 107.6 (CH, 3-CH), 
113.8 (CH, 7-CH), 121.1 (CH, 5-CH), 124.2 (CH, 6-CH), 126.4 (CH, 2-CH), 126.8 (CH, 
ArCH), 129.0 (C, 9-C), 129.9 (CH, ArCH), 131.8 (C, 4-C), 135.1 (C, ArC), 135.6 (C, 8-C), 
145.1 (C, Ar-C), 213.8 (C, 10-C); MS (ESI) m/z 406.2 ([M+Na]
+
, 100%); HRMS (ESI) m/z 
406.1082 [M+Na]
+
, C21H21NO4SNa 406.1089. 
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2-(1H-Indol-4’-yl)-6-(propan-2’’-ylidene)cyclohexanone (179) 
 
Cs2CO3 (79 mg, 0.24 mmol) was added to a solution of 189 (33 mg, 0.08 mmol) in a 2:1 
mixture of THF/MeOH (8 mL) at rt. After 18 h at 65 °C, the reaction mixture was poured into 
H2O and extracted with CH2Cl2 (3  5 mL). The combined organic layers were washed with 
brine (15 mL), dried over MgSO4 and concentrated under reduced pressure. The residue was 
purified by column chromatography on silica gel (petroleum ether/EtOAc, 95/10) to afford 
indole 179 (19 mg, 95%) as a yellow oil; Rf 0.53 (petroleum ether/EtOAc, 80/20); IR υmax 
3331, 1670, 1336, 752 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 1.75-1.89 (m, 1H, 13-CH2), 1.85 
(s, 3H, CH3), 1.94 (s, 3H, CH3), 1.97-2.09 (m, 1H, 13-CH2), 2.09-2.23 (m, 2H, 12-CH2), 2.35-
2.46 (m, 1H, 14-CH2), 2.77-2.89 (m, 1H, 14-CH2), 3.94-4.02 (m, 1H, 11-CH), 6.41-6.45 (m, 
1H, 3-CH), 6.91 (d, J 7.1, 1H, 5-CH), 7.11-7.22 (m, 2H, 2-CH and 6-CH), 7.29 (d, J 8.2, 1H, 
7-CH), 8.17 (br s, 1H, NH); 
13
C NMR (100 MHz, CDCl3) δ 22.0 (CH3), 23.0 (CH3), 24.0 
(CH2, 13-CH2), 30.3 (CH2, 14-CH2), 32.3 (CH2, 12-CH2), 56.1 (CH, 11-CH), 101.1 (CH, 3-
CH), 109.8 (CH, 7-CH), 119.0 (CH, 5-CH), 121.9 (CH, 6-CH), 123.8 (CH, 2-CH), 127.0 (C), 
133.0 (C), 133.2 (C), 136.0 (C), 141.7 (C), 204.4 (C, 10-C); MS (ESI) m/z 276.2 ([M+Na]
+
, 
100%); HRMS (ESI) m/z 276.1356 [M+Na]
+
, C17H19NONa requires 276.1364. 
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2-(1’-Methyl-1H-indol-4’-yl)-6-(propan-2’’-ylidene)cyclohexanone (180) 
 
A solution of P
t
Bu3 (1 M solution in toluene, 1.3 mL, 0.13 mmol) was added to a solution of 
Pd(OAc)2 (16 mg, 0.071 mmol), Bu3SnF (1.03 g, 3.33 mmol) and CsF (506 mg, 3.33 mmol) 
in toluene (10 mL). A solution of indole 75 (500 mg, 2.38 mmol) and silyl enol ether 188 
(700 mg, 3.33 mmol) in toluene (3 mL) was added and the mixture was heated at 85 °C 
overnight. After cooling to rt, the mixture was diluted with Et2O (20 mL), filtered through a 
plug of silica and concentrated under reduced pressure. The residue was purified by column 
chromatography on silica gel (petroleum ether/EtOAc, 95/5) to provide enone 180 as a yellow 
oil (347 mg, 55%); Rf 0.29 (petroleum ether/EtOAc, 90/10); IR υmax 2930, 1673, 1443, 1287, 
745 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 1.76-1.88 (m, 1H, 13-CH2), 1.85 (s, 3H, CH3), 1.95 
(s, 3H, CH3), 1.99-2.07 (m, 1H, 13-CH2), 2.26-2.33 (m, 2H, 12-CH2), 2.48-2.60 (m, 1H, 14-
CH2), 2.79-2.87 (m, 1H, 14-CH2), 3.78 (s, 3H, NCH3), 3.95-4.01 (m, 1H, 11-CH), 6.36 (d, J 
3.1, 1H, 3-CH), 6.92 (d, J 7.0, 1H, 5-CH), 7.03 (d, J 3.1, 1H, 2-CH), 7.17-7.25 (m, 2H, 6-CH 
and 7-CH); 
13
C NMR (100 MHz, CDCl3) δ 22.0 (CH3), 22.9 (CH3), 24.0 (CH2, 13-CH2), 30.3 
(CH2, 14-CH2), 32.3 (CH2, 12-CH2), 32.9 (CH3, NCH3), 56.0 (CH, 11-CH), 99.5 (CH, 3-CH), 
108.0 (CH, 7-CH), 118.6 (CH, 5-CH), 121.6 (CH, 6-CH), 127.6 (CH, 2-CH), 128.4 (C), 133.2 
(C), 133.2 (C), 136.8 (C), 141.5 (C), 204.2 (C); MS (EI) m/z 267.2 ([M]
+
, 100%); HRMS (EI) 
m/z 267.1622 [M]
+
, C18H21NO requires 267.1623. 
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4-Bromo-1-methyl-1H-indole (75)
8 
 
A solution of 4-bromoindole (10.0 g, 15 mmol) in THF (30 mL) was added to a suspension of 
NaH (3.0 g, 60% dispersion in mineral oil, 77 mmol) in THF (40 mL) at 0 °C. After 15 min, a 
solution of MeI (14.5 g, 102 mmol) was added dropwise, over a period of 10 min, at 0 °C and 
the mixture was stirred overnight at rt. The excess of NaH was destroyed by addition of 
MeOH/H2O solution (1/1, 80 mL). The aqueous layer was subsequently extracted with Et2O 
(3  80 mL). The combined organic layers were dried over MgSO4 and concentrated under 
reduced pressure. The residue was purified by column chromatography on silica gel 
(petroleum ether/EtOAc, 95/5) to provide indole 75 as a yellow oil
8
 (10.3 g, 97%); Rf 0.60 
(petroleum ether/EtOAc, 80/20); 
1
H NMR (400 MHz, CDCl3) δ 3.78 (s, 3H, NCH3), 6.56 (d, J 
3.2, 1H, 3-CH), 7.10 (d, J 3.2, 1H, 2-CH), 7.12 (app t, 8.0, 1H, ArH), 7.29 (d, J 8.0, 1H, 7-
CH), 7.32 (dd, J 7.6, 0.8, 1H, 5-CH); 
13
C NMR (100 MHz, CDCl3) δ 33.2 (CH3, NCH3), 
101.4 (CH, 3-CH), 108.5 (CH, 7-CH), 114.9 (C, 4-C), 122.2 (CH, 6-CH), 122.4 (CH, 5-CH), 
129.2 (C, 9-C), 129.4 (CH, 2-CH), 137.0 (C, 8-C); MS (EI) m/z 209.1 ([M]
+
, 100%), 211.1 
(97%); HRMS (EI) m/z 208.9849 [M]
+
, C9H8
79
Br requires 208.9840. 
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Cyclohexanone (9.8 mL, 0.10 mol) and bromoindole 75 (5 g, 0.02 mol) were sequentially 
added to a solution of Pd2(dba)3·CHCl3 (370 mg, 0.36 mmol), (S)-Tol-Binap (582 mg, 0.86 
mmol) and NaO
t
Bu (3.0 g, 0.03 mol) in THF (125 mL). After 3 h at 70 °C, the mixture was 
cooled to rt, diluted with with H2O (125 mL) and extracted with Et2O (3  100 mL). The 
combined organic layers were dried over MgSO4 and concentrated under reduced pressure. 
The residue was purified by column chromatography on silica gel (petroleum ether/EtOAc, 
80/20) to give indole 77 as a yellow solid (4.1 g, 76%); Rf 0.30 (petroleum ether/EtOAc, 
90/10); mp 121-123 °C [lit.,
9
 mp 124-125 °C]; 
1
H NMR (400 MHz, CDCl3) δ 1.85-1.98 (m, 
2H, 13-CH2), 1.99-2.11 (m, 1H, 14-CH2), 2.22-2.29 (m, 1H, 14-CH2), 2.30-2.44 (m, 2H, 12-
CH2), 2.51-2.68 (m, 2H, 15-CH2), 3.79 (s, 3H, NCH3), 4.00 (dd, J 11.5, 6.5, 1H, 11-CH), 6.33 
(dd, J 3.1, 0.6, 1H, 3-CH), 6.85 (dd, J 6.9, 0.7, 1H, 5-CH), 7.04 (d, J 3.2, 1H, 2-CH), 7.18-
7.28 (m, 2H, 6-CH and 7-CH); 
13
C NMR (100 MHz, CDCl3) δ 25.6 (CH2, 13-CH2), 27.8 
(CH2, 14-CH2), 30.9 (CH3, NCH3), 34.2 (CH2, 12-CH2), 42.4 (CH2, 15-CH2), 55.3 (CH, 11-
CH), 99.4 (CH, 3-CH), 108.3 (CH, 7-CH), 118.4 (CH, 5-CH), 121.6 (CH, 6-CH), 128.0 (C, 9-
C), 128.5 (CH, 2-CH), 131.4 (C, 4-C), 136.7 (C, 8-C), 209.9 (C, 10-C); MS (EI) m/z 250.2 
([M+Na]
+
, 100%); HRMS (ESI) m/z 250.1202 [M+Na]
+
, C15H17NONa requires 250.1202. 
 
2-(1’-Methyl-1H-oxindol-4’-yl)cyclohexanone (200) 
 
NBS (2.2 g, 12.3 mmol) was added in small portions over a period of 20 min to a solution of 
indole 77 (2 g, 8.8 mmol) in 
t
BuOH/H2O (95/5, 150 mL) and the reaction mixture was stirred 
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for 3 h at rt. The solution was concentrated under reduced pressure at rt, and H2O was added 
to the residue (150 mL). The mixture was extracted with CH2Cl2 (3  150 mL) and the 
combined organic layers were dried over MgSO4 and concentrated under reduced pressure. 
The residue was purified by column chromatography on silica gel (petroleum ether/EtOAc, 
60/40) to afford 200 as a white solid (1.22 g, 57%); Rf 0.17 (petroleum ether/EtOAc, 60/40); 
mp 105-106 °C; IR υmax 2948, 1701, 1608, 1470, 1335, 1289, 781 cm
-1
; 
1
H NMR (400 MHz, 
CDCl3) δ 1.67-1.91 (m, 2H, 13-CH2 and 14-CH2), 1.96-2.11 (m, 2H, 12-CH2 and 13-CH2), 
2.14-2.32 (m, 2H, 12-CH2 and 14-CH2), 2.40-2.61 (m, 2H, 15-CH2), 3.19 (s, 3H, NCH3), 3.31 
(AB system, JA-B  21.9, 1H, 3-CH2), 3.40 (AB system, JA-B 21.9, 1H, 3-CH2), 3.56 (dd, J 12.8, 
5.5, 1H, 11-CH), 6.74 (d, J 7.8, 1H, 5-CH), 6.85 (d, J 7.8, 1H, 7-CH), 7.28 (app t, J 7.8, 1H, 
6-CH); 
13
C NMR (100 MHz, CDCl3) δ 25.4 (CH2, 13-CH2), 26.2 (CH3, NCH3), 27.4 (CH2, 
14-CH2), 33.5 (CH2, 12-CH2), 34.9 (CH2, 15-CH2), 42.1 (CH2, 3-CH2), 54.9 (CH, 11-CH), 
106.9 (CH, 7-CH), 122.0 (CH, 5-CH), 123.6 (CH, 6-CH), 127.9 (C, 9-C), 135.1 (C, 4-C), 
144.9 (C, 8-C), 174.8 (C, 2-C), 208.7 (C, 10-C); MS (ESI) m/z 266.1 ([M+Na]
+
, 100%); 
HRMS (EI) m/z 266.1160 [M+Na]
+
, C15H17NO2Na requires 266.1157. 
 
1-Methyl-4-(2’-oxocyclohexyl)indoline-2,3-dione (203) 
 
IBX (154 mg, 0.55 mmol) and CeCl3·7H2O (8 mg, 0.02 mmol) were added to a solution of 
indole 77 (50 mg, 0.22 mmol) in CH3CN/H2O (2.5 mL of a 9/1 solution). The reaction 
mixture was stirred for 15 h at rt, filtered through Celite
®
 and washed with EtOAc (2  3 mL). 
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The organic layer was washed with NaHCO3 solution (5 mL of a saturated aqueous solution) 
and brine (5 mL), dried over MgSO4 and concentrated under reduced pressure. The residue 
was purified by column chromatography on silica gel (petroleum ether/EtOAc, 70/30) to 
afford oxindole 200 (6 mg, 11%) as a white solid, data as previously described (p.131); along 
with isatin 203 (15 mg, 26%) as a red solid; Rf 0.14 (petroleum ether/EtOAc, 60/40); mp 65-
66 °C; IR υmax 2924,1725, 1707, 1595, 1460, 1068, 786 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 
1.81-1.94 (m, 2H, 13-CH2 and 14-CH2), 1.95-2.07 (m, 2H, 12-CH2 and 13-CH2), 2.15-2.27 
(m, 2H, 12-CH2 and 14-CH2), 2.52-2.61 (m, 2H, 15-CH2), 3.22 (s, 3H, NCH3), 4.30 (dd, J 
12.6, 5.4, 1H, 11-CH), 6.77 (d, J 7.8, 1H, 5-CH), 6.93 (d, J 7.8, 1H, 7-CH), 7.53 (t, J 7.8, 1H, 
6-CH); 
13
C NMR (100 MHz, CDCl3) δ 25.2 (CH2, 13-CH2), 26.1(CH3, NCH3), 26.9 (CH2, 14-
CH2), 32.9 (CH2, 12-CH2), 42.0 (CH2, 15-CH2), 52.8 (CH, 11-CH), 108.4 (CH, 7-CH), 115.33 
(C, 9-C), 124.0 (CH, 5-CH), 137.9 (CH, 6-CH), 141.6 (C, 4-C), 151.8 (C, 8-C), 158.0 (C, 2-
C), 183.4 (C, 3-C), 208.0 (C, 10-C), one C not observed; MS (EI) m/z 257 ([M]
+
, 100%); 
HRMS (EI) m/z 257.1043 [M]
+
, C15H15NO3 requires 257.1051. 
 
2-(2’-(tert-Butyldimethylsilyloxy)-1’’-methyl-1H-indol-4’’-yl)cyclohexanone (208) 
 
TBDMSOTf (208 μL, 0.94 mmol) was added to a solution of oxindole 200 (200 mg, 0.82 
mmol) and Et3N (137 μL, 0.99 mmol) in CH2Cl2 (6 mL) at rt. After 1 h at rt, the reaction was 
quenched with NaHCO3 solution (6 mL of a saturated aqueous solution) and extracted with 
Et2O (10 mL). The combined organic layers were washed with brine (20 mL), dried over 
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MgSO4 and concentrated under reduced pressure. The residue was purified by column 
chromatography on silica gel (petroleum ether/Et2O/Et3N, 49/49/2) to give silyl enol ether 
208 (226 mg, 77%) as a colourless oil; Rf 0.56 (petroleum ether/EtOAc, 90/10); IR υmax 2931, 
1709, 1552, 1470, 1254, 840, 785 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 0.31 (d, J 1.7, 6H, 
CH3), 1.04 (s, 9H, CH3), 1.81-1.95 (m, 2H, 13-CH and14-CH), 2.00-2.21 (m, 2H, 13-CH and 
14-CH), 2.22-2.37 (m, 2H, 12-CH), 2.46-2.63 (m, 2H, 15-CH2), 3.53 (s, 3H, NCH3), 3.86 (dd, 
J 11.5, 5.9, 1H, 11-CH), 5.37 (s, 1H, 3-CH), 6.90 (dd, J 5.8, 2.6, 1H, 5-CH), 7.05-7.10 (m, 
2H, 6-CH and 7-CH); 
13
C NMR (100 MHz, CDCl3) δ -4.8 (CH3), 18.1 (C), 25.5 (CH2, 13-
CH2), 25.6 (CH3), 27.4 (CH3, NCH3), 27.8 (CH2, 14-CH2), 34.0 (CH2, 12-CH2), 42.2 (CH2, 
15-CH2), 54.9 (CH, 11-CH), 79.0 (CH, 3-CH), 107.1 (CH, 7-CH), 118.6 (CH, 5-CH), 119.1 
(CH, 6-CH), 126.3 (C, 9-C), 128.9 (C, 4-C), 132.1 (C, 8-C), 148.4 (C, 2-C), 210.1 (C, 10-C); 
MS (ESI) m/z 380.3 ([M+Na]
+
, 100%); HRMS (ESI) m/z 380.2027 [M+Na]
+
, C21H31NO2SiNa 
requires 380.2022. 
 
2-(tert-Butyldimethylsilyloxy)-4-(2’-(tert-butyldimethylsilyloxy)cyclohex-2’’-enyl)-1-
methyl-1H-indole (209) 
 
TBDMSOTf (1.22 mL, 5.31 mmol) was added dropwise over a period of 5 min to a solution 
of oxindole 200 (614 mg, 2.52 mmol) and Et3N (774 μL, 5.55 mmol) in dry CH2Cl2 (15 mL) 
at rt. After 1 h at rt, the reaction was quenched with NaHCO3 solution (30 mL of a saturated 
aqueous solution) and extracted with Et2O (30 mL). The combined organic layers were 
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washed with brine (50 mL), dried over MgSO4 and concentrated under reduced pressure. The 
residue was purified by column chromatography on silica gel (petroleum ether/Et2O/Et3N, 
95/4/1) to provide silyl enol ether 209 (1.08 g, 91%) as a colourless oil; Rf 0.80 (petroleum 
ether/Et2O, 99/1); IR υmax 2929, 837, 781 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ -0.04 (s, 3H, 
CH3), 0.07 (s, 3H, CH3), 0.34 (s, 3H, CH3), 0.34 (s, 3H, CH3), 0.65 (s, 9H, CH3), 1.07 (s, 9H, 
CH3), 1.47-1.58 (m, 1H, 13-CH2), 1.60-1.71 (m, 1H, 13-CH2), 1.88-1.97 (m, 1H, 12-CH2), 
1.99-2.09 (m, 1H, 12-CH2), 2.11-2.28 (m, 2H, 14-CH2), 3.55 (s, 3H, NCH3), 3.70 (app t, J 
5.7, 1H, 11-CH), 5.09 (app t, J 3.9, 1H, 15-CH), 5.63 (s, 1H, 3-CH), 6.93 (dd, J 6.3, 2.1, 1H, 
5-CH), 6.99-7.04 (m, 2H, 6-CH and 7-CH); 
13
C NMR (100 MHz, CDCl3) δ -4.8 (CH3), -4.4 
(CH3), 17.8 (C), 18.2 (C), 20.1 (CH2, 13-CH2), 24.3 (CH2, 14-CH2), 25.4 (CH3), 25.7 (CH3), 
27.4 (CH3, NCH3), 31.0 (CH2, 12-CH2), 43.5 (CH, 11-CH), 79.0 (CH, 3-CH), 104.8 (CH, 15-
CH), 106.0 (CH, 7-CH), 118.7 (CH, 6-CH), 119.1 (CH, 5-CH), 126.1 (C, 9-C), 132.2 (C, 4-
C), 134.0 (C, 8-C), 148.0 (C, 10-C), 151.4 (C, 2-C); MS (ESI) m/z 494.3 ([M+Na]
+
, 100%); 
HRMS (ESI) m/z 494.2893 [M+Na]
+
, C27H45NO2Si2Na requires 494.2887. 
 
3-(2’-Methoxypropan-2’-yl)-1-methyl-4-(2’’-oxocyclohexyl)indolin-2-one (212) 
 
2,2-Dimethoxypropane (26 μL, 0.21 mmol) was added to a solution of TiCl4 (1 M solution in 
toluene, 212 μL, 0.21 mmol) in CH2Cl2 (1 mL) at -78 °C. A solution of 209 (100 mg, 0.21 
mmol) in CH2Cl2 (1 mL) was added immediately to the reaction mixture, which was stirred 
for 4.5 h at -78 °C. The reaction was quenched with H2O (2 mL) at -78 °C. The separated 
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aqueous phase was extracted with Et2O (2  2 mL). The combined organic layers were dried 
over MgSO4 and concentrated under reduced pressure. The residue was purified by column 
chromatography on silica gel (petroleum ether/EtOAc, 70/30) to give oxindole 200 (8 mg, 
16%) as a white solid, data as previously described (p.131) and a mixture of diatereoisomers 
(ratio 2.4:1) of oxindole 212 (44 mg, 66%) as a white solid; Rf 0.34 (petroleum ether/EtOAc, 
60/40); mp 115-117 °C; IR υmax 2936, 1707, 1052, 779 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 
0.69 (s, 3H, CH3, major), 0.74 (s, 3H, CH3, minor), 1.52 (s, 3H, CH3, major), 1.57 (s, CH3, 
minor), 1.70-1.89 (m, 3H), 1.91-2.06 (m, 2H), 2.10-2.24 (m, 1H) 2.38-2.56 (m, 2H), 2.98 (s, 
3H, OCH3, major), 3.11 (s, 3H, NCH3, minor), 3.14 (s, 3H, NCH3, major), 3.23 (s, 3H, OCH3, 
minor), 3.43 (s, 1H, 3-CH, minor), 3.48 (s, 1H, 3-CH, major), 4.27 (dd, J  12.0, 5.0, 1H, 11-
CH, major), 4.40 (dd, 12.3, 5.3, 1H, 11-CH, minor), 6.60-6.70 (m, 1H, ArH), 6.81 (d, J 8.0, 
1H, ArH, minor), 6.87 (d, J 8.0, ArH, major), 7.20-7.31 (m, 1H, ArH); 
13
C NMR (100 MHz, 
CDCl3) δ 18.0 (CH3, major), 18.5 (CH3, minor), 22.6 (CH3, minor), 22.7 (CH3, major), 25.6 
(CH2, minor), 26.0 (CH2, major), 26.1 (CH3, NCH3), 27.7 (CH2, minor), 28.3 (CH2, major), 
34.9 (CH2, minor), 36.4 (CH2, major), 42.3 (CH2, minor), 42.6 (CH2, major), 48.7 (CH3, 
OCH3, major), 48.8 (CH3, OCH3, minor), 54.4 (CH, minor), 55.0 (CH, major), 55.4 (CH, 
minor and major), 78.2 (C minor and major), 105.6 (CH, 7-CH, major), 106.1 (CH, 7-CH, 
minor), 123.1 (CH, 5-CH, minor), 123.3 (CH, 5-CH, major), 126.0 (C, major), 126.2 (C, 
minor), 127.6 (CH, 6-CH, minor), 127.8 (CH, 6-CH, major), 137.9 (C, minor), 138.4 (C, 
major), 144.8 (C, major), 145.1 (C, minor), 175.5 (C, 2-C, minor and major), 210.1 (C, 10-C, 
major), 210.8 (C, 10-C, minor); MS (ESI) m/z 338.2 ([M+Na]
+
, 100%); HRMS (ESI) m/z 
338.1736 [M+Na]
+
, C19H25NO3Na requires 338.1732. 
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4-(2’-(tert-Butyldimethylsilyloxy)cyclohex-2’-enyl)-3-(2’’-methoxypropan-2’-yl)-1-
methylindolin-2-one (213) and 4-(2’-(tert-butyldimethylsilyloxy)cyclohex-2’’-enyl)-1-
methylindolin-2-one (214) 
 
A solution of ZnCl2 (1 M in CH2Cl2, 411 μL, 0.41 mmol) was added to a solution of 209 (194 
mg, 0.41 mmol) and 2,2-dimethoxypropane (51 μL , 0.41 mmol) in CH2Cl2 (2 mL) at -78 °C. 
The reaction mixture was stirred for 6 h at -78 °C and a further 2 h at -40 °C and quenched 
with NaHCO3 solution (5 mL of a saturated aqueous solution). The separated aqueous phase 
was extracted with Et2O (2  10 mL) and the combined organic layers were dried over 
MgSO4 and concentrated under reduced pressure. The residue was purified by column 
chromatography on silica gel (petroleum ether/Et2O/Et3N, 95/4/1) to afford enol silane 213 
(48 mg, 27%) as a colourless oil and oxindole 214 (73 mg, 50%) as a white solid. 
Data for 213; Rf 0.55 (peteoleum ether/EtOAc, 80/20); IR υmax 2929, 1692, 1252, 832, 774 
cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 0.08 (s, 3H, CH3), 0.16 (s, 3H, CH3), 0.736 (s, 9H, CH3), 
0.92 (s, 3H, CH3), 1.35-1.48 (m, 3H, 12-CH2 and 13-CH2), 1.51 (s, 3H, CH3), 1.77-1.92 (m, 
1H, 12-CH2), 2.00-2.17 (m, 2H, 14-CH2), 3.13 (s, 3H, NCH3), 3.24 (s, 3H, CH3), 3.66 (s, 1H, 
2-CH), 4.47-4.53 (m, 1H, 11-CH), 5.00-5.03 (m, 1H, 15-CH), 6.61 (d, J 7.4, 1H, 5-CH), 6.91 
(d, J 8.0, 1H, 7-CH), 7.16 (app t, J 7.8, 1H, 6-CH); 
13
C NMR (100 MHz, CDCl3) δ -4.9 
(CH3), -4.3 (CH3), 17.9 (C), 19.4 (CH2, 13-CH2), 21.1 (CH3), 23.3 (CH3), 24.2 (CH2, 14-
CH2), 25.5 (CH3), 26.1 (CH3, NCH3), 31.9 (CH2, 12-CH2), 41.4 (CH, 11-CH), 48.8 (CH3, 
OCH3), 54.1 (CH, 3-CH), 78.5 (C, 16-C), 104.4 (CH, 15-CH), 105.3 (CH, 5-CH), 122.9 (CH, 
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7-CH), 125.8 (C, 9-C), 127.1 (CH, 6-CH), 143.4 (C, 4-C), 145.4 (C, 8-C), 151.3, (C, 10-C), 
176.2 (C, 2-C); MS (ESI) m/z 452.2 ([M+Na]
+
, 100%); HRMS (ESI) m/z 452.2596 [M+Na]
+
, 
C25H39NO3SiNa requires 452.2597. 
Data for 214, Rf 0.23 (petroleum ether/EtOAc, 90/10); mp 96-97 °C; IR υmax 2925, 1701, 
1603, 1225, 836, 774 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 0.01 (s, 3H, CH3), 0.04 (s, 3H, 
CH3), 0.62 (s, 9H, CH3), 1.46-1.57 (m, 1H, 13-CH2), 1.58-1.70 (m, 2H, 12-CH2 and 13-CH2), 
1.94-2.04 (m, 1H, 12-CH2), 2.06-2.22 (m, 2H, 14-CH2), 3.19 (s, 3H, NCH3), 3.37 (app t, J 
6.1, 1H, 11-CH), 3.49 (d, J 3.0, 2H, 3-CH2), 5.00-5.05 (m, 1H, 15-CH), 6.65 (d, J 7.7, 1H, 5-
CH), 6.89 (d, J 7.9, 1H, 7-CH), 7.19 (app t, J 7.8, 1H, 6-CH); 
13
C NMR (100 MHz, CDCl3) δ 
-4.7 (CH3), 17.7 (CH), 20.7 (CH2, 13-CH2), 24.1 (CH2, 14-CH2), 25.3 (CH3), 26.2 (CH3, 
NCH3), 31.2 (CH2, 12-CH2), 34.7 (CH2, 2-CH2), 44.1 (CH, 11-CH), 105.5 (CH, 5-CH), 105.8 
(CH, 15-CH), 122.7 (CH, 7-CH), 122.9 (C, 9-C), 127.5 (CH, 6-CH), 140.5 (C, 4-C), 144.9 (C, 
8-C), 149.9 (C, 10-C), 175.3 (C, 2-C); MS (ESI) m/z 380.3 ([M+Na]
+
, 100%); HRMS (ESI) 
m/z 380.2033 [M+Na]
+
, C21H31NO2SiNa requires 380.2022. 
 
4-Bromo-1-methylindolin-2-one (217)
10
 
 
NaH (414 mg, 60% dispersion in mineral oil, 0.01 mmol) was added to a solution of             
4-bromoisatin (2.00 g, 0.09 mmol) in DMF (15 mL) at 0 °C. After 30 min at rt, MeI (0.72 mL, 
0.06 mmol) was added and the resultant mixture was stirred for 28 h at rt. Addition of ice-
cold H2O and filtration of the solid after evaporation of the solvent under reduced pressure 
afforded 216. The crude 216 was dissolved in H2NNH2 (12 mL) and heated under reflux for 
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1.5 h. The mixture was cooled to rt and H2O (120 mL) and EtOAc (120 mL) were added. The 
separate aqueous phase was extracted with EtOAc (3  60 mL) and the combined organic 
layers were dried over MgSO4 and concentrated under reduced pressure. The residue was 
purified by column chromatography on silica gel (petroleum ether/EtOAc, 75/25) to give 
oxindole 217 (1.20 g, 60%) as a pale yellow solid; mp 135-137 °C [lit.,
10
 138-139 °C]; Rf 
0.56 (petroleum ether/EtOAc, 60/40); 
1
H NMR (400 MHz, CDCl3) δ 3.19 (s, 3H, NCH3), 3.46 
(s, 2H, 3-CH2), 6.75-6.71 (m, 1H, 6-CH), 7.15-7.17 (m, 2H, 5-CH and 7-CH); 
13
C NMR (100 
MHz, CDCl3) δ 26.5 (CH3, NCH3), 37.1, (CH2, 3-CH2), 106.8 (CH, 7-CH), 119.0 (C, 4-C), 
125.3 (CH, 6-CH), 125.4 (C, 9-C), 129.5 (CH, 5-CH), 146.1 (C, 8-C), 173.8 (C, 2-C); MS 
(EI) m/z 225.0 ([M]
+
, 100%), 227.0 (97%); HRMS (EI) m/z 224.9783 [M]
+
, C9H8NO
79
Br 
requires 224.9789. 
 
4-Bromo-2-(tert-butyldimethylsilyloxy)-1-methyl-1H-indole (218) 
 
TBDMSOTf (256 L, 1.11 mmol) was added dropwise over a period of 5 min to a solution of 
oxindole 217 (229 mg, 1.01 mmol) and Et3N (184 L, 1.32 mmol) in dry CH2Cl2 (5 mL) at rt. 
The reaction mixture was stirred for 1 h at rt and then quenched with NaHCO3 solution (5 mL 
of a saturated aqueous solution). The separated aqueous phase was extracted with Et2O (5 
mL). The organic extract was washed with brine (5 mL), dried over MgSO4 and concentrated 
under reduced pressure. The residue was purified by column chromatography on silica gel 
(petroleum ether/Et2O/Et3N, 30/69/1) to provide enol silane 218 (227 mg, 80%) as a yellow 
oil; Rf 0.79 (petroleum ether/EtOAc, 90/10); IR υmax 2929, 1551, 1470, 1254, 830, 786, 725 
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cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 0.34 (s, 6H, CH3), 1.04 (s, 9H, CH3), 3.54 (s, 3H, NCH3), 
5.57 (s, 1H, 3-CH), 6.92 (app t, J 7.9, 1H, 6-CH), 7.08 (d, J 8.0, 1H, 7-CH), 7.18 (dd, J 7.7, 
0.8, 1H, 5-CH); 
13
C NMR (100 MHz, CDCl3) δ -4.8 (CH3), 18.2 (C), 25.6 (CH3), 27.7 (CH3, 
NCH3), 80.8 (CH, 3-CH), 107.2 (CH, 7-CH), 112.5 (C, 4-C), 120.0 (CH, 5-CH), 122.4 (CH, 
6-CH), 127.8 (C, 9-C), 132.5 (C, 8-C); 149.1 (C, 2-C); MS (ESI) m/z 340.1 ([M+H]
+
, 100%), 
342.1 (97%); HRMS (ESI) m/z 340.0726 [M+H]
+
, C15H23NOSi
79
Br requires 340.0732. 
 
1-(4’-Bromo-1H-indol-3’-yl)ethanone (220)11 
 
AcCl (6.2 mL, 87 mmol) was added to a solution of 4-bromoindole (8.6 g, 44 mmol) in 
toluene (500 mL) at 0 °C. The mixture was stirred for 15 min at that temperature and a 
solution of SnCl4 (10.3 mL, 87 mmol) in toluene (200 mL) was added. After 2 h at 0 °C, 
NaHCO3 solution (750 mL of a 8% aqueous solution) was added and the mixture was 
extracted with EtOAc (2  1 L). The combined organic layers were dried over MgSO4 and 
concentrated under reduced pressure. The residue was purified by recrystallisation from 
acetone to provide indole 220 (8.7 g, 88%) as a white solid
11
; mp 166-168 °C [lit.,
11
 167-168 
°C]; 
1
H NMR (400 MHz, CD3OD) δ 2.56 (s, 3H, CH3), 7.13 (app t, J 7.9, 1H, 6-CH), 7.73 
(dd, J 7.7, 0.8, 1H, 5-CH), 7.47 (dd, J 8.1, 0.8, 7-CH), 8.18 (s, 1H, 2-CH);
13
C NMR (100 
MHz, CD3OD) δ 30.3 (CH3), 113.2 (CH, 7-CH), 116.2 (C), 120.4 (C), 126.0 (CH, 6-CH), 
126.7 (C), 129.2 (CH, 5-CH), 136.8 (CH, 2-CH), 141.2 (C), 196.4 (C); MS (ESI) m/z 259.9 
([M+Na]
+
, 100%), 261.9 (97%); HRMS (ESI) m/z 259.9684 [M+Na]
+
, C10H8NO
79
BrNa 
requires 259.9687. 
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1-(4’-Bromo-1’-tosyl-1H-indol-3’-yl)ethanone (131)11 
 
DMAP (234 mg, 1.91 mmol), TsCl (8.0 g, 42 mmol) and 
i
Pr2NH (10 mL, 57 mmol) were 
added to a solution of 220 (8.7 g, 38 mmol) in CH2Cl2 (190 mL). The resultant mixture was 
stirred overnight at rt and HCl solution (250 mL of a 10% aqueous solution) and CH2Cl2 (500 
mL) were added and the mixture was extracted with CH2Cl2 (3  500 mL). The combined 
organic layers were dried over MgSO4 and concentrated under reduced pressure. The residue 
was purified by column chromatography on silica gel (petroleum ether/EtOAc, 80/20) to give 
sulfonamide 131 (14.3 g, 95%) as a white solid;
 11
 Rf 0.22 (petroleum ether/EtOAc, 80/20); 
mp 142-144 °C [lit.,
11
 142.5-143 °C]; 
1
H NMR (400 MHz, CDCl3) δ 2.38 (s, 3H, ArCH3), 
2.63 (s, 3H, CH3), 7.21 (app t, J 8.1, 1H, 6-CH), 7.28 (d, J 8.3, 2H, ArH), 7.51 (dd, J 7.8, 0.6, 
1H, 5-CH), 7.79 (d, J 8.3, 2H, ArH), 7.94 (dd, J 8.3, 0.6, 1H, 7-CH), 8.04 (s, 1H, 2-CH); 
13
C 
NMR (100 MHz, CDCl3) δ 21.6 (CH3), 31.2 (CH3), 112.4 (CH, 7-CH), 115.0 (C), 124.2 (C), 
126.5 (CH, 6-CH), 126.9 (C), 127.1 (CH, ArCH), 129.5 (CH, 5-CH), 130.2 (CH, 7-CH), 
130.3 (CH, ArCH), 134.3 (C), 136.1 (C), 146.2 (C), 194.1 (C); MS (ESI) m/z 414 ([M+Na]
+
, 
100%), 416 (97%); HRMS (ESI) m/z 413.9768 [M+Na]
+
, C17H14NO3S
79
BrNa requires 
413.9775. 
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2-(4’-Bromo-1’-tosyl-1H-indol-3’-yl)propan-2-ol (132)11 
 
MeMgBr (3 M solution in Et2O, 28 mL, 83 mmol) was added via cannula into a solution of 
131 (14.3 g, 36 mmol) in THF (325 mL) at 0 °C. After 30 min at 0 °C, a 1:1 mixture (250 
mL) of H2O and NH4Cl solution (saturated aqueous solution) was added. The resultant 
mixture was extracted with Et2O (3  400 mL) and the combined organic layers were dried 
over MgSO4 and concentrated under reduced pressure. The residue was purified by column 
chromatography on silica gel (petroleum ether/EtOAc, 80/20) to afford alcohol 132 (13.8 g, 
92%) as a white solid;
11
 Rf 0.24 (petroleum ether/EtOAc, 80/20), mp 98-100 °C [lit.,
11
 100-
101°C]; 
1
H NMR (400 MHz, CDCl3) δ 1.81 (s, 6H, CH3), 2.36 (s, 3H, ArCH3), 3.27 (br s, 1H, 
OH), 7.14 (app t, J 8.1, 1H, 6-CH), 7.24 (d, J 8.4, 2H, ArH), 7.50 (dd, J 7.8, 0.9, 1H, 5-CH), 
7.65 (s, 1H, 2-CH), 7.74 (d, J 8.4, 2H, ArH), 8.02 (dd, J 8.4, 0.9, 1H, 7-CH); 
13
C NMR (100 
MHz, CDCl3) δ 21.58 (CH3, ArCH3), 31.7 (CH3), 68.9 (C), 113.1 (C), 113.1 (CH, 7-CH), 
124.2 (CH, 2-CH), 125.3 (CH, 6-CH), 126.9 (CH, ArCH), 128.3 (C), 128.9 (CH, 5-CH), 
129.2 (C), 130.1 (CH, ArCH), 134.8 (C), 137.6 (C), 145.4 (C); MS (ESI) m/z 430.1 
([M+Na]
+
, 100%), 431.1 (97%); HRMS (ESI) m/z 430.0093 [M+Na]
+
, C18H18NO3S
79
BrNa 
requires 430.0088. 
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2-(2’-(4’’-Bromo-1’’-tosyl-1H-indol-3’’-yl)propan-2-yl)cyclohexanone (221)11 
 
Silyl enol ether 144 (12.2 g, 75 mmol) and TiCl4 (1 M solution in toluene, 71 mL, 71 mmol) 
were added to a solution of alcohol 132 (13.8 g, 34 mmol) in toluene (560 mL) at -78 °C. 
After 1 h at -78 °C, NaHCO3 solution (200 mL of a saturated aqueous solution) was added 
dropwise over a period of 15 min. H2O (400 mL) and CH2Cl2 (600 mL) were added and the 
mixture was extracted with CH2Cl2 (400 mL). The combined organic layers were washed with 
NaHCO3 solution (400 mL), HCl solution (400 mL of a 10% aqueous solution), and brine, 
then dried over MgSO4 and concentrated under reduced pressure. The residue was purified by 
column chromatography on silica gel (toluene/Et2O, 98/2) to afford indole 221 (11.3 g, 69%) 
as a white solid
11
; Rf 0.51 (toluene/Et2O, 95/5); mp 74-75 °C [lit.,
 
74-75 °C]; 
1
H NMR (400 
MHz, CDCl3) δ 1.43-1.53 (m, 2H), 1.54 (s, 3H), 1.71 (s, 3H, CH3), 1.57-1.80 (m, 3H), 1.99-
2.03 (m, 1H), 2.27 (br s, 2H), 2.34 (s, 3H, ArCH3), 4.04-4.07 (m, 1H), 7.08 (app t, J 8.1, 1H), 
7.22 (d, J 8.4, 2H, ArH), 7.50 (d, J 7.8, 1H), 7.55 (br s, 1H), 7.70 (d, J 8.4, 2H, ArH), 8.00 (d, 
J 8.3, 1H); 
13
C NMR (100 MHz, CDCl3) δ 21.5 (CH3, ArCH3), 26.0 (CH3), 26.8 (CH2), 28.3 
(CH2), 30.2 (CH2), 36.5 (C), 44.3 (CH2), 55.9 (CH), 113.2 (CH), 113.7 (C), 124.8 (CH), 125.6 
(CH), 126.8 (CH, ArCH), 128.9 (CH), 129.8 (C), 129.9 (CH, ArCH), 130.9 (C), 134.6 (C), 
138.0 (C), 145.1 (C), 211.8 (C), one CH3 not observed; MS (ESI) m/z 510.3 ([M+Na]
+
, 
100%), 512.2 (97%); HRMS (ESI) m/z 510.0720 [M+Na]
+
, C24H26NO3S
79
BrNa requires 
510.0714. 
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2-(2’-(4’’-Bromo-1H-indol-3’’-yl)propan-2’-yl)cyclohexanone (221a)11 
 
Crushed KOH pellets (27.3 g, 0.49 mol) were added to a solution of 221 (11.9 g, 24 mmol) in 
EtOH (950 mL) and stirred for 3 h at 40 °C. The reaction mixture was cooled to rt and NH4Cl 
solution (1 L, of a saturated aqueous solution) was added. The mixture was extracted with 
EtOAc (4  1 L), then the combined organic layers were washed with brine (1 L), dried over 
MgSO4 and concentrated under reduced pressure. The residue was purified by column 
chromatography on silica gel (petroleum ether/EtOAc, 70/30) to furnish indole 221a (7.3 g, 
90%) as a white solid;
11
 Rf 0.14 (petroleum ether/EtOAc, 90/10), mp 164-166 °C [lit.,
11
 167-
168 °C], 
1
H NMR (400 MHz, CDCl3) δ 1.45-1.72 (m, 3H), 1.57 (s, 3H, CH3), 1.72-1.87 (m, 
2H), 1.77 (s, 3H, CH3), 2.00-2.11 (m, 1H), 2.23-2.48 (m, 2H), 4.26 (dd, J 11.6, 4.5, 1H), 6.97 
(app t, J 7.8, 1H, 6-CH), 7.10 (d, J 2.6, 1H, 2-CH), 7.31 (dd, J 8.0, 1.0, 1H), 7.41 (dd, J 7.6, 
1.0, 1H), 8.54 (br s,1 H, NH); 
13
C NMR (100 MHz, CDCl3) δ 26.1 (CH3), 26.1 (CH2), 27.4 
(CH3), 28.6 (CH2), 30.5 (CH2), 36.1 (C), 44.5 (CH2), 57.3 (CH), 111.1 (CH), 113.6 (C), 122.1 
(CH), 123.7 (CH), 124.8 (C), 125.4 (C), 125.8 (CH), 139.5 (C), 213.5 (C); MS(ESI) m/z 356.0 
([M+Na]
+
, 100%), 358.0 (97%); HRMS (ESI) m/z 356.0628 [M+Na]
+
, C17H20NO
79
BrNa 
requires 356.0626. 
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2-(2’-(4’’-Bromo-1’’-methyl-1H-indol-3’’-yl)propan-2’-yl)cyclohexanone (215) 
 
NaH (290 mg, 60% dispersion in mineral oil, 7.24 mmol) was added to a solution of indole 
221a (1.86 g, 5.57 mmol) in THF (45 mL) at 0 °C. After 20 min, MeI (416 L, 6.68 mmol) 
was added dropwise over a period of 5 min, and the reaction mixture was stirred for 1 h at 0 
°C. The reaction mixture was quenched by addition of H2O (25 mL) and NH4Cl solution (25 
mL of a saturated aqueous solution). The resulting mixture was extracted with EtOAc (3  
200 mL) and the combined organic layers were dried over MgSO4 and concentrated under 
reduced pressure. The residue was purified by column chromatography on silica gel 
(petroleum ether/EtOAc, 90/10) to provide indole 215 (1.88 g, 97%) as a white solid; Rf 0.50 
(petroleum ether/EtOAc, 80/20); mp 80-82 °C [lit.,
11
 mp 80-81 °C], 
1
H NMR (400 MHz, 
CDCl3) δ 1.30-1.63 (m, 3H), 1.46 (s, 3H, CH3),1.63-1.85 (m, 2H), 1.67 (br s, 3H, CH3), 1.90-
1.99 (m, 1H), 2.12-2.33 (m, 2H), 3.63 (s, 3H, NCH3), 4.12 (dd, J 12.2, 4.4, 1H, 15-CH), 6.90 
(s, 1H, 2-CH), 6.92 (app t, J 7.9, 1H, 6-CH), 7.15 (dd, J 8.1, 0.9, 1H, 7-CH), 7.30 (dd, J 7.6, 
0.9, 1H, 5-CH); 
13
C NMR (100 MHz, CDCl3) δ 26.1 (CH3), 26.1(CH2), 27.7 (CH3), 28.7 
(CH2), 30.0 (CH2), 33.0 (CH3, NCH3), 36.1 (C), 44.5 (CH2), 57.3 (CH, 15-CH), 108.9 (CH, 7-
CH), 113.7 (C), 121.7 (CH, 6-CH), 124.0 (C), 125.2 (C), 125.3 (CH, 5-CH), 128.6 (CH, 2-
CH), 139.9 (C), 213.0 (C, 10-C); MS (ESI) m/z 370.0 ([M+Na]
+
, 100%), 372.0 (97%); HRMS 
(ESI) m/z 370.0775 [M+Na]
+
, C18H22NO
79
BrNa requires 370.0782. 
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4-Bromo-1-methyl-3-(2’-(2’’-(trimethylsilyloxy)cyclohex-2’’-enyl)propan-2’-yl)-1H-
indole (222) 
 
A solution of KHMDS (0.5 M solution in toluene, 1.9 mL, 0.95 mmol) was added dropwise, 
over a period of 5 min, to a solution of 215 (300 mg, 0.86 mmol) in THF (7 mL) at -78 °C. 
The mixture was stirred 30 min at this temperature. Et3N (0.24 mL, 1.72 mmol) and TMSCl 
(0.22 mL, 1.72 mmol) were added and the solution was stirred for 1 h at -78 °C. The reaction 
was quenched with H2O (7 mL) and extracted with Et2O (2  7 mL). The combined organic 
layers were dried over MgSO4 and concentrated under reduced pressure. The residue was 
purified by column chromatography on silica gel (petroleum ether/Et2O, 90/10) to give silyl 
enol ether 222 (296 mg, 82%) as a white solid; Rf 0.72 (petroleum ether/EtOAc, 90/10); mp 
95-96 °C; IR υmax 2927, 1163, 839, 735 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 0.06 (br s, 9H, 
CH3), 1.34 (br s, 3H), 1.48 (s, 3H, CH3), 1.61 (br s, 4H), 1.97 (br s, 2H), 3.71-3.78 (m, 1H, 
15-CH), 3.71 (s, 3H, NCH3), 4.90 (br s, 1H, 11-CH), 6.91 (s, 1H, 2-CH), 7.00 (app t, J 7.9, 
1H, 6-CH), 7.23 (d, J 8.1, 1H, 5-CH), 7.39 (d, J 7.6, 1H, 7-CH); 
13
C NMR (100 MHz, CDCl3) 
δ -0.1 (CH3), 22.7 (2 × CH2), 22.7 (CH3), 24.5 (CH2), 27.6 (CH3), 32.9 (CH3, NCH3), 37.0 (C, 
16-C), 45.8 (CH, 15-CH), 106.5 (CH, 11-CH), 108.6 (CH, 7-CH), 114.2 (C, 4-C), 121.5 (CH, 
6-CH), 125.0 (C), 125.0 (CH, 5-CH), 125.9 (C), 127.5 (CH, 2-CH), 139.6 (C, 8-C), 153.8 (C, 
10-C); MS (ESI) m/z 442.3 ([M+Na]
+
, 100%), 444.3 (97%); HRMS (ESI) m/z 442.1189 
[M+Na]
+
, C21H30NO
79
BrSiNa requires 442.1178. 
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Bicyclo[4.3.1]decane compound (182) 
 
A solution of P
t
Bu3 (1M solution in toluene, 64 μL, 0.06 mmol) was added to a solution of 
Pd(OAc)2 (8 mg, 0.04 mmol), Bu3SnF (442 mg, 1.43 mmol) and CsF (217 mg, 1.43 mmol) in 
toluene (5 mL). Then, silyl enol ether 222 (500 mg, 1.19 mmol) was added and the reaction 
mixture was heated for 21 h at 85 °C. After cooling to rt, the reaction mixture was diluted 
with Et2O (5 mL) and filtered through a pad of silica gel. The filtrate was concentrated under 
reduced pressure and the crude product was purified by column chromatography on silica gel 
(petroleum ether/Et2O, 90/10) to provide the cyclised product 182 (263 mg, 83%) as a white 
foam; Rf 0.34 (petroleum ether/EtOAc, 90/10); mp 100-101 °C; IR υmax 2909, 1687, 734 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 1.15 (s, 3H, CH3), 1.19-1.26 (m, 1H, 13-CH2), 1.34-1.47 (m, 
1H, 13-CH2), 1.55 (s, 3H, CH3), 1.83-1.98 (m, 2H, 12-CH2 and 14-CH2), 2.18-2.32 (m, 2H, 
12-CH2 and 14-CH2), 2.60 (br d, J 7.2, 1H, 15-CH), 3.75 (s, 3H, NCH3), 4.04-4.09 (m, 1H, 
11-CH), 6.84 (d, J 6.8, 1H, 5-CH), 6.94 (s, 1H, 2-CH), 7.16 (dd, J 8.1, 1.2, 1H, 7-CH), 7.21 
(dd, J 8.1, 6.8, 1H, 6-CH); 
13
C NMR (100 MHz, CDCl3) δ 18.1 (CH2, 13-CH2), 28.1 (CH3), 
28.7 (CH2, 14-CH2), 32.8 (CH3, NCH3), 34.9 (C, 16-C), 36.3 (CH3), 39.5 (CH2, 12-CH2), 58.3 
(CH, 11-CH), 61.3 (CH, 15-CH), 107.2 (CH, 7-CH), 118.3 (CH, 5-CH), 122.3 (CH, 6-CH), 
122.7 (C, 9-C), 125.3 (C, 3-C), 126.0 (CH, 2-CH), 132.1 (C, 4-C), 136.9 (C, 8-C), 214.5 (C, 
10-C); MS (ESI) m/z 290.1 ([M+Na]
+
, 100%); HRMS (ESI) m/z 290.1506 [M+Na]
+
, 
C18H21NONa requires 290.1521. 
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2-Bromo-6-(2’-(4’’-bromo-1’’-methyl-1H-indol-3’’-yl)propan-2’-yl)cyclohexanone (231) 
 
Powdered NaHCO3 (21 mg, 0.25 mmol) and NBS were successively added to a solution of 
silyl enol ether 222 (100 mg, 0.21 mmol) in THF (1.3 mL) at -78 °C. After 2 h at this 
temperature the mixture was warmed to rt and partitioned between NaHCO3 solution (2 mL of 
a saturated aqueous solution) and Et2O (5 mL). The mixture was extracted with Et2O (5 mL). 
The combined organic layers were washed with brine (5 mL), dried over MgSO4 and 
concentrated under reduced pressure. The residue was purified by column chromatography on 
silica gel (petroleum ether/EtOAc, 90/10) to afford a mixture of diastereoisomers (1:0.7) of 
indole 231 (91 mg, quantitative) as a white solid; Rf 0.33 (petroleum ether/EtOAc, 90/10); mp 
76-77 °C; IR υmax 2945, 1708, 737 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 1.40-1.66 (m, 2H, 
CH2, minor and major), 1.56 (s, 3H, CH3, major), 1.58 (s, 3H, CH3, minor), 1.77 (br s, 4H, 
minor and major), 1.99-2.29 (m, 3H, minor and major), 2.59-2.69 (m, 1H, minor), 3.73 (s, 3H, 
NCH3), 4.24-4.34 (m, 1H, 11-CH, major and 15-CH, minor), 4.66 (br s, 1H, 11-CH, minor), 
4.94 (dd, J 13.1, 4.9, 1H, 15-CH, major), 6.96-7.06 (m, 2H, 2-CH and 6-CH, minor and 
major), 7.23-7.28 (m, 1H, 7-CH, minor and major), 7.36-7.43 (m, 1H, 5-CH, minor and 
major); 
13
C NMR (100 MHz, CDCl3) δ 20.9 (CH2, minor and major), 25.1 (CH3, minor and 
major), 26.8 (CH2, major), 27.9 (CH3, minor and major), 29.8 (CH2, minor), 33.1 (CH3, 
NCH3, minor and major), 36.2 (CH2, major), 36.9 (C, 16-C), 41.2 (CH2, minor), 51.5 (CH, 
15-CH, major), 54.2 (CH, 15-CH, minor), 57.2 (CH, 11-CH, major), 58.8 (CH, 11-CH, 
minor), 108.7 (CH, 7-CH, major), 109.0 (CH, 7-CH, minor), 113.8 (C, 4-C, minor), 114.0 (C, 
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4-C, major), 121.8 (CH, 6-CH, minor), 121.9 (CH, 6-CH, major), 123.4 (C, major), 124.1 (C, 
minor), 125.0 (C, major), 125.3 (C, minor), 125.4 (CH, 5-CH, major), 125.5 (CH, 5-CH, 
minor), 128.8 (CH, 2-CH, minor and major), 139.9 (C, 8-C, major), 140.0 (C, 8-C, minor), 
205.3 (C, 10-C, major), 209.8 (C, 10-C, minor); MS (ESI) m/z 448.0 (50%), 450.0 ([M+Na]
+
, 
100%), 452.0 (50%); HRMS (ESI) m/z 449.9863 [M+Na]
+
, C18H21NO
79
Br
81
BrNa requires 
449.9867. 
 
2-Azido-6-(2’-(4’’-bromo-1’’-methyl-1H-indol-3’’-yl)propan-2’-yl)cyclohexanone (228) 
and 2-amino-6-(2’-(4’’-bromo-1’’-methyl-1H-indol-3’’-yl)propan-2’-yl)cyclohex-2-enone 
(235) 
 
NaN3 (9 mg, 0.14 mmol) was added to a solution of 231 (50 mg, 0.12 mmol) in DMF (4 mL). 
After 2 h at 70 °C, the reaction mixture was cooled to rt, poured into H2O (20 mL) and 
extracted with Et2O (3  20 mL). The combined organic layers were washed with cold H2O (2 
 20 mL), brine (20 mL), dried over MgSO4 and concentrated under reduced pressure. The 
residue was purified by column chromatography on silica gel (petroleum ether/EtOAc, 90/10) 
to furnish a mixture of diastereoisomers (2:1) of azide 228 (26 mg, 57%) as a brown oil and 
enamine 235 (5 mg, 12%) as a yellow oil. 
Data for azide 228; Rf 0.40 (petroleum ether/EtOAc, 80/20); IR υmax 2936, 2097, 1708, 738 
cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 1.42-1.58 (m, 2H, minor and major), 1.59 (s, 3H, CH3, 
minor and major ), 1.63-1.73 (m, 2H, minor and major), 1.76 (br s, 3H), 1.81-2.08 (m, 1H, 
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minor and major), 2.21-2.30 (m, 1H, minor), 2.31-2.40 (m, 1H, major), 3.74 (s, 3H, NCH3), 
3.77-3.82 (br m, 1H, 11-CH, major), 3.92 (app t, J 4.9, 1H, 11-CH, minor), 4.17-4.29 (m, 1H, 
15-CH, major), 4.57 (dd, J 12.3, 4.9, 1H, 15-CH minor),  6.94-7.06 (m, 2H, 2-CH and 6-H, 
minor and major), 7.22-7.29 (m, 1H, minor and major), 7.37-7.44 (m, 1H, minor and major); 
13
C NMR (100 MHz, CDCl3) δ 24.1 (CH3, minor and major), 24.1 (CH2, minor and major), 
28.5 (CH3, minor and major), 30.6 (CH2, minor and major), 33.1 (CH3, NCH3), 32.3 (CH2, 
minor), 35.0 (CH2, major), 35.9 (C, 16-C, minor), 36.2 (C, 16-C, major), 56.8 (CH, 15-CH, 
major), 57.3 (CH, 15-CH, minor), 68.0 (CH, 11-CH, major), 68.2 (CH, 11-CH, minor), 108.9 
(CH, 7-CH, minor), 109.1 (CH, 7-CH, major), 113.6 (C, 4-C, minor), 113.8 (C, 4-C, major), 
121.7 (CH, 6-CH, minor), 121.9 (CH, 6-CH, major), 123.1 (C, major), 123.2 (C, minor), 
125.0 (C, minor), 125.3 (C, major), 125.4 (CH, 5-CH, minor), 125.5 (CH, 5-CH, major), 
128.6 (CH, 2-CH, major), 128.7 (CH, 2-CH, minor) 139.9 (C, 8-C, major), 140.0 (C, 8-C, 
minor), 208.8 (C, 10-C, major), 213.0 (C, 10-C, minor); MS (ESI) m/z 411.1 ([M+Na]
+
, 
100%), 413.1 (97%); HRMS (ESI) m/z 411.0785 [M+Na]
+
, C18H21N4O
79
BrNa requires 
411.0796. 
Data for enamine 235; Rf 0.18 (petroleum ether/EtOAc, 80/20); IR υmax 3353, 2925, 1726, 
1666, 1110, 734 cm
-1;
 
1
H NMR (400 MHz, CDCl3) δ 1.52 (s, 3H, CH3), 1.64-1.91 (broad m, 
5H, CH3 and 14-CH2), 2.10-2.32 (broad m, 2H, 13-CH2), 3.44 (broad s, 2H, NH2), 3.74 (s, 
3H, NCH3), 4.17 (dd, J 12.0,  4.6, 1H, 15-CH), 5.79 (dd, J 5.7, 3.4, 1H, 12-CH), 7.00 (s, 1H, 
2-CH), 7.01 (t, J 7.6, 1H, 6-CH), 7.25 (dd, J 7.6, 1.0, 1H, 7-CH), 7.38 (dd, J 7.6, 1.0, 1H, 5-
CH); 
13
C NMR (100 MHz, CDCl3) δ 24.2 (CH2, 13-CH2), 26.6 (CH3), 26.6 (CH2, 14-CH2), 
28.7 (CH3), 33.1 (CH3, NCH3), 37.2 (16-C), 53.0 (CH, 15-CH), 108.8 (CH, 7-CH), 113.8 (C, 
4-C), 116.3 (CH, 12-CH), 121.9 (CH, 6-CH), 123.3 (C), 124.5 (C), 125.4 (CH, 5-CH), 128.2 
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(CH, 2-CH), 139.8 (C, 8-C), 140.2 (C, 11-C), 197.8 (C); MS (ESI) m/z 361.2 ([M+Na]
+
, 
100%), 363.2 (97%); HRMS (ESI) m/z 361.0913 [M+H]
+
, C18H22N2O
79
Br requires 361.0915. 
 
Alternative procedure for the preparation of enamine compound (235) 
 
NaN3 (2.59 g, 39.9 mmol) was added to a solution of 231 (1.42 g, 3.32 mmol) in DMF (20 
mL). After 6 h at 100 °C, the mixture was cooled to rt, poured into H2O (200 mL) and 
extracted with Et2O (3  200 mL). The combined organic layers were washed with cold H2O 
(2  400 mL) followed by brine (400 mL). The organic extracts were dried over MgSO4 and 
concentrated under reduced pressure. The residue was purified by column chromatography on 
silica gel (petroleum ether/EtOAc, 80/20) to furnish enamine 235 (526 mg, 44%) as an yellow 
oil; data as previously described (p.148).  
 
N-(5-(2’-(4’’-Bromo-1’’-methyl-1H-indol-3’’-yl)propan-2’-yl)-6-oxocyclohex-1-
enyl)formamide (249) 
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Acetic formic anhydride (prepared by stirring 1 equivalent of acetic anhydride and 1.1 
equivalent of formic acid for 2 h at 55 °C; 76 L, 0.29 mmol) was added to a solution of 235 
(100 mg, 0.14 mmol) in CH2Cl2 (1 mL) at 0 °C. The reaction mixture was stirred for 3 h at rt 
and concentrated under reduced pressure. The residue was purified by column 
chromatography on silica gel (petroleum ether/EtOAc, 70/30) to give formamide 249 (94 mg, 
97%) as a grey solid; Rf 0.41 (petroleum ether/EtOAc, 60/40); mp 199-200 °C; IR υmax 3344, 
2926, 1699, 1662, 736 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 1.52 (s, 3H, CH3), 1.66-1.90 (br s, 
5H, CH3 and 14-CH2), 2.33-2.46 (br s, 2H, 13-CH2), 3.75 (s, 3H, NCH3), 4.27 (dd, J 12.2, 4.8, 
1H, 15-CH), 7.00 (s, 1H, 2-CH), 7.03 (app t, J 7.9, 1H, 6-CH), 7.27 (dd, J 8.1, 0.8, 1H, 7-
CH), 7.38 (dd, J 7.6, 0.8, 1H, 5-CH), 7.72 (t, J 4.5, 1H, 12-CH), 7.97-8.04 (broad s, 1H, NH), 
8.34 (s, 1H, 17-CHO); 
13
C NMR (100 MHz, CDCl3) δ 24.6 (CH2, 13-CH2), 25.2 (CH2, 14-
CH2), 26.0 (CH3), 28.7 (CH3), 33.1 (CH3, NCH3), 37.1 (C, 16-C), 52.6 (CH, 15-CH), 109.0 
(CH, 7-CH), 113.6 (C, 4-C), 122.0 (CH, 6-CH), 123.8 (C), 125.3 (C), 125.4 (CH, 5-CH), 
128.2 (CH, 2-CH), 130.6 (CH, 12-CH), 132.3 (C, 11-C), 139.8 (C, 8-C), 159.2 (C, 17-C), 
195.9 (C, 10-C); MS (ESI) m/z 411.1 ([M+Na]
+
, 100%), 413.1 (97%); HRMS (ESI) m/z 
411.0695 [M+Na]
+
, C19H21N2O2
79
BrNa requires 411.0684. 
 
N-(5-(2’-(1’’-Methyl-1H-indol-3’’-yl)propan-2’’-yl)-6’-oxocyclohex-1’-enyl)formamide 
(251) 
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A solution of Bu3SnH (69 L, 0.26 mmol) and AIBN (13 mg, 0.08 mmol) in degassed toluene 
(18 mL) was added dropwise over 2 h via a syringe pump to a solution of 249 in boiling 
degassed toluene (6 mL). After a further 3 h, the mixture was cooled to rt and Et2O (5 mL) 
and KF solution (5 mL of a 10% aqueous solution) were added. The organic layer was 
separated, washed with H2O (20 mL), brine (20 mL), dried over MgSO4 and concentrated 
under reduced pressure. The residue was purified by colum chromatography on silica gel 
(petroleum ether/EtOAc, 80/20) to provide 251 (10 mg, 25%) as a white solid; Rf 0.27 
(petroleum ether/EtOAc, 70/30); mp 158-160 °C; IR υmax 3246, 2925, 1696, 1662, 730 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 1.46 (s, 3H, CH3), 1.66-1.77 (m, 2H, 14-CH2), 1.74 (s, 3H, 
CH3), 2.21-2.40 (m, 2H, 13-CH2), 3.14 (dd, J 10.6, 5.7, 1H, 15-CH), 3.76 (s, 3H, NCH3), 6.82 
(s, 1H, 2-CH), 7.07 (app t, J 7.6, 1H, 6-CH), 7.22 (app t, J 7.6, 1H, 5-CH), 7.31 (d, J 8.3, 1H, 
4-CH), 7.68-7.73 (m, 2H, 7-CH and 12-CH), 7.97 (broad s, 1H, NH), 8.36 (d, J 1.7, 1H, 17-
CHO); 
13
C NMR (100 MHz, CDCl3) δ 23.4 (CH3), 24.8 (CH2, 13-CH2), 25.3 (CH2, 14-CH2), 
28.6 (CH3), 32.7 (CH3, NCH3), 37.9 (C, 16-C), 53.0 (CH, 15-CH), 109.6 (CH, 4-CH), 118.5 
(CH, 6-CH), 120.9 (CH, 7-CH), 121.3 (CH, 5-CH), 123.2 (C), 125.8 (CH, 2-CH), 130.8 (CH, 
12-CH), 132.4 (C, 11-C), 137.8 (C, 8-C), 159.2 (C, 17-C), 195.7 (C, 10-C), one C not 
observed; MS (ESI) m/z 333.2 ([M+Na]
+
, 100%); HRMS (ESI) m/z 333.1566 [M+Na]
+
, 
C19H22N2O2Na requires 333.1579. 
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Bicylo[4.2.2]decane compound (259) 
 
A solution of 249 (20 mg, 0.05 mmol), PdCl2(PPh3)2 (7 mg, 0.01mmol) and Et3N (18 L, 0.13 
mmol) in DMF (1 mL) was heated at 150 °C. After 3 h, the reaction was cooled to rt and 
diluted with EtOAc (1 mL). The organic layer was washed with H2O (4  2 mL) and brine  (3 
 2 mL), dried over MgSO4 and concentrated under reduced pressure. The residue was 
purified by column chromatography on silica gel (petroleum ether/EtOAc, 70/30) to afford 
cyclised product 259 (8 mg, 50%) as a grey solid; Rf 0.26 (petroleum ether/EtOAc, 60/40); 
mp 144-142 °C; IR υmax 3308, 2930, 1714, 1651, 796 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 
1.45 (s, 3H, CH3), 1.80 (s, 3H, CH3), 2.11-2.24 (m, 1H, 13-CH2), 2.24-2.32 (m, 2H, 14-CH2), 
2.59-2.66 (m, 1H, 13-CH2), 2.66-2.70 (m, 1H, 15-CH), 3.71 (s, 3H, CH3), 3.91-3.98 (m, 1H, 
12-CH), 5.14 (t, J 6.5, 1H, 11-CH), 5.84 (broad s, 1H, NH), 6.72 (d, J 7.1, 1H, 5-CH), 7.01 
(dd, J 8.2, 7.1, 1H, 6-CH), 7.04 (s, 1H, 2-CH), 7.15 (d, J 8.2, 1H, 7-CH), 8.13 (s, 1H, 
HNCHO); 
13
C NMR (100 MHz, CDCl3) δ 21.0 (CH2, 14-CH2), 25.0 (CH2, 13-CH2), 32.9 
(CH3, NCH3), 34.1 (CH3), 36.9 (CH3), 38.1 (C, 16-C), 41.4 (CH, 12-CH), 55.9 (CH, 15-CH), 
56.9 (CH, 11-CH), 109.0 (CH, 7-CH), 113.4 (C), 120.5 (CH, 6-CH), 121.9 (CH, 5-CH), 122.4 
(C), 128.6 (CH, 2-CH), 134.5 (C), 137.3 (C, 8-C), 160.8 (C, 17-C), 210.9 (C, 10-C); MS 
(ESI) m/z 333.1 [M+Na]
+
; HRMS (ESI) m/z 333.1573 ([M+Na]
+
, 100%), C19H22N2O2Na 
requires 333.1579. 
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Bridgehead silylated compound (262) 
 
A solution of LTMP was prepared as followed: to a solution of TMP (5.0 mL, 30 mmol) in 
THF (35 mL) at -78 °C was added 
n
BuLi (1.6 M solution in hexanes; 18.8 mL, 30 mmol). The 
solution was allowed to warm to 0 °C and after 10 min, it was cooled to -78 °C. The freshly 
prepared LTMP solution was added via cannula into a solution of indole 182 (1.11 g, 4.15 
mmol) and TMSCl (5.2 mL, 41.5 mmol) in THF (60 mL) at -78 °C. After 1 h the reaction was 
quenched with NH4Cl solution (40 mL of a saturated aqueous solution) and extracted with 
Et2O (3  50 mL). The combined organic layers were washed with brine (100 mL), dried over 
MgSO4 and concentrated under reduced pressure. The residue was purified by column 
chromatography on silica gel (petroleum ether/Et2O, 90/10) to provide the silylated compound 
262 (853 mg, 60%) as a white solid, alongside unreacted indole 182 (311 mg, 28%); Rf 0.31 
(petroleum ether/Et2O, 90/10); mp 148-149 °C; IR υmax 2955, 1672, 1245, 744 cm
-1
; 
1
H NMR 
(400 MHz, CDCl3) δ 0.31 (s, 9H, CH3), 1.24-1.31 (m, 1H, 13-CH2), 1.33 (s, 3H, CH3), 1.54 
(s, 3H, 16- CH3), 1.55-1.70 (m, 1H, 13-CH2), 1.78-1.88 (m, 1H, 14-CH2), 2.00-2.08 (m, 1H, 
12-CH2), 2.18-2.35 (m, 2H, 12-CH2 and 14-CH2), 2.51 (dd, J 6.6, 3.2, 1H, 15-CH), 3.73 (s, 
3H, NCH3), 6.95 (s, 1H, 2-CH), 7.11-7.16 (m, 2H, 5-CH and 7-CH), 7.20 (dd, J 8.0, 7.0, 1H, 
6-CH); 
13
C NMR (100 MHz, CDCl3) δ 0.26 (CH3), 18.5 (CH2, 13-CH2), 27.7 (CH2, 14-CH2), 
29.5 (CH3), 32.7 (CH3), 35.1 (C, 16-C), 36.9 (CH3), 39.8 (CH2, 12-CH2), 52.4 (C, 11-C), 60.0 
(CH, 15-CH), 106.8 (CH, 7-CH), 117.9 (CH, 5-CH), 121.7 (CH, 6-CH), 123.6 (C), 126.1 
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(CH, 2-CH), 126.2 (C), 136.7 (C), 136.9 (C), 216.5 (C, 10-C); MS (ESI) m/z 362.3 ([M+Na]
+
, 
100%); HRMS (ESI) m/z 362.1916 [M+Na]
+
, C21H29NOSiNa requires 362.1916. 
 
Bridgehead selenide compound (282) 
 
TBAT (95 mg, 0.18 mmol) and PhSeSePh (276 mg, 0.88 mmol) were successively added to a 
solution of 262 (30 mg, 0.08 mmol) in THF (3 mL). After 1 h at reflux, the solution was 
cooled down to rt and NH4Cl solution (3 mL of a saturated aqueous solution) was added and 
extracted with Et2O (3  5 mL). The combined organic layers were dried over MgSO4 and 
concentrated under reduced pressure. The residue was purified by column chromatography on 
silica gel (petroleum ether/Et2O, 95/5) to give indole 282 (19 mg, 51%) as a pale yellow solid; 
Rf 0.27 (petroleum ether/EtOAc, 90/10); mp 54-55 °C; IR υmax  2949, 1697, 1415, 739 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 1.21-1.27 (m, 1H, 13-CH2), 1.28 (s, 3H, CH3), 1.38-1.48 (m, 
1H, 13-CH2), 1.50 (s, 3H, CH3), 1.70-1.82 (m, 1H, 14-CH2), 2.15 (dm, J 14.2, 1H, 14-CH2), 
2.40 (ddd, J 12.9, 10.5, 4.8, 1H, 12-CH2), 2.50 (dtd, J 12.9, 2.4, 2.0, 1H, 12-CH2), 2.77 (dd, J 
7.6, 3.4, 1H, 15-CH), 3.73 (s, 3H, NCH3), 6.96 (s, 1H, 2-CH), 7-15-7.25 (m, 5H, ArH), 7.65-
7.68 (m, 2H, ArH), 7.94 (dd, J 7.4, 1.1, 1H, ArH); 
13
C NMR (100 MHz, CDCl3) δ 20.4 (CH2, 
13-CH2), 27.4 (CH2, 14-CH2), 29.3 (CH3), 32.9 (CH3, NCH3), 34.9 (C, 16-C), 36.1 (CH3), 
46.0 (CH2, 12-CH2), 60.6 (CH, 15-CH), 72.3 (C, 11-C), 108.3 (CH, 7-CH), 119.7 (CH, 5-
CH), 122.1 (CH, 2-CH), 122.3 (C), 124.4 (C), 126.4 (CH, 6-CH), 127.5 (CH, ArCH), 128.4 
(CH, ArCH), 130.8 (C), 133.0 (C), 136.3 (CH, ArCH), 136.7 (C, 8-C), 207.9 (C, 10-C); MS 
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(ESI) m/z 446.0 ([M+Na]
+
, 100%); HRMS (ESI) m/z 446.0997 [M+Na]
+
, C24H25NOSeNa 
requires 446.0999. 
 
Alternative procedure for the preparation of bridgehead selenide compound (282) 
 
A solution of LTMP was prepared as previously described (p.154): TMP (18.9 mL, 0.11 mol) 
in dry THF (200 mL) at -78 °C with 
n
BuLi (1.6 M solution in hexanes; 71 mL, 0.11 mol). The 
freshly prepared LTMP solution was added via cannula into a solution of ketone 182 (6.6 g, 
0.03 mol) in THF (400 mL) at -10 °C, immediately followed by a solution of PhSeSePh (35 g, 
0.11 mol) in THF (50 mL). The reaction mixture was stirred for 1 h at -10 °C, quenched with 
NH4Cl solution (1 L of a saturated aqueous solution) and extracted with Et2O (3  1 L). The 
combined organic layers were dried over MgSO4 and concentrated under reduce pressure. The 
residue was purified by column chromatography on silica gel (petroleum ether/CH2Cl2, 70/30) 
to give indole 282 (8.6 g, 82%) as a pale yellow solid; data as previously reported (p.155). 
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m-CPBA (196 mg, 0.77 mmol) was added to a solution of 282 (326 mg, 0.77 mmol) in 
CH2Cl2 (30 mL) at -10 °C. After 15 min at that maintained temperature, the reaction was 
quenched with H2O (75 mL), washed with Na2SO3 solution (75 mL of saturated aqueous 
solution) then brine (75 mL) and extracted with CH2Cl2 (3  150 mL). The combined organic 
layers were washed with NH4Cl solution (75 mL of a saturated aqueous solution), brine (75 
mL) and extracted with CH2Cl2 (3  150 mL). The combined organic layers were dried over 
MgSO4 and concentrated under reduce pressure. The residue was purified by column 
chromatography on silica gel (petroleum ether/EtOAc, 90/10) to provide bridgehead alkene 
275 (159 mg, 76%) as a white solid; Rf 0.19 (petroleum ether/EtOAc, 90/10); mp 103-104 °C; 
IR υmax  2921, 1691, 742 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 1.35 (s, 3H, CH3), 1.44 (s, 3H, 
CH3), 1.95-2.06 (m, 1H, 14-CH2), 2.12-2.23 (m, 2H, 13-CH2 and 14-CH2), 2.29-2.39 (m, 1H, 
13-CH2), 2.84 (dd, J 7.6, 4.9, 1H, 15-CH3), 3.72 (s, 3H, NCH3), 6.33 (dd, J 7.3, 4.3, 1H, 12-
CH), 6.91 (s, 1H, 2-CH), 7.04 (dd, J 6.8, 1.3, 1H, 5-CH), 7.15 (dd, J 8.3, 1.3, 1H, 7-CH), 7.20 
(dd, J 8.3, 6.8, 1H, 6-CH); 
13
C NMR (100 MHz, CDCl3) δ 23.0 (CH2, 13-CH2), 24.6 (CH2, 
14-CH2), 29.3 (CH3), 32.7 (CH3, NCH3), 34.3 (CH3), 36.9 (C, 16-C), 59.5 (CH, 15-CH), 
108.4 (CH, 7-CH), 113.7 (CH, 5-CH), 122.4 (CH, 6-CH), 123.5 (C, 9-C), 124.8 (C, 3-C), 
126.9 (CH, 2-CH), 130.8 (C, 4-C), 132.9 (CH, 12-CH), 135.9 (C, 8-C), 142.1 (C, 11-C), 
208.6 (C, 10-C); MS (ESI) m/z 288.2 ([M+Na]
+
, 100%); HRMS (ESI) m/z 288.1363 
[M+Na]
+
, C18H19NONa requires 288.1364. 
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Bridgehead ester compound (55)
11
 
 
A solution of LTMP was prepared as previously described (p.154): to a solution of TMP (120 
L, 0.71 mmol) in THF (2 mL) at -78 °C was added 
n
BuLi (1.6 M solution in hexanes; 444 
L, 0.71 mmol). The solution was allowed to warm to 0 °C and after 10 min, it was cooled to        
-78 °C. The freshly prepared LTMP solution was added via cannula into a solution of indole 
182 (38 mg, 0.14 mmol) in THF (1 mL) at -78 °C and stirred at that maintained temperature 
for 1 h. Then methylchloroformate (80 L, 1.42 mmol) was added and the reaction mixture 
was stirred for 1 h at -78 °C then for 4 h at rt. The reaction was subsequently quenched with 
NH4Cl solution (2 mL of a saturated aqueous solution) and extracted with Et2O (3  3 mL). 
The combined organic layers were washed with brine (5 mL), dried over MgSO4 and 
concentrated under reduced pressure. The residue was purified by column chromatography on 
silica gel (petroleum ether/Et2O, 90/10) to provide bridgehead ester 55 (12 mg, 26%) as a red 
solid; Rf 0.42 (petroleum ether/ EtOAc, 70/30); mp 150-152 °C [lit.,
11
 153-154 °C]; 
1
H NMR 
(300 MHz, CDCl3) δ 1.21 (s, 3H, CH3), 1.23-1.38 (m, 2H), 1.51 (s, 3H, CH3), 1.88-2.00 (m, 
1H), 2.08-2.17 (m, 1H), 2.17-2.24 (m, 1H), 2.67 (ddd, J 13.5, 13.5, 4.7), 2.74 (dd, J 8.2, 2.4, 
1H), 3.77 (s, 3H, CH3), 3.81 (s, 3H, CH3), 6.63-6.69 (m, 1H), 6.98 (m, 1H), 7.19-7.24 (m, 
2H); 
13
C NMR (100 MHz, CDCl3) δ 18.8 (CH2), 28.0 (CH2), 28.4 (CH3), 32.9 (CH3), 34.7 
(C), 35.4 (CH3), 42.5 (CH2), 52.4 (CH), 62.0 (CH3), 69.8 (C), 107.9 (CH), 118.0 (CH), 121.5 
(C), 122.1 (CH), 125.2 (C), 126.5 (CH), 131.2 (C), 136.8 (C), 173.9 (C), 210.8 (C); MS (ESI) 
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m/z 348.3 ([M+Na]
+
, 100%); HRMS (ESI) m/z 348.1585 [M+Na]
+
, C20H23NO3Na requires 
348.1576. 
 
Allylic alcohol compound (274)  
 
SeO2 (1.81 g, 16.3 mmol) was added in one portion to a solution of bridgehead alkene 275 
(3.94 g, 14.8 mmol) in dioxane (80 mL) and H2O (4.9 mL). After 18 h at 70 °C, the reaction 
mixture was cooled to rt, diluted with H2O (400 mL) and extracted with CH2Cl2 (3  150 
mL). The combined organic layers were dried over MgSO4 and concentrated under reduced 
pressure. The residue was purified by column chromatography on silica gel (petroleum 
ether/EtOAc, 60/40) to give alcohol 274 (2.80 g, 67%) as a pale yellow solid; Rf 0.23 
(petroleum ether/EtOAc, 60/40); mp 175-176 °C; IR υmax  3464, 2921, 1696, 749 cm
-1
; 
1
H 
NMR (400 MHz, CDCl3) δ 1.39 (s, 3H, CH3), 1.46 (s, 3H, CH3), 2.01 (br s, 1H, OH); 2.11 
(ddd, J 14.2, 4.9, 3.3, 1H, 14-CH2), 2.42 (ddd, J 14.2, 7.5, 2.6, 1H, 14-CH2), 2.95 (dd, J 7.5, 
4.9, 1H, 15-CH), 3.72 (s, 3H, NCH3), 4.61-4.68 (m, 1H, 13-CH), 6.44 (d, J 5.7, 1H, 12-CH), 
6.95 (s, 1H, 2-CH), 7.04 (dd, J 5.7, 2.3, 1H, 5-CH), 7.17-7.21 (m, 2H, ArH); 
13
C NMR (100 
MHz, CDCl3) δ 29.2 (CH3), 32.8 (CH3, NCH3), 35.2 (CH2, 14-CH2), 35.7 (CH3), 37.2 (C, 16-
C), 55.6 (CH, 15-CH), 64.8 (CH, 13-CH), 108.8 (CH, 7-CH), 113.6 (CH, 5-CH), 122.3 (CH, 
6-CH), 123.0 (C, 9-C), 124.0 (C, 3-C), 127.7 (CH, 2-CH), 130.3 (C, 4-C), 134.3 (CH, 12-
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CH), 135.7 (C, 8-C), 145.9 (C, 11-C), 207.0 (C, 10-C); MS (ESI) m/z 304.1 ([M+Na]
+
, 
100%); HRMS (ESI) m/z 304.1317 [M+Na]
+
, C18H19NO2Na requires 304.1313. 
 
Enedione compound (277) 
 
DMP (52 mg, 0.12 mmol) was added to a solution of 274 (23 mg, 0.08 mmol) in CH2Cl2 (1 
mL). After 1 h at rt, the reaction mixture was diluted with H2O (2 mL) and extracted with 
CH2Cl2 (3  2 mL). The combined organic layers were dried over MgSO4 and concentrated 
under reduced pressure. The residue was purified by column chromatography on silica gel 
(petroleum ether/EtOAc, 90/10) to provide enedione 277 (15 mg, 65%) as a white solid; Rf 
0.35 (petroleum ether/EtOAc, 70/30); mp 193-195 °C; IR υmax  2957, 1719, 1674, 1230, 742 
cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 1.27 (s, 3H, CH3), 1.58 (s, 3H, CH3), 2.85 (dd, J 19.0, 
5.7, 1H, 14-CH2), 3.17 (dm, J 19.0, 1H, 14-CH2), 3.27 (d, J 4.8, 1H, 15-CH2), 3.74 (s, 3H, 
NCH3), 6.40 (d, J 1.7, 1H, 12-CH), 6.93 (s, 1H, 2-CH), 7.13 (t, J 3.9, 1H, 6-CH), 7.25-7.27 
(m, 2H, ArH); 
13
C NMR (100 MHz, CDCl3) δ 30.1 (CH3), 30.7 (CH3), 32.8 (CH3, NCH3), 
35.5 (C, 16-C), 39.8 (CH2, 14-CH2), 60.3 (CH, 15-CH), 110.5 (CH, 7-CH), 113.7 (CH, 6-
CH), 122.5 (CH, 5-CH), 124.2 (C, 9-C), 125.4 (C, 3-C), 126.4 (CH, 2-CH), 127.0 (CH, 12-
CH), 128.7 (C, 4-C), 136.6 (C, 8-C), 159.6 (C, 11-C), 195.2 (C, 13-C), 204.4 (C, 10-C); MS 
(ESI) m/z 302.1 ([M+Na]
+
, 100%); HRMS (ESI) m/z 302.1140 [M+Na]
+
, C18H17NO2Na 
requires 302.1157. 
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Iodo ester compound (273) 
 
Iodoacetic acid (24 mg, 0.13 mmol), DCC (26 mg, 0.13 mmol) and DMAP (1 mg, 0.08 
mmol) were added to a solution of allylic alcohol 274 (30 mg, 0.11 mmol) in CH2Cl2 (8 mL). 
After 30 min at rt, the solvent was evaporated under reduced pressure and the residue was 
purified by column chromatography on silica gel (petroleum ether/EtOAc, 90/10) to provide 
iodoester 273 (38 mg, 79%) as a white solid; Rf 0.31 (petroleum ether/EtOAc, 70/30); mp 
140-142 °C; IR 2962, 1740, 1710, 1110, 747 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 1.39 (s, 3H, 
CH3), 1.47 (s, 3H, CH3), 2.28 (dt, J 14.8, 4.3, 1H, 14-CH2), 2.48 (ddd, J 14.8, 7.6, 2.5, 1H, 
14-CH2), 2.96 (dd, J 7.6, 4.3, 1H, 15-CH), 3.67 (AB q, J 9.9, 2H, 18-CH2), 3.73 (s, 3H, 
NCH3), 5.35-5.40 (m, 1H, 13-CH), 6.47 (d, J 6.0, 1H, 12-CH), 6.95 (s, 1H, 2-CH), 7.06 (dd, J 
5.5, 2.5, 1H), 7.18-7.22 (m, 2H); 
13
C NMR (75 MHz, CDCl3) δ -5.6 (CH2, 18-CH2), 29.3 
(CH3), 31.5 (CH2, 14-CH2), 32.8 (CH3, NCH3), 35.3 (CH3), 37.3 (C, 16-C), 55.8 (CH, 15-
CH), 68.7 (CH, 13-CH), 109.1 (CH, 7-CH), 113.7 (CH, 5-CH), 122.3 (CH, 6-CH), 122.6 (C), 
124.0 (C), 127.7 (CH, 2-CH), 129.2 (C), 129.7 (CH), 135.7 (C, 8-C), 147.2 (C, 11-C), 168.2 
(C, 17-C), 205.5 (C, 10-C); MS (ESI) m/z 472.1 ([M+Na]
+
, 100%); HRMS (ESI) m/z 
472.0382 [M+Na]
+
, C20H20NO3NaI requires 472.0386. 
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Bridgehead isocyanate compound (297) 
 
Trichloroacetylisocyanate (19 L, 0.16 mmol) was added to a solution of allylic alcohol 274 
(30 mg, 0.11 mmol) in CH2Cl2 (1 mL) at 0 °C. After 1 h at 0 °C, the solvent was evaporated 
under reduced pressure and the residue was dissolved in a mixture MeOH (711 L) and H2O 
(352 L). The solution was cooled to 0 °C and K2CO3 (44 mg, 0.32 mmol) was added. The 
reaction mixture was allowed to warm to rt and stirred for 3 h. MeOH was evaporated under 
reduced pressure and the mixture was extracted with CH2Cl2 (3  1 mL). The combined 
organic layers were dried over MgSO4 and concentrated under reduced pressure. The crude 
allyl carbamate 296 was dissolved in CH2Cl2 (0.8 mL) and cooled down to 0 °C. Et3N (45 L, 
0.32 mmol) and trifluoroacetic anhydride (15 L, 0.11 mmol) were added sequentially to the 
solution. After 15 min at 0 °C, the reaction was quenched with NH4Cl solution (1 mL of a 
saturated aqueous solution) and extracted with Et2O (3  1 mL). The combined organic layers 
were dried over MgSO4 and concentrated under reduce pressure to furnish isocyanate 297 (5 
mg, 15%) as a white solid; Rf 0.58 (petroleum ether/EtOAc, 70/30); mp 135-136 °C; IR 2920, 
2223, 1713, 1143, 743 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 1.29 (s, 3H, CH3), 1.50 (s, 3H, 
CH3), 2.54-2.64 (m, 1H, 14-CH2), 2.66-2.76 (m, 1H, 14-CH2), 3.01 (dd, J 9.2, 4.8, 1H, 15-
CH), 3.75 (s, 3H, NCH3), 5.51-5.57 (m, 1H, 13-CH), 5.79 (dd, J 9.4, 3.0, 1H, 12-CH), 6.93 (s, 
1H, 2-CH), 7.23-7.26 (m, 2H, 6-CH and 7-CH), 7.36-7.38 (dd, J 5.8, 2.7, 1H, 5-CH); 
13
C 
NMR (100 MHz, CDCl3) δ 28.4 (CH3), 30.0 (CH2, 14-CH2), 33.0 (CH3, NCH3), 33.7 (CH3), 
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37.0 (C, 16-C), 53.8 (CH, 15-CH), 65.9 (C, 11-C), 109.1 (CH, 7-CH), 117.1 (CH, 5-CH), 
120.4 (C), 122.2 (CH, 6-CH), 125.3 (CH, 13-CH), 127.1 (CH, 2-CH), 127.3 (C), 129.9 (C), 
132.3 (C), 134.5 (CH, 12-CH), 137.8 (C, 8-C), 205.6 (C, 10-C); MS (ESI) m/z 329.2 
([M+Na]
+
, 100%); HRMS (ESI) m/z 329.1271 [M+Na]
+
, C19H18N2O2Na requires 329.1266. 
 
Diketoazide compound (276) 
 
AcOH (119 L, 2.08 mmol) was added to a solution of TMSN3 (276 L, 2.08 mmol) in 
CH2Cl2 (2.3 mL) at rt. The mixture was stirred for 20 min and Et3N (12 L, 0.08 mmol) was 
added, followed by a solution of enedione 277 (116 mg, 0.42 mmol) in CH2Cl2 (1.3 mL). The 
resultant solution was stirred for 1 h at rt and concentrated under reduced pressure. The 
residue was purified by column chromatography on silica gel (petroleum ether/EtOAc, 90/10) 
to afford azide 276 (127 mg, 95%) as a white solid; Rf 0.40 (petroleum ether/EtOAc, 70/30); 
mp 153-154 °C; IR υmax  2923, 2115, 1715, 1241, 750 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 
1.33 (s, 3H, CH3), 1.48 (s, 3H, CH3), 2.82-2.85 (m, 2H, 14-CH2), 2.97 (AB system, JA-B 17.0, 
1H, 12-CH2), 3.03 (dd, J 9.0, 6.8, 1H, 15-CH), 3.09 (AB system, JA-B 17.0, 1H, 12-CH2), 3.78 
(s, 3H, NCH3), 7.02 (s, 1H, 2-CH), 7.32 (dd, J 8.1, 1.2, 1H, 7-CH), 7.37 (app t, J 7.7, 1H, 6-
CH), 7.43 (dd, J 7.4, 1.2, 1H, 5-CH); 
13
C NMR (100 MHz, CDCl3) δ 29.1 (CH3), 32.9 (CH3), 
33.1 (CH3), 36.9 (C, 16-C), 42.7 (CH2, 14-CH2), 55.46 (CH2, 12-CH2), 55.48 (CH, 15-CH), 
74.9 (C, 11-C), 110.3 (CH, 7-CH), 118.7 (CH, 5-CH), 119.3 (C), 122.7 (C), 122.9 (CH, 6-
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CH), 127.7 (C), 128.1 (CH, 2-CH), 137.4 (C, 8-C), 204.0 (C), 205.2 (C); MS (ESI) m/z 345.2 
([M+Na]
+
, 100%); HRMS (ESI) m/z 345.1337 [M+Na]
+
, C18H18N4O2Na requires 345.1327. 
 
Aldol compound (309) 
 
A solution of azide 277 (206 mg, 0.64 mmol) in THF (4.5 mL) was added via cannula into a 
solution of LHMDS (1 M solution in THF, 3.2 ml, 3.2 mmol) and TMSCl (0.4 mL, 3.2 mmol) 
in THF (2.3 mL) at -78 °C. After 1 h at -78 °C, the reaction was quenched with NaHCO3 
solution (5 mL of a saturated aqueous solution) and extracted with Et2O (3  5 mL). The 
combined organic layers were dried over MgSO4, filtered and concentrated under reduced 
pressure. Crude 307 was dissolved in CH2Cl2 (1 mL) and CH3CHO (179 L, 3.20 mmol) was 
added. The mixture was cooled to -60 °C and a solution of BF3·Et2O (79 L, 0.64 mmol) in 
CH2Cl2 (0.2 mL) was added via cannula. The reaction mixture was stirred at that maintained 
temperature for 3 h, quenched with NaHCO3 solution (5 mL of a saturated aqueous solution) 
and extracted with Et2O (3  5 mL). The combined organic layers were washed with brine (10 
mL), dried over MgSO4 and evaporated under reduced pressure. The residue was purified by 
column chromatography on silica gel (toluene/Et2O, 80/20) to afford alcohol 309 (101 mg, 
43%) as a white solid; Rf 0.15 (petroleum ether/EtOAc, 70/30); mp 174-176 °C; IR υmax  3506, 
2922, 2118, 1712, 1247, 745 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 1.13 (d, J 6.1, 3H, 18-CH3), 
1.26 (s, 3H, CH3), 1.51 (s, 3H, CH3), 2.72-2.74 (m, 2H, 14-CH2), 2.91 (dd, J 7.3, 1.1, 1H, 12-
CH), 3.08 (dd, J 8.8, 4.8, 1H, 15-CH), 3.77 (s, 3H, NCH3), 3.84 (d, J 3.5, 1H, OH), 4.04-4.16 
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(m, 1H, 17-CH), 7.00 (s, 1H, 2-CH), 7.31 (dd, J 7.9, 1.5, 1H, 7-CH), 7.37 (app t, J 7.6, 1H, 6-
CH), 7.43 (dd, J 7.3, 1.5, 1H, 5-CH); 
13
C NMR (100 MHz, CDCl3) δ 21.0 (CH3, 18-CH3), 
28.6 (CH3), 33.1 (CH3), 33.2 (CH3), 36.7 (C, 16-C), 41.0 (CH2, 14-CH2), 55.6 (CH, 15-CH), 
67.2 (CH, 12-CH), 71.8 (CH, 17-CH), 78.7 (C, 11-C), 110.6 (CH, 7-CH), 118.8 (CH, 5-CH), 
119.0 (C, 3-C), 122.1 (C, 9-C), 123.0 (CH, 6-CH), 126.9 (C, 4-C), 127.8 (CH, 2-CH), 137.5 
(C, 8-C), 204.7 (C), 205.0 (C); MS (ESI) m/z 389.2 ([M+Na]
+
, 100%); HRMS (ESI) m/z 
389.1591 [M+Na]
+
, C20H22N4O3Na requires 389.1590. 
  
Enone compound (306) 
 
Tf2O (92 L, 0.55 mmol) and pyridine (44 L, 0.55 mmol) were successively added to a 
solution of alcohol 309 (40 mg, 0.11 mmol) in CH2Cl2 (2 mL) at 0 °C. The mixture was 
stirred 30 min at this temperature, quenched with NaHCO3 solution (3 mL of a saturated 
aqueous solution) and extracted with CH2Cl2 (3  2mL). The combined organic layers were 
washed with brine (5 mL), dried over MgSO4 and concentrated under reduced pressure. The 
residue was purified by column chromatography on silica gel (petroleum ether/EtOAc, 95/5) 
to provide enone 306 (16 mg, 42%) as a white solid; Rf 0.45 (petroleum ether/EtOAc, 90/10); 
mp 180-182 °C; IR υmax  2919, 2109, 1717, 1689, 1258, 743 cm
-1
; 
1
H NMR (400 MHz, 
CDCl3) δ 1.39 (s, 3H, CH3), 1.42 (s, 3H, CH3), 2.14 (d, J 7.5, 3H, 18-CH3), 2.76-2.83 (m, 2H, 
14-CH2), 2.92 (app t, J 8.5, 1H, 15-CH), 3.75 (s, 3H, NCH3), 6.91 (q, J 7.5, 1H, 17-CH), 7.02 
(s, 1H, 2-CH), 7.22-7.33 (m, 3H); 
13
C NMR (100 MHz, CDCl3) δ 16.3 (CH3, 18-CH3), 30.0 
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(CH3), 32.3 (CH3, NCH3), 33.1 (CH3), 37.4 (C, 16-C), 42.4 (CH2, 14-CH2), 54.2 (CH, 15-
CH), 80.0 (C, 11-C), 109.8 (CH, 7-CH), 119.3 (C), 120.0 (CH, 5-CH), 122.3 (CH, 6-CH), 
123.2 (C), 127.5 (C), 128.4 (CH, 2-CH), 136.2 (C), 137.0 (C), 140.5 (CH, 17-CH), 196.9 (C), 
203.3 (C); MS (ESI) m/z 371.1 ([M+Na]
+
, 100%); HRMS (ESI) m/z 371.1491 [M+Na]
+
, 
C20H20N4O2Na requires 371.1484. 
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1
H NMR of tetracycle 182 
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13
C NMR of tetracycle 182 
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1
H NMR of silylated bridgehead 262 
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13
C NMR of silylated bridgehead 262 
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1
H NMR of bridgehead selenide 282 
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13
C NMR of bridgehead selenide 282 
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1
H NMR of bridgehead alkene 275 
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13
C NMR of bridgehead alkene 275 
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1
H NMR of allylic alcohol 274 
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13
C NMR of allylic alcohol 274 
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1
H NMR of enedione 277 
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13
C NMR of enedione 277 
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1
H NMR of diketoazide 276 
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1
H NMR of diketoazide 276 
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1
H NMR of diketoazide 309 
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13
C NMR of diketoazide 309 
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